UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A
(RULE 14a-101)
INFORMATION REQUIRED IN PROXY STATEMENT

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a)

of
the
Securities Exchange Act of 1934

Filed by the Registrant

Filed by a Party other than the Registrant

Check the appropriate box:

Preliminary Proxy Statement
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
Definitive Proxy Statement
Definitive Additional Materials
Soliciting Material Pursuant to §240.14a-12
§240.14a-12

DYNATRONICS CORPORATION

(Name of Registrant as Specified in itsIn Its Charter)

(Name of Person(s) Filing Proxy Statement if Other Than the Registrant)

Payment of Filing Fee (Check the appropriate box):

No fee required.
Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.
(1)Title of each class of securities to which transaction applies:
(2)Aggregate number of securities to which transaction applies:
(3)Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
(4)Proposed maximum aggregate value of transaction:
(5)Total fee paid:
required
Fee paid previously with preliminary materials.
materials
Check box if any part of the fee is offset as providedFee computed on table in exhibit required by Item 25(b) per Exchange Act Rule 0-11(a)(2)Rules 14a-6(i)(1) and identify the filing for which the offsetting fee was paid previously.
Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
(1)Amount Previously Paid:
(2)Form, Schedule or Registration Statement No.:
(3)Filing Party:
(4)Date Filed:0-11

i

TABLE OF CONTENTS
Page
Chairman's Letteriii
Notice of Annual Meeting of Shareholdersiv
Proxy Statement1
Purpose of Meeting1
Additional Information About the Meeting1
Proxy Solicitation and Costs4
Proposal No. 1 - Election of Directors5
Executive Officers, Corporate Governance6
Director Compensation11
Executive Officers12
Executive Compensation13
Summary Compensation Table14
Outstanding Equity Awards as of Fiscal Year-End 201715
Security Ownership of Certain Beneficial Owners and Management16
Section 16(a) Beneficial Ownership Reporting Compliance19
Certain Relationships and Related Transactions19
Proposal No. 2 - Ratification of Appointment of Independent Registered Public Accounting Firm20
Changes in Certifying Accountant20
Principal Accountant Fees and Services21
Report of the Audit Committee22
Proposal No. 3 – Issuance of Shares in Connection with Acquisition of Bird & Cronin22
Information About the Acquisition26
Risk Factors30
Additional Information About Bird & Cronin33
Management's Discussion and Analysis of Financial Condition and Results of Operations of Bird & Cronin33
Unaudited Pro Forma Financial Information36
Special Note Regarding Forward-Looking Information36
Shareholder Proposals for the 2018 Annual Meeting of Shareholders36
Shareholders Sharing the Same Address37
Annual Report on Form 10-K37
Other Business37
Attachment A – Compensation Committee Charter
Attachment B – Audit Committee Charter
Attachment C – Financial Statements of Bird & Cronin, Inc.
Attachment D – Proforma Financial Statements
ii

DYNATRONICS CORPORATION

7030 Park Centre Drive
Cottonwood Heights,

1200 Trapp Road

Eagan, MN 55121

October 24, 2023

Dear Dynatronics Shareholders:

On behalf of Dynatronics Corporation, a Utah 84121

(801) 568-7000
October [●], 2017
Dear Shareholder:
You arecorporation, I cordially invitedinvite you to attend the 2017 Annual Meeting of Shareholders of Dynatronics Corporation that will be held on Wednesday, November 29, 2017,Thursday, December 7, 2023 at 3:8:00 p.m. Mountaina.m. Central Time at our corporate headquartersprincipal executive offices located at 7030 Park Centre Drive, Cottonwood Heights, Utah.
Details of1200 Trapp Road, Eagan, Minnesota 55121. In addition, prior to the businessMeeting, we encourage you to be conducted atvote online by following the meeting are contained ininstructions provided on the accompanying Notice of Internet Availability of Proxy Materials described below.

As part of our efforts to conserve environmental resources and prevent unnecessary corporate expense, we are using the "Notice and Access" method of providing proxy materials to you via the Internet pursuant to the regulations promulgated by the U.S. Securities and Exchange Commission. We believe that this process will provide you with a safe, convenient and efficient way to access your proxy materials and vote your shares, while also allowing us to conserve natural resources and reduce the costs of printing and distributing the proxy materials for the Annual Meeting and the Proxy Statement.

We will be mailing a Proxy Statement and voting materials to shareholders onby postal mail. On or about October 24, 2017. Those materials include2023 we are mailing to our shareholders a one-page Notice of Internet Availability of Proxy Materials (the "Notice") containing instructions on how you mayto access our Proxy Statement and vote your shares overelectronically via the Internet or by mail, by telephone ortelephone. The Notice will also contain instructions on how to receive a paper copy of your proxy materials.

We will be conducting the business outlined and described in person.detail in the Notice and the accompanying Proxy Statement. We have also made a copy of our Annual Report on Form 10-K for the year ended June 30, 2023 ("Annual Report") available with the Proxy Statement. We encourage you to read our Annual Report. It includes our audited financial statements and provides information about our business.


Your vote is very important to us. Whether or not you plan to attend the Annual Meeting, please carefully review the accompanying Proxy Statement and then cast your vote by Internet, telephone or postal mail as soonpromptly as possible. Every vote is important. As an alternative to voting in personpossible so that your shares will be represented and voted at the Annual Meeting,Meeting. Please refer to the Notice for instructions on submitting your vote. Our Board of Directors has unanimously approved the proposals set forth in the accompanying Proxy Statement and we recommend that you may vote via the Internet, by telephone or by mailing the completed Proxy Card. Voting by anyin favor of these methods will ensureeach such proposal.

Thank you for your vote is represented at the Annual Meeting.

support of Dynatronics. We look forward to seeing youyour participation at the Annual Meeting.

 Sincerely, yours,
  
 /s/ Brian Baker     
 
/s/ Kelvyn H. Cullimore, Jr.
Brian Baker
 Kelvyn H. Cullimore, Jr.
Chairman, President and CEOChief Executive Officer
Cottonwood Heights, Utah
October [•], 2017 
YOUR VOTE IS IMPORTANT
In order to ensure your representation at the Annual Meeting, you may submit your proxy and voting instructions via the Internet, by telephone or by mail by completing, signing and dating the Proxy Card as promptly as possible and returning it in the enclosed envelope (to which no postage need be affixed if mailed in the United States). Please refer to the section entitled "Voting via the Internet, by Telephone or by Mail" on page 3 of the Proxy Statement for a description of these voting methods. If your shares are held by a bank, brokerage firm or other holder of record (your record holder) and you have not given your record holder instructions to do so, your record holder will NOT be able to vote your shares with respect to any matter other than ratification of the appointment of Dynatronics' independent registered public accounting firm. We strongly encourage you to vote.


iii

DYNATRONICS CORPORATION

NOTICE OF 2023 ANNUAL MEETING OF SHAREHOLDERS

To be held November 29, 2017
TO OUR SHAREHOLDERS:
The 2017 AND PROXY STATEMENT

DYNATRONICS CORPORATION

Annual Meeting of Shareholders

December 7, 2023

8:00 a.m. Central Time

1200 Trapp Road

Eagan, Minnesota 55121

To the Shareholders of Dynatronics Corporation:

Notice ofMeeting - We are pleased to invite you to attend the 2023 Annual Meeting of Shareholders (the "Annual Meeting" or "Meeting") of Dynatronics Corporation, a Utah corporation (the "Company," "us," "we" or "our"), on December 7, 2023, at 8:00 a.m. Central Time. The Annual Meeting will be held at our corporate headquartersprincipal executive offices located at 7030 Park Centre Drive, Cottonwood Heights, Utah, on Wednesday, November 29, 2017, at 3:00 p.m. Mountain Time for1200 Trapp Road, Eagan, Minnesota 55121.

Items ofBusiness - At the Annual Meeting, we will conduct the following purposes, all as more fully describedbusiness:

1. Elect the three director nominees named in the accompanying Proxy Statement:

1.To elect three directors to hold office until the next annual meeting of the Company's shareholders or until their respective successors have been elected or appointed and qualified;
2.To ratify on an advisory basis the appointment of Tanner LLC as our independent registered public accounting firm for the fiscal year ending June 30, 2018;
3.To approve, for purposes of complying with NASDAQ Listing Rule 5635, the issuance of shares of our common stock (or securities convertible into or exercisable for common stock) representing more than 19.99% of the outstanding common stock or voting power of the Company, including the issuance of common stock upon conversion of the Company's Series C Non-Voting Convertible Preferred Stock and Series D Non-Voting Convertible Preferred Stock and the exercise of warrants, issued in connection with the acquisition of Bird & Cronin, Inc.; and
4.To transact such other business that properly comes before the Annual Meeting or any adjournment or postponements thereof.
These itemsStatement to our board of directors (the "Board"), each to serve until our next annual meeting of shareholders and until her or his successor is duly elected and qualified, or until the director's earlier resignation, removal or death;

2. Ratify the appointment of Tanner LLC as our independent registered public accounting firm for the fiscal year ending June 30, 2024;

3. Approve a resolution authorizing the Board to effect a reverse stock split of our common stock at a ratio of not less than one-for-five and not more than one-for-ten at any time within one year from the date of shareholder approval, in the sole discretion of the Board, pursuant to an amendment to our Articles of Incorporation; and

4. Consider and transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.

The foregoing proposals are more fully described in the attached Proxy Statement.

The Board recommends that you vote your shares "FOR" each of the director nominees included in Proposal 1 and "FOR" Proposals 2 and 3.

Notice and Access - We have elected to provide access to our proxy materials primarily electronically via the Internet, pursuant to the "Notice and Access" method regulations promulgated by the U.S. Securities and Exchange Commission (the "SEC"). We believe this method expedites our shareholders' receipt of proxy materials, conserves natural resources and significantly reduces the costs of the Annual Meeting. On or about October 24, 2023, we will begin mailing a one-page Notice of Internet Availability of Proxy Materials (the "Notice") to each of our shareholders entitled to notice of and to vote at the Annual Meeting, which Notice contains instructions for accessing the attached Proxy Statement, our Annual Report on Form 10-K for our fiscal year ended June 30, 2023 (the "Annual Report") via the Internet, as well as voting instructions. The Notice also includes instructions on how you can receive a paper copy of your proxy materials. The Proxy Statement and the Annual Report are both available on the Internet at:www.proxyvote.com.

RecordDate for determining those shareholders whoandNotice - You are entitled to receive notice of attend, and to vote at the Meeting if you were a shareholder of record holding shares of any of our voting securities (our common stock, Series A 8% Convertible Preferred Stock, or Series B Convertible Preferred Stock) as of the close of business on October 10, 2023 (the date fixed as the record date for determining those shareholders eligible to receive notice of and entitled to vote at the Annual Meeting andor any adjournmentsadjournment or postponements ofpostponement thereof) (the "Record Date"). For 10 days prior to the Annual Meeting, is October 16, 2017. The stock transfer books will not be closed between the Record Date and the date of the Annual Meeting. Aa complete list of shareholders entitled to vote at the Annual Meeting will be available for inspectionexamination by any shareholder, for any purpose relating to the Annual Meeting, during ordinary business hours at our principal executive offices located at 1200 Trapp Road, Eagan, Minnesota 55121. This list will also be available for examination by shareholders of record during the address listed above.

Whether or not you planMeeting.


You are entitled to attend the Annual Meeting please voteonly if you were a shareholder as soonof the close of business on the Record Date or hold a valid proxy for the Annual Meeting. If you are a shareholder of record, your ownership as possible. Asof the Record Date will be verified prior to admittance into the Annual Meeting. If you are not a shareholder of record but hold shares through a broker, trustee or nominee, you must provide proof of beneficial ownership as of the Record Date, such as an alternativeaccount statement or similar evidence of ownership, to voting in person atattend the Annual Meeting. Further information about how to attend the Annual Meeting and vote your shares is included in the accompanying Proxy Statement. For instructions on how to vote your shares, please refer to the instructions on the Notice you mayreceived by postal mail, the section titled "Voting" beginning on page 1 of the Proxy Statement or, if you requested to receive printed proxy materials, your enclosed proxy card.

Voting - Your vote is very important to us. Whether or not you expect to attend the Annual Meeting, we urge you to vote your shares in advance of the Meeting, as promptly as possible, online via the Internet, by telephone or by mailingpostal mail so that your shares may be represented and voted at the Meeting. If your shares are held in the name of a completed Proxy Card tobank, broker, brokerage firm or other fiduciary, please follow the Company.instructions on the voting instruction card furnished by the record holder. Telephone and Internet voting are available. You may also vote by mail by requesting a paper copy of our proxy materials. For detailed information regardingspecific instructions on voting, instructions, please refer to the section entitled "Voting viainstructions in the Internet, by TelephoneNotice. If you hold your shares through an account with a brokerage firm, bank or by Mail"other nominee, please follow the instructions you receive from them to vote your shares.

Adjournments andPostponements - Any action on page 3the items of business described above may be considered at the Proxy Statement. You may revoke a previously delivered proxyAnnual Meeting at the time and on the date specified above or at any time priorand date to the Annual Meeting. If you decide to attendwhich the Annual Meeting may be properly adjourned or postponed.

By Order of the Board of Directors,

/s/ Brian Baker

Brian Baker

President and wish to change your proxy vote, you may do so automatically by voting in person at the Annual Meeting.

Chief Executive Officer

CONTENTS

NOTICE OF 2023 ANNUAL MEETING OF SHAREHOLDERS AND PROXY STATEMENTBY ORDER1
IMPORTANT NOTICE REGARDING AVAILABILITY OF PROXY MATERIALS1
Record Date and Shares Outstanding1
Quorum1
Shareholder List1
Attendance at Annual Meeting1
Voting2
Proposals and Required Vote for Approval2
Abstentions and Broker Non-Votes3
Proxies and Revocation of Proxies 3
Solicitation4
Voting Results4
Questions4
PROPOSAL NO. 1 ELECTION OF DIRECTORS5
General5
Vote required5
Nominees for Director5
Business Experience and Qualifications of Nominees5



Recommendation of the Board6
INFORMATION REGARDING THE BOARD OF DIRECTORS6
General Information6
Preferred Directors7
Family Relationships8
Director Attendance at the Annual Meeting8
Director Compensation8
Director Compensation Table - Fiscal 20239
CORPORATE GOVERNANCE9
Independence of the Board of Directors9
Board Leadership Structure10
Role of the Board in Risk Oversight10
Communications with the Board of Directors11
Meetings of the Board of Directors11
Executive Sessions11
Information Regarding Committees of the Board of Directors11
Audit Committee12
Compensation Committee12
Nominating and Governance Committee13
Code of Ethics14
Prohibition against Pledging Dynatronics Securities and Hedging Transactions14
Corporate Governance Guidelines14
Board Diversity Matrix14
Audit Committee Report for Fiscal 202315
REPORT OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS15
PROPOSAL NO. 2 - RATIFICATION OF SELECTION OF TANNER LLC AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR FISCAL 202416
General16
Vote Required
/s/ Kelvyn H. Cullimore, Jr.
16
IndependenceKelvyn H. Cullimore, Jr.17
Principal Accountant Fees and ServicesChairman, President17
Pre-approval Policies and CEOProcedures17
Recommendation of the Board17
PROPOSAL NO. 3 -APPROVAL OF A REVERSE STOCK SPLIT18
General18
Vote Required18
Reasons for the Reverse Split Proposal18
Board Discretion to Implement the Reverse Stock Split19
Effect of a Reverse Stock Split20
Anti-Takeover and Dilutive Effects23
Certain Risks Associated with the Reverse Stock Split23
Fractional Shares25
No Dissenters' Rights25
U.S. Federal Income Tax Consideration26
Accounting Consequences26
Procedure for Effecting the Reverse Stock Split26
Exchange of Stock Certificates27
Book-Entry27
Interests of Directors and Executive Officers28
Recommendation of the Board28
EXECUTIVE COMPENSATION28
Executive Officers28
Summary Compensation Table28
Our Compensation Objectives28
2023 Summary Compensation Table29
Outstanding Equity Awards at June 30, 202329
Cottonwood Heights, Utah
October [•], 2017
iv



Employment Agreements30
Payments upon Termination31
Retirement Benefits31
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDERS MATTERS32
Security Ownership of Certain Beneficial Owners and Management32
Beneficial Ownership Table33
Securities Authorized for Issuance Under Equity Compensation Plans34
Certain Relationships and Related Transactions36
SHAREHOLDER PROPOSALS FOR 2024 ANNUAL MEETING OF SHAREHOLDERS36
HOUSEHOLDING OF PROXY MATERIALS36
OTHER MATTERS37


DYNATRONICS CORPORATION

1200 Trapp Road

Eagan, Minnesota 55121

Telephone (801) 568-7000

PROXY STATEMENT

FOR

2017 THE 2023 ANNUAL MEETING OF SHAREHOLDERS
NOVEMBER 29, 2017
This Proxy Statement contains information regarding

December 7, 2023

The enclosed proxy is solicited on behalf of the 2017 Annual MeetingBoard of ShareholdersDirectors (the "Board") ofDynatronics Corporation, a Utah corporation ("Dynatronics(sometimes referred to as the "Company," "we," "us," or "our"), for use at our 2023 Annual Meeting of Shareholders (the "Annual Meeting" or the "CompanyMeeting"), to at 8:00 a.m. Central Time on December 7, 2023. The Annual Meeting will be held at 3:00 p.m. Mountain Time on Wednesday, November 29, 2017, at our corporate headquarters, 7030 Park Centre Drive, Cottonwood Heights, Utah andlocated at any postponements or adjournments thereof. These1200 Trapp Road, Eagan, Minnesota 55121.

IMPORTANT NOTICE REGARDING AVAILABILITY OF PROXY MATERIALS

We have elected to provide access to the proxy materials were first being sent or made available to our shareholders onfor the Annual Meeting primarily over the Internet in accordance with the U.S. Securities and Exchange Commission's ("SEC") "Notice and Access" rules. On or about October 24 2017.

PURPOSE OF MEETING
The business of the 2017 Annual Meeting will be to:
·
Elect three members of our board of directors ("Board of Directors" or "Board") to hold office until the next annual meeting of shareholders or until their respective successors have been elected and qualified ("Proposal No. 1");
·
Ratify the appointment of Tanner LLC as the Company's independent registered public accounting firm for the fiscal year ending June 30, 2018 ("Proposal No. 2");
·
Approve, for purposes of complying with NASDAQ Listing Rule 5635(a), which requires shareholder approval prior to the issuance of securities in connection with an acquisition of the stock or assets of another company where the total number of shares of common stock to be issued is or will be equal to or in excess of 20% of the total number of shares of common stock outstanding before the issuance of the stock or securities ("Proposal No. 3"); and
·Act upon such other matters as may properly come before the Annual Meeting or any adjournments or postponements thereof.
Recommendations of the Board of Directors
The Board of Directors recommends that you vote:
·
FOR each of the nominees of the Board of Directors;
·
FOR the ratification of the appointment of Tanner LLC as the Company's independent registered public accounting firm for fiscal year 2017; and
·
FOR approval of Proposal No. 3.
ADDITIONAL INFORMATION ABOUT THE MEETING
Date, Time and Place
The Board of Directors has called our 2017 Annual Meeting to be held at the Company's Corporate Headquarters, 7030 Park Centre Drive, Cottonwood Heights, Utah, at 3:00 p.m. (Mountain Standard Time) on Wednesday, November 29, 2017. Registration for shareholders, 2023, we will begin at 2:30 p.m. at that location.
Solicitationmailing a one-page Notice of ProxiesInternet Availability of Proxy Materials (the "Notice") to each of our shareholders entitled to notice of and Proxy Materials
Our Board of Directors is soliciting yourto vote forat the Annual Meeting. We inviteThe Notice contains instructions for accessing this Proxy Statement, our Annual Report on Form 10-K for our fiscal year ended June 30, 2023 ("Annual Report") and Annual Meeting voting instructions. The Notice also includes instructions on how you can receive a paper copy of your proxy materials by postal mail.This Proxy Statement and the Annual Report are available on the Internet at: www.proxyvote.com.

References in this Proxy Statement to fiscal years refer to our fiscal year ended June 30 of the referenced year. For example, "fiscal 2022" refers to the fiscal year ended June 30, 2022, "fiscal 2023" refers to the fiscal year ended June 30, 2023, and "fiscal 2024" refers to the fiscal year ending June 30, 2024.

Record Date and Shares Outstanding. The specific proposals to be considered and acted upon at the Annual Meeting and request that you vote on the election of directors and other proposalsare each described in this Proxy Statement. RegardlessOnly holders of whether you intend to attend the Annual Meeting, we ask that you complete your Proxy Cardour voting securities (common stock, Series A 8% Convertible Preferred Stock ("Series A Preferred"), or Voting Instruction Card,Series B Convertible Preferred Stock ("Series B Preferred")) as the case may be, or otherwise vote electronically as described in the Proxy Statement. The Board has made information available to you in conjunction with our Annual Meeting, including the Letter to Shareholders, Notice of Annual Meeting, this Proxy Statement, Proxy Card and our Annual Report on Form 10-K. We will furnish a copy of an exhibit to the Annual Report to a shareholder upon written request to us and payment of a fee to cover our expenses in furnishing that exhibit.

1

Record Date
The Board has chosen the close of business on October 16, 2017,10, 2023 (the "Record Date") are entitled to notice of and to vote at the Annual Meeting. On the Record Date, there were 4,530,837 shares of common stock outstanding and entitled to vote at the Annual Meeting (including shares of Series A Preferred and Series B Preferred on an as-converted basis), held by 382 holders of record. The Series A Preferred and Series B Preferred are sometimes referred to in this Proxy Statement collectively as the record date"Voting Convertible Preferred Stock."

Quorum.In order for our 2017any business to be conducted at the Annual Meeting, ("Record Date"). All shareholders who ownthe holders of a majority of the issued and outstanding shares of Company common stock, no par value ("Common Stock") or our Series A 8%the applicable voting group entitled to vote (including, as applicable, the Voting Convertible Preferred Stock ("Series A Preferred Stock") or Series B Convertible Preferred Stock ("Series B Preferred Stock")on an as-converted basis, as indicated above) as of the Record Date may attend and votemust be present, in person or by proxy, at ourthe Annual Meeting.

Shareholders This is a "quorum." If a quorum is not present at the scheduled time of Recordthe Annual Meeting, the shareholders who are present may adjourn the Annual Meeting until a quorum is present. The time and Beneficial Owners
place of the adjourned Annual Meeting will be announced at the time the adjournment is taken, and no other notice will be given. An adjournment will have no effect on the business that may be conducted at the Annual Meeting.

Shareholder List.A shareholder may hold shares through a broker, bank or other nominee rather than directly inlist of registered shareholders as of the shareholder's own name. As summarized below, there are some differences between shares heldclose of record and those owned beneficially.

·
Shareholder of Record. If your shares are registered directly in your name with our transfer agent, Interwest Transfer Co, Inc. ("Interwest"), you are considered the shareholder of record with respect to those shares and these proxy materials are being sent directly to you. As the shareholder of record, you have the right to grant your voting proxy directly to us, to vote electronically or to vote in person at our Annual Meeting.
·
Beneficial Owner. If your shares are held in a stock brokerage account or by a bank or other nominee, you are considered the beneficial owner of the shares held in "street name," and the proxy materials are being forwarded to you by your broker, bank or nominee who is considered the shareholder of record with respect to those shares. As a beneficial owner, you have the right to direct your broker, bank or nominee on how to vote and are also invited to attend our Annual Meeting. However, since you are not the shareholder of record, you may not vote these shares in person at our Annual Meeting, unless you request, complete and deliver a legal proxy from your broker, bank or nominee. Your broker, bank or nominee will provide you a voting instruction card for use in directing them as to how to vote your shares.
Voting Rights
Only shareholders of record of Dynatronics Common Stock, Series A Preferred Stock, and Series B Preferred Stockbusiness on the Record Date will be entitledopen for examination by any shareholder for a period of 10 days prior to receive noticethe Annual Meeting for a purpose pertaining to the Annual Meeting at our corporate headquarters at 1200 Trapp Road, Eagan, Minnesota 55121.

Attendance at Annual Meeting.The Annual Meeting will be held at our corporate headquarters at 1200 Trapp Road, Eagan, Minnesota 55121, at 8:00 a.m., Central Time on December 7, 2023.


Voting.Shareholders may vote using one of attend,the following four methods:

If you hold shares in street name, the organization holding your account is considered the shareholder of record for purposes of voting at the Annual Meeting. The shareholder of record will provide you with instructions on how to ensure your shares are voted according to your directions. Internet and telephone voting will be offered to shareholders owning shares through most brokerage firms and banks. Additionally, if you would like to vote in person at the Annual Meeting, contact the brokerage firm, bank or other nominee who holds your shares to obtain a proxy from them and bring it with you to the Annual Meeting. You will not be able to vote at the Annual Meeting. Each holderMeeting unless you have a proxy from your brokerage firm, bank or other nominee.

You may vote at the Annual Meeting if you owned shares of any of our common stock or Voting Convertible Preferred Stock as of the close of business on the Record Date. These shares vote as follows:

Common Stock. Holders of record of Common Stock will beshares of common stock are entitled to one vote for each share of Common Stock held oncommon stock owned by them as of the Record Date.

Voting Convertible Preferred Stock. Holders of record of shares of Series A Preferred Stock and Series BVoting Convertible Preferred Stock vote those shares on an as-converted to common stock basis, one vote for each share of Common Stockcommon stock issuable upon an assumed conversion of the preferred stock; Voting Convertible Preferred Stock;provided,however, that the voting rights of some holders of the preferred stock may beVoting Convertible Preferred Stock are subject to limitations pursuant to a rule of The NASDAQ Stock Market ("NASDAQ") referred to as thea "Voting Cutback." The Voting Cutback limits the number of "as-if-converted common shares" that may be voted by asuch shareholder to the number of shares of Common Stockcommon stock issuable upon conversion of the preferred stockVoting Convertible Preferred Stock held by such holder that exceedsequals the quotient of (x) the aggregate purchase price paid by such holder of preferred stockthe Voting Convertible Preferred Stock for its preferred stock,the shares of Voting Convertible Preferred Stock, divided by (y) the greater of (i) $2.50 and (ii) the market price of the Common Stockcommon stock on the trading day immediately prior to the date of issuance of suchthe holder's preferred stock.

TheVoting Convertible Preferred Stock (in each case subject to proportionate adjustments to reflect applicable stock splits, stock dividends, combinations or other proportionate recapitalizations).

As of the Record Date, the total number of shares of common stock issued and outstanding Common Stock (including as-converted Series AVoting Convertible Preferred Stock and Series B Preferred Stock) as of the Record Date entitled to vote at the Annual Meeting is 7,808,926 5,103,556 shares (after taking into consideration the applicable Voting Cutback). This number includes 4,823,6944,530,837 shares of Common Stock, 2,000,000common stock, 398,400 shares of Series A Preferred Stock (1,636,130(325,627 shares "as-converted" voting power after the applicable Voting Cutback), and 1,484,000271,800 shares of Series B Preferred Stock (1,349,091(247,092 shares "as-converted" voting power after the applicable Voting Cutback).

Cumulative voting is not permitted, and shareholders are not entitled to appraisal or dissenters' rights with respect to any matter to be voted on at the Annual Meeting.

Proposals and Required Vote for Approval. You will be voting on each of the following:


The required vote for each of these proposals is as follows:

Proposal No. 1: Election of Directors. The three director nominees who receive the greatest number of votes cast at the Annual Meeting by the shares present, either in person or by proxy, and entitled to vote will be elected to serve on our Board until our 2024 annual meeting or shareholders, or until her or his successor is duly elected and qualified. The election of directors requires the affirmative vote of a plurality of the voting shares present or represented by proxy and entitled to vote at the Annual Meeting.

Admission Unless otherwise instructed or unless authority to Meeting
You are entitled to attendvote is withheld, shares represented by executed proxies will be voted "FOR" the Annual Meeting andelection of the nominees. 

Proposal No. 2: Ratification of Appointment of our Independent Registered Public Accounting Firm. The affirmative "FOR" vote of a majority of the shares cast on the proposals presentedthis proposal at the Annual Meeting if you were a shareholder of record or a beneficial owner of our Common Stock, Series A Preferred Stock, or Series B Preferred Stock as of October 16, 2017, the Record Date, or you hold a valid legal proxyis required for the Annual Meeting. If you attend the Annual Meeting, you may be asked to present valid picture identification, such as a driver's license or passport, for admission to the Annual Meeting. In addition, if your shares are registered in the name of a bank, brokerage firm or other holder of record (your record holder), you may be asked to provide proof of beneficial ownership as of the Record Date, such as a brokerage account statement or voting instruction form provided by your record holder, or other similar evidence of ownership, as well as picture identification, for admission. If you wish to be able to vote in person at the Annual Meeting, you must obtain a legal proxy from your brokerage firm, bank or other holder of record and present it to the inspector of elections with your ballot at the Annual Meeting.

2

Registration will begin at 2:30 p.m. Mountain Time on the date of the Annual Meeting. If you do not provide picture identification and comply with the other procedures outlined above, you may not be admitted to the Annual Meeting. We recommend that you arrive early to ensure that you are seated by the commencement of the Annual Meeting.
Quorum
A quorum is the minimum number of shares that must be present at the Annual Meeting to conduct business. The presence at the Annual Meeting, in person or by proxy, of the holders of at least 3,904,464 shares of Common Stock (including the Series A Preferred Stock and Series B Preferred Stock on an as converted basis, subject, as the case may be, to the Voting Cutback) entitled to vote at the meeting will constitute a quorum. In general, shares represented by a properly signed and returned Proxy Card will be counted as shares present and entitled to vote at the meeting for purposes of determining a quorum. Abstentions will be counted as "represented" for the purpose of determining the presence or absence of a quorum, but will not be counted for any other purpose. Inasmuch as street name holders have discretionary voting rights with respect to Proposal No. 2, ratification of the appointmentselection of Tanner LLC ("Tanner") as our independent registered public accounting firm broker non-votes (as explained below) will also be counted as "represented" for our current fiscal year.

Proposal No. 3: Approval of Resolution Authorizing the purpose of determining the presence or absenceBoard to Effect Reverse Stock Split. The affirmative "FOR" vote of a quorum for all purposesmajority of the Annual Meeting.

Voting via the Internet, by Telephone or by Mail
Holders of shares of Dynatronics Common Stock whose shares are registered in their own name with Dynatronics' transfer agent, Interwest, are record holders. As an alternative to voting in personvotes cast on this proposal at the Annual Meeting recordby the holders may vote viaof our Common Stock, voting separately as a voting group, and by a majority of the Internet, by telephone or by mailing a completed Proxy Card.
Instructions for voting via the Internet, telephone or by mail are set forthvotes cast on the Proxy Card. If you are a shareholder who elects to vote by mail, you should sign and mail the Proxy Card in the addressed, postage paid envelope that was enclosed with the proxy materials, and your shares will be votedthis proposal at the Annual Meeting and  by the holders of our Common Stock and Voting Convertible Preferred Stock, voting together as a single voting group, is required for the approval of a resolution authorizing the Board to effect a reverse stock split of the our common stock at a ratio of not less than one-for-five and not more than one-for-ten at any time within one year from the date of shareholder approval, in the manner you direct. In the event that you return a signed Proxy Card on which no directions are specified, your shares will be voted FOR each of the nomineessole discretion of the Board, pursuant to amendment to our Articles of Directors (Proposal No. 1); FOR the ratificationIncorporation.

As of the appointmentdate of Tanner LLC as Dynatronics' independent registered public accounting firm forthis Proxy Statement, the fiscal year ended June 30, 2018 (Proposal No. 2); FOR approvalBoard knows of no other matters to be brought before the issuance of shares of our common stock (or securities convertible into or exercisable for common stock) representing more than 19.99% of the outstanding common stock or voting power of the CompanyAnnual Meeting.

Broker Non-Votes. Brokers are prohibited in connection with the acquisition of Bird & Cronin, Inc. ("Bird & Cronin") as described in this Proxy Statement (Proposal No. 3); and in the discretion of the proxy holders as to any other matters that may properly come before the Annual Meeting or any postponement or adjournment of the Annual Meeting.

Dynatronics shareholders whose shares arenon-routine proposals from exercising discretionary authority for beneficial owners who have not registered in their own name with Interwest are beneficial holders of shares held in street name. Such shares may be held in an account at a bank or at a brokerage firm (your record holder). As the beneficial holder, you have the right to direct your record holder on how to vote your shares, and you will receive instructions from your record holder that must be followed in order for your record holder to vote your shares per your instructions. Many banks and brokerage firms have a process for their beneficial holders to provide instructions via the Internet or by telephone. Shares held beneficially in street name may be voted by you in person at the Annual Meeting only if you obtain a legal proxy from your record holder giving you the right to vote such shares in person at the Annual Meeting.
Revocation of Proxies
You may revoke or change a previously delivered proxy at any time before the Annual Meeting by delivering another proxy with a later date, by voting again via the Internet or by telephone, or by delivering written notice of revocation of your proxy to our Corporate Secretary at the Company's principal executive offices before the beginning of the Annual Meeting. You may also revoke your proxy by attending the Annual Meeting and voting in person, although attendance at the Annual Meeting will not, in and of itself, revoke a valid proxy that was previously delivered. If you hold shares through a bank or brokerage firm, you must contact that bank or brokerage firm to revoke any prior voting instructions. You also may revoke any prior voting instructions by voting in person at the Annual Meeting if you obtain a legal proxy as described under "Admission to Meeting" above.
3

Vote Required
In the election of directors, a nominee who receives a plurality of the votes cast at the Annual Meeting will be elected as a director. The "plurality" standard means the three nominees who receive the largest number of "FOR" votes will be elected. The number of shares not voted for the election of a nominee are not counted and will not affect the determination of whether that nominee has received the necessary votes for election under Utah law. Votes that are withheld will not be included in the vote tally for the election of directors. Shareholders may not cumulate votes in the election of directors.
If a quorum is present, each of the other proposals will be approved if the votes cast for the proposal exceed the votes cast against it.
Voting of Proxies
Your shares will be voted as you direct on your Proxy Card. If you do not specify on your Proxy Card how you want to vote your shares, we will vote signed returned proxies FOR each nominee for director, FOR Proposal No. 2, and FOR Proposal No. 3. We do not know of any other business that may be presented atto the meeting. If a proposal other thanbrokers (so-called "broker non-votes"). In these circumstances, those listed in the Notice is presented at the Annual Meeting, your proxy authorizes the persons named in the proxy to vote your shares on such matters in their discretion.
Broker Non-votes
A broker non-vote occurs when a bank, broker or other holder of record holding shares for a beneficial owner submits a proxy for the Annual Meeting but does not vote on a particular proposal, except for Proposal No. 2, because that broker or other holder of record does not have discretionary voting power with respect to that proposal and has not received voting instructions from the beneficial owner. Brokers do not have authority to vote on matters considered to be non-routine unless they have received instructions from the beneficial owners of the shares. If the broker returns a valid proxy without marking a vote or abstaining, the shares represented by the proxy will be counted in determining whether a quorum is present.
Counting the Votes
Votes will be tabulated through a vendor selected by the Company to establish the platform for Internet voting. Proxy Cards and other evidences of voting are to be reviewed by an independent inspector of election, retained by the Company for the Annual Meeting, for compliance with instructions adopted by our Board for voting in the context of that meeting. Separate counts of "FOR," "AGAINST" and "ABSTAIN" on votes on any proposal are to be made along with separate counts of broker non-votes. Abstentions will be counted for the purpose of determining whetherif a quorum is present, but such shares will not be included in the vote totals and, therefore, will have no effect on any such non-routine proposals. Under the rules that govern brokers, brokers do not have discretionary authority to vote on the election of directors; however, brokers do have discretionary authority to vote on the ratification of our independent registered public accounting firm and the approval of the reverse stock split, and may choose to do so.

All votes will be tabulated by the inspector of election appointed for the Annual Meeting, who will separately tabulate affirmative and negative votes, abstentions and broker non-votes. An abstention is the voluntary act of not voting by a shareholder who is present at a meeting and entitled to vote.

As noted above, the three director nominees identified under Proposal No. 1 who receive the most votes at the Annual Meeting will be elected to serve on our Board until our 2024 annual meeting of shareholders, or until their respective successors are duly elected and qualified, thus broker non-votes will have no effect on the outcome of Proposal No. 1.

Under Utah law and our Amended and Restated Bylaws, each other matter will be determined by the vote of vote of a majority of the shares cast at the Annual Meeting. For these matters, any broker non-votes with respect to matters as to which brokers do not have discretionary authority, will not be counted towards an affirmative vote total foras votes in favor of such proposals, and will havealso not be counted as shares voting on such matters.

Proxies and Revocation of Proxies. If you return a signed and dated proxy card or otherwise vote without marking voting selections, your shares will be voted by us "FOR" each of the nominees for director, "FOR" ratification of the appointment of Tanner as our independent registered public accounting firm, and "FOR" approval of the resolution authorizing the Board to effect the reverse stock split, according to the recommendation of the Board as indicated in the Proxy Statement. If any other matter is properly presented at the meeting, your proxyholder (one of the individuals named on your proxy card) will vote your shares using their best judgment.


How can I change or revoke my vote?

You may revoke a proxy given by you at any time before the final vote against a proposal at ourthe Annual Meeting. Broker non-votesIf you are the record holder of your shares, you may revoke your proxy in any one of the following ways:

Your most current proxy card or Internet proxy is the one that is counted. If your shares are held by your broker or bank as a nominee or agent, you should follow the instructions provided by your broker or bank.

What if my shares are registered in more than one person's name?

If you own shares that are registered in the name of more than one person, each person registered as a shareholder must sign the proxy. If an attorney, executor, administrator, trustee, guardian or any other person signs the proxy in a representative capacity, the full title of the person signing the proxy should be given and a certificate should be furnished showing evidence of appointment.

If you receive more than one Notice, that is an indication that you have multiple accounts with brokers or with our transfer agent. Please vote all of these shares. We recommend that you contact your broker or our transfer agent, as applicable, to consolidate as many accounts as possible under the same name and address. You may contact our transfer agent, Colonial Stock Transfer Company, Inc., by telephone at (801) 355-5740.

Solicitation. We will pay for the entire cost of soliciting proxies, including any costs associated with printing and mailing proxy materials for those shareholders who request to receive printed versions of them. In addition, directors, officers and employees of Dynatronics and its subsidiaries may solicit proxies by mail, personal interview, telephone, email or facsimile transmission without additional compensation. We may also solicit proxies through press releases and postings on our website at www.dynatronics.com. Arrangements will be countedmade with brokerage houses, voting trustees, banks, associations and other custodians, nominees and fiduciaries, who are record holders of our voting stock not beneficially owned by them, for forwarding these proxy materials to, and obtaining proxies from, the beneficial owners of such stock entitled to vote at the Annual Meeting. We will reimburse these persons for their reasonable expenses incurred in performing these services. Except as described above, we do not presently intend to solicit proxies other than by the Internet, telephone, email and postal mail.

Voting Results. All votes will be tabulated by the inspector of election for the purpose of determining whether a quorum is present, butAnnual Meeting, who will otherwise be excluded from the tallies.

Announcing the Results
Votingseparately tabulate affirmative and negative votes, abstentions and broker non-votes. Preliminary voting results will be announced at ourthe Annual Meeting. Also, theIn addition, final voting results will be includedpublished in our current reporta Current Report on Form 8-K filed with the United States Securities & Exchange Commission ("Commission") subsequentthat we expect to file within four business days after the Annual Meeting. Furthermore, we will post theIf final voting results on our website at www.dynatronics.com. After theare not available to us in time to file a Form 8-K is filed, you may obtainwithin four business days after the meeting, we intend to file a copyForm 8-K to publish preliminary results and, within four business days after the final results are known to us, file an additional Form 8-K to publish the final results.

Questions. You can contact our President and Chief Executive Officer, Brian Baker, by visiting our website.

PROXY SOLICITATION AND COSTS
We are soliciting proxies from our shareholders for usetelephone, at (801) 727-1780 or by our Board of Directors at our Annual Meeting. The Company will paywriting to Dynatronics Corporation, 1200 Trapp Road, Eagan, Minnesota 55121, Attn: President and Chief Executive Officer, with any questions about the cost of solicitation of proxies from our shareholders, including preparation, assembly, printing and mailing ofproposals described in this Proxy Statement or how to execute your vote.


MATTERS TO BE CONSIDERED AT THE ANNUAL MEETING

PROPOSAL NO. 1

ELECTION OF DIRECTORS

General

Under our Bylaws, as amended and the Proxy Cards. Solicitation materials will be furnished to banks, brokerage houses, fiduciaries and custodians holding in their names shares of our Common Stock beneficially owned by others. We may reimburse persons representing beneficial owners of our Common Stock for their costs of providing solicitation materials to beneficial owners. In addition to solicitation by use of the mail, proxies may be solicited by our management (includingrestated, our Board may consist of Directors, officers and employees), in person or by telephone, electronic mail, or other means of communication. No additional compensation for soliciting proxies will be paidup to Company management or employees for such services.

4

PROPOSAL NO. 1
ELECTION OF DIRECTORS
Our Board of Directors has sixseven directors. ThreeUp to four of the directors (the "Common Directors") may be elected annually by the holders of our common stock voting as a group, including holders of the Voting Convertible Preferred Stock voting on an as-converted basis. The remaining three directors are standing for re-electionreferred to as the "Preferred Directors" and are elected and hold office at the Annual Meeting. The namespleasure of the nominees for director and their current positions with Dynatronics are set forth in the table below. The proxy holders intend to vote all proxies received by them "FOR" the nominees listed below unless otherwise instructed. Each of the nominees has been nominated for election bySeries A Preferred.

The Board currently consists of three Common Directors - Scott Klosterman, Brian Baker, and Dr. Scott Ward, and three Preferred Directors - Erin S. Enright, who is also the Chairman of the Board, of Directors upon recommendationDavid B. Holtz, and Brian M. Larkin.

The nominees identified below have been selected and recommended by the Nominating and Governance Committee of the Board to serve as Common Directors for one-year terms until the 2024 annual meeting of shareholders and until their respective successors are elected or appointed, or until such director's earlier resignation, termination or death.

Vote required

Directors ("Nominating Committeeare elected by a plurality of the votes cast in person or by proxy, assuming a quorum is present. This means that the three director nominees receiving the highest number of ")FOR" votes at the Annual Meeting (even if they receive less than a majority) will be elected to the Board. Since the nominees are running unopposed, a nominee only needs one vote to be elected if there is a quorum present at the Annual Meeting.

Shares represented by executed proxies will be voted, if authority to do so is not withheld, "FOR" the election of the nominees named below. If a nominee becomes unavailable for election as a result of an unexpected occurrence, shares that would have been voted for that nominee instead will be voted for the election of a substitute nominee that we may propose. If you hold your shares through a broker and each has indicated his intentionyou do not instruct the broker on how to standvote on this proposal, your broker will not have authority to vote your shares. Abstentions and broker non-votes will be counted as present for purposes of determining the presence of a quorum, but will not have any effect on the outcome of the election of directors.

Nominees for Director

Three directors are standing for election.

Each nominee named below has agreed to serve if elected. We have no reason to believe that any nominee will be unable to serve. Our policy is to encourage directors and nominees for director to attend the Annual Meeting.

The Board has determined that two of the nominees to be considered for election at the Annual Meeting, Mr. Klosterman and Dr. Ward, qualify as "independent" as defined by the rules and regulations of NASDAQ. The other nominee is our current President and Chief Executive Officer, Brian Baker. Because of applicable NASDAQ Rules, Mr. Baker is not considered independent.

Business Experience and Qualifications of Nominees

Kelvyn H. Cullimore, Jr.
Chairman,Brian Baker
Director, President and Chief Executive Officer
Age 57
Director Since 2023







Brian Baker is Chief Executive Officer and President

Age 61
Director since 1983
Principal Executive Officer at Dynatronics, appointed on October 3, 2023. Mr. Cullimore has beenBaker rejoined Dynatronics as our Chairman sinceChief Operating Officer in January 2005 and President and2022, following his temporary resignation from Chief Executive Officer since 1992. He served as our Secretary/Treasurer from 1983in July 2020 due to 1992 and as Administrativehealth concerns. Prior to joining Dynatronics, he was Vice President of Global Operations of SeaSpine Holdings Corporation from 1988July 2015 to 1992. Mr. Cullimore graduated cum laudeJanuary 2018, and held several senior leadership roles within Integra LifeSciences Corporation from Brigham Young University in 1980 with a Bachelor's degree in Financial and Estate Planning. Mr. CullimoreMay 2007 to November 2013. Prior to joining Integra LifeSciences, he was Executive Vice President and CEO of Physician Industries.

Mr. Baker brings a directorwealth of our former parent companyexperience, having held multiple leadership positions in the medical device industry. He has the ability to navigate complex challenges and was previously on the board of directors of a printing company, lumber company, theaterexecute strategic plans by building and restaurant company,inspiring high performing teams. Mr. Baker continues to leverage his strong customer and travel agency. He is the Mayor of Cottonwood Heights, Utah, a suburb of Salt Lake City, where the Company corporate headquarters are located. Based on his experience in management and his long association with and effective leadership of the Company, the Nominating Committee believes Mr. Cullimore is well qualifiedvendor relationships to serve on our Board.shape Dynatronics' future. 




  
Scott A. Klosterman

Director

Age 59
65
Director since 2016

Independent Director
Mr. Klosterman is Chief Financial Officerof Staff at HNI Healthcare, a technology-enabled physician management company, since May 2017,April 2020 where he previously served as Chief Financial Officer (2018-2020) and Executive Vice President of Financial Operations (2016-2017). From 2010 to 2015, he was Vice President and General Manager, Post-Operative Products and Services at Hanger, Inc., a leading provider of prosthetic, orthotic, and therapeutic solutions. From 2009 to 2010, he was an executive consultant, providing consulting services to healthcare businesses, advising on product development and new product launches. He was Division President of Chattanooga Group from 2003 to 2008, where he previously served as Chief Operating Officer (1997-2003) and Chief Financial Officer, Secretary, and Treasurer (1994 -1997)(1994-1997). Mr. KlostermanHe was a licensed certified public accountant in Pennsylvania from 1982 until 1994 and has an MBAM.B.A. degree from Baylor University and a BSB.S. degree in Accounting (with highest honors) from the University of Delaware. BasedWe selected Mr. Klosterman to serve on Mr. Klosterman'sour Board based on his extensive experience in the medical industry the Nominating Committee believes that he is well qualified to serve on our Board.and as a finance executive.
  
R. Scott Ward, Ph.D.

Director

Age 61
67
Director since 2013

Independent Director
Dr. Ward serves as the chairman ofprofessor in the Department of Physical Therapy at the University of Utah. He is the past president of the American Physical Therapy Association, a position he held from 2006 to 2012. In addition, Dr. Ward served as chair of the rehabilitation committee of the American Burn Association. He has published extensive research studies related to wound care and burn rehabilitation. Dr. Ward received a Bachelor of ArtsB.A. degree in Physical Therapy and a Doctor of PhilosophyPh.D. degree in Physiology from the University of Utah. BasedWe selected Dr. Ward to serve as a member of our Board based on Dr. Ward'shis prominence in his field, and his extensive experience and expertise in physical therapy, the Nominating Committee believes that Dr. Ward is well qualified to serve as a member of our Board of Directors.therapy.

Recommendation of the Board

THE BOARD OF DIRECTORSUNANIMOUSLY RECOMMENDS THAT THE SHAREHOLDERSA VOTE "FOR" THE ELECTION OF EACH OF THE DIRECTORTHREE NOMINEES NAMED IN THIS PROXY STATEMENT.

5

EXECUTIVE OFFICERS, CORPORATE GOVERNANCE
Directors
The remaining three membersABOVE.

INFORMATION REGARDING THE BOARD

General Information

Members of the Board are "Preferred Directors," as discussed below. Except for the Preferred Directors, directors are elected at the Annual Meeting serve until our next annual meeting of shareholders and serve until the earlier of resignation or removal, or until their successors are elected and qualified. Information about nominees for director to be voted upon atqualified, or their earlier resignation or removal. Three members of the Annual Meeting is contained above. Attendance atBoard are Preferred Directors appointed under the Annual Meeting is encouraged, but not requiredprovisions of our directors, given travel and other commitments. None of our directors attended the 2016 Annual Meeting of Shareholders. Additional information about our other directors and executive officers follows.

Preferred Directors
Under our Bylaws, our Board can include up to seven members. The Certificate of Designations, Preferences and Rights of the Series A Preferred Stock(the "Series ACertificate of Designations") as discussed in the following section of this Proxy Statement.


Preferred Directors

Under our Bylaws as amended and restated, the Board can include up to seven members. The Series A Certificate of Designations grants to the holders of the Series A Preferred Stock certain rights, ("referred to as "Director Rights,") to appoint up to three members of the Board (the- the Preferred Directors)Directors - for as long as the original Series A Preferred Stock investors own or would directly or indirectly beneficially own at least 28.6% of Dynatronics' Common Stock either directly or indirectlyour common stock (the "Threshold Ownership Percentage"). This period of ownership is known as the "Director Rights Period"), but excluding. Excluded from the calculation of the Threshold Ownership Percentage are any shares of Common Stockcommon stock issuable upon the exercise of the warrants held by such investors (the "Threshold Ownership Percentage").these investors. In compliance with NASDAQ Rule 5640, the number of Preferred Directors is towill be reduced pro rata with any reduction in ownership by the preferred investors below the Threshold Ownership Percentage, so that the number of Preferred Directors is approximately equalproportionate to the preferred investors' direct or indirect ownership of our common stock. By agreement among the Series A Preferred shareholders and Dynatronics, Common Stock. Thethe Director Rights may be exercised at the discretion of certain affiliates of Prettybrook Partners, LLC, a private investment firm (collectively,(with its affiliates, collectively referred to as "Prettybrook") for as long as Prettybrook owns at least 50% of the outstanding Series A Preferred Stock.

Notwithstanding anything set forth above, the holders of the Series A Preferred Stock do not have any rights to elect Preferred Directors unless they own or would beneficially own at least 10% of Dynatronics' Preferred.

Common Stock either directly or indirectly, through ownership of Common Stock or Series A Preferred Stock convertible into Common Stock, but excluding any warrants to purchase Common Stock. Common Stock of the Companystock has no voting, nomination, election or other rights with respect to the Preferred Directors. Each Preferred Director serves as a member of the Board during the Director Rights Period or until his or her successor is appointed by the holders of the Series A Preferred Stock(or Prettybrook, exercising such rights, as discussed above) during the Director Rights Period.

In accordance with

The current Preferred Directors are Erin S. Enright, who is also the terms set forth above, the holdersChairman of the Series A Preferred Stock have previously appointed Erin S. Enright,Board, David B. Holtz, and Brian M. Larkin to the Board as Preferred Directors. TheLarkin. Their business experience and other qualifications of these Preferred Directors are as follows:

Erin S. Enright. Ms. Enright, 56, is62, currently serves as a Managing Member of Prettybrook Partners LLC, a family office dedicated to investing in healthcare companies. Prettybrook has approximately 20 active investments in a variety of companies, typically as a co-investor with institutional private equity. In addition to her service as Chairman, Ms. Enright is Chairman of the Nominating and Governance Committee and a general partnermember of the Audit Committee and Compensation Committee of the Board. She is a member of the Board of Directors and Chair of the Nominating/Governance and Compensation Committee of Medical Facilities Corporation (TSX: DR), and a member of the Board of Directors and Chair of the Audit Committee of Keystone Dental, Inc., a private company controlled by the private equity firm Accelmed. Previously, she was on the Board of Directors and Chair of the Audit Committee of Amarin Corporation, plc (NASDAQ: AMRN) from 2022-23, on the Board of Directors and Chair of the Audit Committee of Brooklyn ImmunoTherapeutics, Inc. (NASDAQ: BTX) during 2022, and on the Board of Directors and Audit Committee of Biolase, Inc. (NASDAQ: BIOL) during 2013. She was a also member of the Board of Directors of Tigerlabs, a Princeton-based business accelerator.accelerator, from 2012 to 2018, and from 2010 to 2015 served on the Board of Directors of Ceelite Technologies, LLC. She was the President of Lee Medical, a medical device manufacturer based in Plainsboro, New Jersey, from 2004-13. She served on the Board of Directors and the Audit Committee of Biolase, Inc. (NASDAQ: BIOL) during 2013, and from 2010 to 2015 served on the Board of Directors of Ceelite Technologies, LLC.2004-2013. She was Chief Financial Officer of InfuSystem, Inc. (NASDAQ: INFU) from 2005 to 2007. From 1993 to 2003, Ms. Enright was with Citigroup, most recently aswhere she was a Managing Director in its Equity Capital Markets group. While at Citigroup, Ms. Enright was Chairperson of the firm's Institutional Investors'Investors Committee, responsible for screening and approving the firm's participation in equity underwritings and a member of the Citigroup Global Equity Commitment Committee, responsible for reviewing and approving the firm's underwritings. From 1989 until 1993, Ms. Enright was an attorney with Wachtell, Lipton, Rosen & Katz in the firm's New York office. Ms. Enright received her A.B. degree from the Woodrow Wilson School of Public and International Affairs at Princeton University and J.D. degree from the University of Chicago Law School.

We believe that Ms. Enright's extensive experience in various capacities within our industry and her legal background qualify her to serve as a member of our Board.

David B. Holtz. Mr. Holtz, 51,57, has been a principal of Provco Group Ltd., ("Provco") since 2012. Provco became a preferred shareholder of Dynatronics since 2012.in 2015. He serves as part of Provco's executive management group responsible for managing investment portfolios and the accounting function. From 2011 to 2012, Mr. Holtz was executive manager of Grey Street Holdings, a property investment holding company. From 2008 to 2010, he served as Chief Financial Officer and then Interim President of Nucryst Pharmaceuticals Corp. From 1993 to 2006, Mr. Holtz worked at Integra LifeSciences in various capacities including Vice President, Finance and Treasurer, and Senior Vice President, Finance and Treasurer. Before joining Integra, Mr. Holtz was an associate with Coopers & Lybrand, L.L.P. in Philadelphia and Cono Leasing Corporation, a private leasing company. He received a BSB.S. degree in Business Administration from Susquehanna University and was a certified public accountant in Pennsylvania until 1998. We believe Mr. Holtz's extensive financial experience and background qualify him to serve as a member of our Board.

6

Brian M. Larkin. Larkin.Mr. Larkin, 48, currently serves54, is President and CEO of Comar, Inc., a privately held manufacturer of devices and rigid packaging used in the medical, pharmaceutical and consumer industries, where he has held the position since April of 2022.  From February of 2018 to March of 2022, he served as President and CEO of privately held SP Industries, Inc.  From May 2017 to February 2018, he served as the Vice President and General Manager of the Diabetes Care business at Becton Dickinson, where he has worked since May 2017.Dickinson. From May 2015 to May 2017, he served as Senior Vice President and General Manager for the LifeCell, Regenerative Medicine business atInc., a Division of Acelity L.P., Inc. Prior to joining Acelity, Mr. Larkin was Corporate Vice President of Integra Lifesciences Holdings Corporation, which he joined in January of 2000 and where he served most recently as President of the Global Spine and Orthobiologics businesses,business and Head of Strategic Development. His responsibilities included executive oversight and leadership of Integra's worldwide Spine and Orthobiologics businesses, in addition to executive oversight of several of Integra's corporate functions, including corporate marketing and strategic planning. Mr. Larkin joined Integra in January 2000, as a Regional Sales Manager. He was promoted to National Sales Manager in 2003, Vice President, North American Sales in 2005, and President of Integra's Neurosurgery business in 2007. In 2010, he was appointed President, Global Spine & Orthobiologics, and Head of Strategic Development. Mr. Larkin has over 25 years of sales, marketing, and executive management experience in the medical technology industry. Prior to joining Integra, he was the National Sales Manager for Connell Neurosurgical. Mr. Larkin received a B.S. degree in Chemistry from the University of Richmond and completed the Advanced Management Program at Harvard Business School.

We believe that Mr. Larkin's extensive and varied business background and executive experience qualify him to serve as a member of our Board.

In addition to the Director Rights, the holders of the Series A Preferred Stock have the right to appoint one observer (who is not a Preferred Director) who may attend any meetings of the Board of Directors and participate in discussions among the Board members, but who does not have any voting rights on any matters. So long as Prettybrook owns at least 50% of the outstanding Series A Preferred, Stock, Prettybrook has the right to choose this observer andobserver. Prettybrook has appointed Stuart M. Essig as the observer to the Board. Mr. Essig is a significant shareholder of the CompanyDynatronics and is the husband of Ms. Enright, oneChairman of the Company's Preferred Directors.our Board. Mr. Essig and Ms. Enright are managers of Prettybrook.

Independence
Upon recommendation of the Nominating Committee, the Board of Directors has affirmatively determined that all directors other than Mr. Cullimore

Family Relationships

There are independent under the criteria established by NASDAQ for director independence. All members of the Company's Audit, Compensation, and Nominating committees are independent directors. In addition, the Board of Directors has determined thatno family relationships among the members of the Board and our executive officers.

Director Attendance at the Annual Meeting

We believe the Annual Meeting provides a good opportunity for our directors to hear any feedback that our shareholders may desire to share with the Board and with us. As a result, directors are encouraged to attend the Annual Meeting if their schedules permit. All our directors attended the 2022 annual meeting of shareholders, either in person or via video conference. We reimburse our directors for the reasonable expenses they may incur in attending the Annual Meeting.

Director Compensation

Our directors play a critical role in guiding our strategic direction and overseeing our management. Ongoing developments in corporate governance and financial reporting have resulted in an increased demand for such highly qualified and productive public company directors. The many responsibilities and risks and the substantial time commitment of being a director of a public company require that we provide adequate incentives for our directors' continued performance by paying compensation commensurate with our directors' workload. Our non-employee directors are compensated based upon their respective levels of board participation and responsibilities, including service on Board committees. Our employee directors receive no separate or additional compensation for their service as directors.

Our director compensation is reviewed by the Compensation Committee, which makes recommendations to the Board on the appropriate structure for our non-employee director compensation program and the appropriate amount of compensation. Our Board is responsible for final approval of our non-employee director compensation program and the compensation paid to our non-employee directors. Our non-employee directors are entitled to reimbursement for their reasonable travel and lodging expenses for attending Board and committee meetings.


In fiscal year 2023, we authorized payment to our non-employee directors of an annual equity retainer of 10,000 shares of common stock (adjusted to 2,000 shares after giving effect to our February 2023 reverse stock split) under our 2020 Equity Incentive Plan (the “2020 Plan”) (1,000 to be awarded on January 1 and 1,000 on July 1 of each fiscal year based on service), plus $15,000 cash ($7,500 on July 1 and $7,500 on January 1). Committee chairs were authorized to receive an additional $10,000 cash ($5,000 on July 1 and $5,000 on January 1). All retainer payments were pro-rated for the portion of the year served if a director’s service began after the start of the fiscal year. The following table summarizes the total compensation paid to the non-employee and independent directors during the fiscal year ended June 30, 2023.

Director Compensation Table - Fiscal 2023

Name
(a)
 Fees
Earned or
Paid in Cash
($) (b) (1) 
    Stock
Awards
($)
(c) (1) 
    All other
Compensation
($) (g)
    Total
($) (h) 
 
Erin S. Enright$25,000 $5,011 $- $30,011 
David B. Holtz$25,000 $5,011 $- $30,011 
Scott A. Klosterman$25,000 $5,011 $- $30,011 
Brian M. Larkin$15,000 $5,011 $- $20,011 
R. Scott Ward, Ph.D.$15,000 $5,011 $- $20,011 

_________________

(1) Columns (d) through (f) are omitted from this table as no items of compensation referenced in those columns were paid to the directors during the period covered by the table.

The table below provides information regarding the equity awards we granted to our non-employee directors during our fiscal year ended June 30, 2023.

    July 1, 2022     January 1, 2023     Total  
Ms. Enright$3,051 $1,960 $5,011 
Mr. Holtz$3,051 $1,960 $5,011 
Mr. Larkin$3,051 $1,960 $5,011 
Mr. Klosterman$3,051 $1,960 $5,011 
Dr. Ward$3,051 $1,960 $5,011 
Grant date stock price$3.051 $1.960    
Aggregate share value$15,255 $9,800 $25,055 

CORPORATE GOVERNANCE

Independence of the Board

The Board has determined that a majority of the members of the Board should consist of "independent directors," determined in accordance with the applicable NASDAQ Rules as in effect from time to time. Members of the Board who are also our employees are not considered to be independent for this purpose. Our Board determines the independence of our directors by applying the rules, regulations and listing standards of NASDAQ and the rules and regulations of the SEC. The NASDAQ Rules provide that a director is independent only if the Board affirmatively determines that the director does not have a relationship with us that would interfere with the exercise of his or her independent judgment in carrying out the responsibilities of a director. They also specify certain relationships that preclude a determination of director independence, including certain business, professional and personal relationships. Subject to some exceptions, these standards generally provide that a director will not be independent if (a) the director is, or in the past three years has been, an employee of ours; (b) a member of the director's immediate family is, or in the past three fiscal years has been, an executive officer of ours; (c) the director or a member of the director's immediate family has received more than $200,000 per year in direct compensation from us other than for service as a director (or for a family member, as a non-executive employee); (d) the director or a member of the director's immediate family is, or in the past three years has been, employed in a professional capacity by our independent public accountants, or has worked for such firm in any capacity on our audit; (e) the director or a member of the director's immediate family is, or in the past three years has been, employed as an executive officer of a company where one of our executive officers serves on the compensation committee; or (f) the director or a member of the director's immediate family is an executive officer of a company that makes payments to, or receives payments from, us in an amount which, in any twelve-month period during the past three years, exceeds the greater of $1,000,000 or two percent of that other company's consolidated gross revenues.


Our Board annually reviews the independence of our directors according to these standards, taking into account all relevant facts and circumstances. In its most recent review of information collected from our directors, the Board determined that the non-employee members of our Board are "independent directors" under the NASDAQ standards and the SEC's rules. The Board has determined that Ms. Enright, Mr. Klosterman, Mr. Holtz, Mr. Larkin and Dr. Ward are independent and that these independent directors have no relationship with us that would interfere with the exercise of their independent judgment in carrying out the responsibilities of a director.

None of our directors is a party to any agreement or arrangement that would require disclosure pursuant to NASDAQ Rule 5250(b)(3).

The Board has also determined that all members of the Compensation Committee are independent and meet the additional independence criteria required under NASDAQ Listing Rule 5605(a)(2), and that each member of the Audit Committee of the Board of Directors ("Audit Committee"):Committee: (i) is independent, (ii) meets the financial literacy requirements of the NASDAQ Rules, and (iii) meets the enhanced independence standards under Section 10A(m)(3) of the Securities Exchange Act of 1934, as amended (the "("Exchange Act").

In connection with its determination regarding the independence of our directors, the Board Committeesfound that none of the nominees for director had a material or other disqualifying relationship with us.

Board Leadership Structure

In February 2018, our Board determined to separate the role of Chairman of the Board from the role of Chief Executive Officer, and appointed Erin Enright as Chairman. The Board believes that separating these roles allows us to efficiently develop and implement corporate strategy that is consistent with the Board's oversight role, while facilitating strong day-to-day leadership.

In making the decision to separate the roles of Chief Executive Officer and Chairman of the Board, the Board cited the demands of and differences between each role. The Chief Executive Officer is responsible for setting our strategic direction, with guidance from the Board. The Chairman of the Board is responsible for leadership and for the over-all performance of Dynatronics pursuant to the policies of the Board, while providing guidance to the Chief Executive Officer, and setting the agenda for Board meetings, and presiding over meetings of the Board.

Ms. Enright brings considerable skills and experience to the role of Chairman. In this capacity, she has significant responsibilities, including those described above, as well as calling and presiding over Board meetings, including meetings of the independent directors, setting meeting agendas and determining materials to be distributed to the Board. As Chairman, she has substantial ability to shape the work of the Board. We believe that having an independent Chairman creates an environment that is more conducive to objective evaluation and oversight of management's performance, increases management accountability and improves the ability of the Board to monitor whether management's actions are in our best interests and those of our shareholders. As a result, we believe that having an independent chairman and a separate chief executive can enhance the effectiveness of the Board as a whole. The active involvement of our independent directors, combined with the qualifications and significant responsibilities of our Chairman, provide balance on the Board and promote strong, independent oversight of our management and affairs.

Role of the Board in Risk Oversight

The Board has an active role, both as a whole and at the committee level, in overseeing management of our risks. The Board regularly reviews information regarding our credit, liquidity and operations, as well as the risks associated with each. The Audit Committee's charter mandates that the committee review and discuss with management and our independent registered public accounting firm, as appropriate, our major financial risk exposures and the steps taken by management to monitor and control these exposures. The Compensation Committee is responsible for overseeing the management of risks relating to our executive compensation plans and arrangements. The Nominating and Governance Committee manages risks associated with the independence of the Board and potential conflicts of interest. While each committee is responsible for evaluating certain risks and overseeing the management of such risks, the entire Board is informed regularly through committee reports about such risks.

Our

Communications with the Board

The Board desires that the Board and its committees and individual directors hear the views of shareholders and that appropriate responses are provided to shareholders on a timely basis. Shareholders wishing to formally communicate with the Board, the independent directors as a group or any individual director may send communications directly to Dynatronics Corporation, Board of Directors, has three standing committees:Attn: Legal Department, 1200 Trapp Road, Eagan, Minnesota 55121. All clearly marked written communications, other than unsolicited advertising or promotional materials, are logged and copied, and forwarded to the director to whom the communication was addressed.

Please note that the foregoing communication procedure does not apply to: (1) shareholder proposals pursuant to Exchange Act Rule 14a-8 and communications made in connection with such proposals; (2) service of process or any other notice in a legal proceeding; (3) advertisements, promotions of a product or service, patently offensive material or matters deemed inappropriate for the Board; (4) items solely related to complaints with respect to ordinary course of business, customer service and satisfaction issues; or (5) material clearly unrelated to our business, industry, management, Board, or related committee matters.

Meetings of the Board

Our Board met 7 times during fiscal year 2023. Our Audit Committee met 4 times. Our Compensation Committee met 4 times. Our Nominating and Governance Committee met 1 time. Each director serving during our fiscal year ended June 30, 2023 attended at least 75% of the aggregate of the total number of the meetings of the Board and the total number of meetings held by all committees of the Board upon which such director served that were held during the fiscal year.

Executive Sessions

The Board holds regular executive sessions of the non-employee directors without the presence of management, as required under applicable NASDAQ Rules. In fiscal 2023, 7 executive sessions were convened at which only independent directors were present.

Information Regarding Committees of the Board

The Board has established an Audit Committee, a Compensation Committee and a Nominating and Governance Committee and adopted a written charter for each committee, copies of which are available to shareholders on the Investors section of our website at https://investors.dynatronics.com/governance-documents.

The following table provides membership information for fiscal year 2023 for each of these committees of the Board:

NameAuditCompensationNominating and
Governance
Erin S. EnrightXX*
David B. Holtz*X
Scott A. KlostermanX*X
Brian M. LarkinXX
R. Scott Ward, Ph.D.X

*Committee Chair

Below is a description of the Board committees. Each of the committees has authority to engage legal counsel or other experts or consultants as it deems appropriate to carry out its responsibilities.


Audit Committee

The Audit Committee was established in accordance with requirements of Section 3(a)(58)(A) of the Exchange Act, and is comprised of the following independent directors: David B. Holtz (Chair), Erin S. Enright, and Scott A. Klosterman. The NASDAQ Rules regarding corporate governance require that at least one member of the Audit Committee have past employment experience in finance or accounting, requisite professional certification in accounting, or comparable experience or background which results in the individual's "financial sophistication." This financial sophistication may derive from the person being or having been a chief executive officer, chief financial officer or other senior officer with financial oversight responsibilities. Our Board believes that all three members of its Audit Committee meet the NASDAQ requirements for financial sophistication. Our Board further believes that each of the committee members is an independent director as defined in the NASDAQ Rules. The Board has also determined that the members of the Audit Committee qualify as "audit committee financial experts" ("Audit Committee Financial Experts") as defined by applicable SEC's rules. The SEC rules define an Audit Committee Financial Expert as a person who has all of the following attributes:

  • Understanding of accounting principles generally accepted in the United States of America, or GAAP, and financial statements.

  • Ability to assess the Nominatinggeneral application of GAAP in connection with accounting for estimates, accruals and Governance Committee.

reserves.

  • Experience in preparing, auditing, analyzing or evaluating financial statements that present a breadth and level of complexity of accounting issues that are generally comparable to the breadth and complexity of issues that can reasonably be expected to be raised by our financial statements, or experience actively supervising one or more persons engaged in such activities.

  • Understanding of internal control over financial reporting.

  • Understanding of audit committee functions.

  • The Audit Committee is concerned primarily with the integrity of our financial statements, the selection, independence, qualifications and performance of our independent registered public accounting firm, and our compliance with legal requirements. The Audit Committee charter reflects the standards and requirements adopted by the SEC and NASDAQ.

    Compensation Committee

    The Compensation Committee of the Board of Directors ("Compensation Committee") is responsible for reviewing and approving where required, the compensation, as well as evaluating the performance, of our principal executive officer and other executive officers, and advising and assisting management in developing our overall compensation strategy to assure that it promotes shareholder interests, supports our strategic and tactical objectives, and provides for appropriate rewards and incentives for our management and employees. Each member of the Compensation Committee is an "independent director" as defined by the federal securities laws and in Rule 5605(a)(2) of the Marketplace Rules of The NASDAQ Stock Market. Rules.

    The Compensation Committee is empowered to advise management and make recommendations to the Board of Directors with respect to the compensation and other employment benefits of our executive officers and key employees of the Company.employees. In exercising its responsibilities, the Compensation Committee establishes and monitors policies governing the compensation of executive officers, reviews the performance of and determines salaries and incentive compensation for executive officers, and makesapproves option or other equity-based awards to those individuals. Additionally, the Compensation Committee administers our stock plans. The Compensation Committee has a written charter, a copy of which is available on our corporate Web site, www.dynatronics.com, under "Investors, Corporate Governance, Governance Documents." A copy of this charter is included with this Proxy Statement as Attachment A.

    The Compensation Committee meets as often as it deems necessary, without the presence of any executive officer whose compensation it is then approving. Neither the Compensation Committee nor the Company engaged or received advice from any compensation consultant during fiscal year 2017.2023. As of the date of this Proxy Statement, the following independent directors are members of the Compensation Committee: Scott A. Klosterman (Chair), Erin S. Enright, Brian M. Larkin and R. Scott Ward. Mr. Larkin was appointed

    The charter of the Compensation Committee grants the committee full access to all our books, records, facilities and personnel. In addition, under the charter, the Compensation Committee has the authority to obtain, at our expense, advice and assistance from compensation consultants and internal and external legal, accounting or other advisors and other external resources that the Compensation Committee considers necessary or appropriate in March 2017.the performance of its duties. The Compensation Committee held meetings during fiscal year 2017. All committee members attended at least 75% of these meetings.

    7

    Audit Committee
    The Audit Committee, which has been established in accordance with requirements of Section 3(a)(58)(A)direct responsibility for the oversight of the Exchange Act, is comprisedwork of any consultants or advisers engaged for the following independent directors: David B. Holtz (Chair), Erin S. Enright, and Scott A. Klosterman. Mr. Holtz and Mr. Klosterman were appointedpurpose of advising the committee. In particular, the Compensation Committee has the sole authority to the committee in February 2016. The NASDAQ corporate governance listing standards require that at least one member of our Audit Committee must have past employment experience in finance or accounting, requisite professional certification in accounting, or comparable experience or background which results in the individual's "financial sophistication." This financial sophistication may derive from the person being or having been a chief executive officer, chief financial officer or other senior officer with financial oversight responsibilities. Our Board believes that Ms. Enright and Messrs. Holtz and Klosterman, are audit committee financial experts ("Audit Committee Financial Experts") and also meet the NASDAQ requirements for financial sophistication. Our Board further believes that each of them is an independent director as the term is defined in the NASDAQ Stock Market corporate listing standards (to which the Company is subject), i.e., an individual other than one of our executive officers or employees or any other individual having a relationship which in the opinion of our Board would interfere in carrying out the responsibilities of a director. Under the Commission's rules, an Audit Committee Financial Expert is defined as a person who has all of the following attributes:
    ·
    Understanding of accounting principles generally accepted in the United States of America ("GAAP") and financial statements.
    ·Ability to assess the general application of GAAP in connection with accounting for estimates, accruals and reserves.
    ·Experience in preparing, auditing, analyzing or evaluating financial statements that present a breadth and level of complexity of accounting issues that are generally comparable to the breadth and complexity of issues that can reasonably be expected to be raised by our financial statements, or experience actively supervising one or more persons engaged in such activities.
    ·Understanding of internal control over financial reporting.
    ·Understanding of audit committee functions.
    The Audit Committee is concerned primarily with the integrity of our financial statements, the independence, qualifications and performance of our independent registered public accounting firm, and our compliance with legal requirements. The Audit Committee operates under a written charter approved by the Board of Directors and the Audit Committee that reflects standards and requirements adopted by the Commission and NASDAQ. The Audit Committee Charter was filed with the Commission as an exhibit to our proxy statement filed October 31, 2001, and as amended is included with this Proxy Statement as Attachment B, to be posted on our website, www.dynatronics.com, under "Investors, Investor Relations, Corporate Governance, Governance Documents." The Audit Committee held five meetings during fiscal year 2017. Each member of the Audit Committee attended at least 75% of the Audit Committee's meetings.
    As indicatedretain, in its charter, the Audit Committee's duties include selectingsole discretion, compensation consultants to assist in its evaluation ofexecutive and engaging our independent registered public accounting firm; reviewing the scope of the audit to be conducted by our independent registered public accounting firm; overseeing our independent registered public accounting firm and reviewing the results of its audit; reviewing our financial reporting processes,director compensation, including the accounting principlesauthority to approve the consultant's reasonable fees and practices followed and the financial information provided to shareholders and others; overseeing our internal controls over financial reporting and disclosure controls and procedures; and serving as our legal compliance committee.other retention terms.


    Nominating and Governance Committee

    The Nominating and Governance Committee is responsible for overseeing, reviewing and making periodic recommendations concerning Dynatronics'our corporate governance policies, and for recommending to the full Board of Directors candidates and nominees for election to the Board of Directors.Board. The committee is comprised of the following directors: Erin S. Enright (Chair), David B. Holtz, Brian M. Larkin and Scott A. Klosterman. Mr. Larkin was appointed to this Committee in March 2017. Each member of this committee is an independent director under applicable NASDAQ listing standards. The Nominating Committee members individually discussed Committee topics during the year. All members were present and participated in the Board meetings on October 31, 2016, March 6, 2017 and June 9, 2017. At these meetings, Committee members discussed and reportedRules.

    Nominees to the Board on a new initiative during fiscal year 2017 to conduct Board and executive management reviews (October 2016), the format for the Board reviews to be conducted during the fiscal fourth quarter of fiscal year 2017, and a plan to conduct executive management reviews during either fiscal fourth quarter 2017 or the fiscal first quarter 2018 (March 2017), and a summary of the Board review results and policy for Form 4 filings (June 2017). Action taken by the Committee is memorialized in minutes of the full Board.

    8

    Nominees for the Board of Directors should be committed to enhancing long-term shareholder value and must possess a high level of personal and professional ethics, sound business judgment and integrity. The Board of Directors is composed of a diverse group of leaders in their respective fields. The Board of DirectorsNominating and Governance Committee encourages selection of directors who will contribute to Dynatronics'our corporate governance, including: responsibility to its shareholders, technology leadership, effective execution, high customer satisfaction and superior employee working environment.

    The Nominating and Governance Committee from time to time reviews the appropriate skills and characteristics required of Board members, including factors that it seeks in Board members such as diversity of business experience, viewpoints and personal background, and diversity of skills in technology, finance, marketing, international business, financial reporting and other areas that are expected to contribute to an effective Boardboard of Directors.directors. In evaluating potential director candidates, for the Board of Directors, the Nominating and Governance Committee considers these factors in light of the specific needs of the Board of Directors at that time. The brief biographical description ofinformation for each nominee set forth in the section under the heading "Business Experience and Qualifications of Nominees" on page 5 above, includes the primary individual experience, qualifications, attributes and skills of each of our directors nominated for election at this Annual Meeting that led the Nominating and Governance Committee to the conclusionconclude that each directornominee should serve as a member of the Board of Directors at this time.

    Board.

    Shareholders may recommend a director nominee to Dynatronics'the Nominating and Governance Committee. In recommending candidates for election to the Board, of Directors, the Nominating Committeecommittee considers nominees recommended by directors, officers, employees, shareholders and others, using the same criteria to evaluate all candidates. The Nominating and Governance Committee reviews each candidate's qualifications, including whether a candidate possesses any of the specific qualities and skills desirable in certain members of the Board of Directors.Board. Evaluations of candidates generally involve a review of background materials, internal discussions and interviews with selected candidates as appropriate. Upon selection of a qualified candidate, the Nominating Committee would recommend the candidate for consideration by the full Board of Directors. The Nominating and Governance Committee may, but is not required to, engage consultants or third-party search firms to assist in identifying and evaluating potential nominees.

    To recommend a prospective nominee for the Nominating and Governance Committee's consideration, submit the candidate's name and qualifications to Dynatronicsus in writing to the following address: Dynatronics Corporation, Attn: Jim Ogilvie, Vice President of Business Development, 7030 Park Centre Drive, Cottonwood Heights, Utah 84121.Legal Department, 1200 Trapp Road, Eagan, Minnesota 55121. When submitting candidates for nomination to be elected at Dynatronics' annual meeting of shareholders,as directors, shareholders must also follow the notice procedures and provide the information required by Dynatronics' bylaws.our Bylaws. In particular, for the Nominating and Governance Committee to consider a candidate recommended by a shareholder for nomination at the 2018 Annual Meeting2024 annual meeting of Shareholders,shareholders, the recommendation must be delivered or mailed to and received by the Companyus as indicated above between July 2, 201826, 2024 and August 1, 201825, 2024 (or, if the 2018 Annual Meeting2024 annual meeting of shareholders is not held within 30 calendar days of the anniversary of the date of the 20172023 Annual Meeting, within 10 calendar days after Dynatronics'our public announcement of the date of the 2018 Annual Meeting)2024 annual meeting of shareholders). The recommendation must include the same information as is specified in Dynatronics' bylawsour Bylaws for shareholder nominees to be considered at an annual meeting, including the following:

    • The shareholder's name and address and the beneficial owner, if any, on whose behalf the nomination is proposed;
    ·The shareholder's name and address and the beneficial owner, if any, on whose behalf the nomination is proposed;
    ·The shareholder's reason for making the nomination at the annual meeting, and the signed consent of the nominee to serve if elected;
    ·The number of shares owned by, and any material interest of, the record owner and the beneficial owner, if any, on whose behalf the record owner is proposing the nominee;
    ·A description of any arrangements or understandings between the shareholder, the nominee and any other person regarding the nomination; and
    ·Information regarding the nominee that would be required to be included in Dynatronics' proxy statement by the Commission rules, including the nominee's age, business experience for the past five years and any directorships held by the nominee, including directorships held during the past five years.
    Meetings
    • The shareholder's reason for making the nomination at the annual meeting, and the signed consent of the nominee to serve if elected;

    • The number of shares owned by, and any material interest of, the record owner and the beneficial owner, if any, on whose behalf the record owner is proposing the nominee;

    • A description of any arrangements or understandings between the shareholder, the nominee and any other person regarding the nomination; and

    • Information regarding the nominee that would be required to be included in our proxy statement by the SEC's rules, including the nominee's age, business experience for the past five years and any directorships held by the nominee, including directorships held during the past five years.

    Code of Ethics

    We have adopted a Code of Business Ethics that applies to all officers, directors and employees. The Code of Business Ethics is available on the Investors section of our website at https://irdirect.net/DYNT/corporate_governance. If we make any substantive amendments to the Code of Business Ethics or grant any waiver from a provision of our Code to any executive officer or director, we will promptly disclose the nature of the amendment or waiver on our website.

    Prohibition against Pledging Dynatronics Securities and Hedging Transactions

    Consistent with our Insider Trading Policy, we prohibit our executive officers and members of the Board of Directors

    There were five meetings of the Board of Directors held during fiscal year 2017. No director attended fewer than 75% of these meetings.
    9

    Executive Sessions of Independent Directors
    During the year ended June 30, 2017, the independent directors met four timesfrom pledging our common stock or other securities and engaging in executive session.
    Board Leadership Structure and Role in Risk Oversight
    Kelvyn H. Cullimore, Jr. serves as the Chairman of our Board of Directors and as our Chief Executive Officer. We do not have a formal policyhedging or monetization transactions or similar arrangements with respect to separation of the offices of chairman of the board and chief executive officer, and the Board of Directors believesour securities that flexibility in appointing the Chairman and Chief Executive Officer allows the Board of Directorscould be used to make a determination as to such positions from time to time and in a manner that it believes ishedge or offset any decrease in the best interestvalue of the Companyour securities. Our policies also specifically prohibit our executive officers and its shareholders.
    non-employee directors from engaging in short sales of our stock, or holding our securities in any margin account for investment purposes or otherwise using our securities as collateral for a loan.

    Corporate Governance Guidelines

    The Board of Directors believes that the traditional practice of combining the roles of Chairman of the Board and Chief Executive Officer currently provides the preferred form of leadership for the Company. Given Mr. Cullimore's long tenure and vast experience with the Company and our industry, the tremendous respect which he has earned from employees, business partners and shareholders, as well as other members of the medical device manufacturers industry, and his proven leadership skills, the Board of Directors believes the best interests of our shareholders are met by Mr. Cullimore's continued service in both capacities. The Board of Directors also believes that Mr. Cullimore's performance of both responsibilities encourages clear accountability and effective decision-making, and provides strong leadership for our employees and other stakeholders.

    not adopted formal written corporate governance guidelines. Given the experience and qualifications our directors contribute to the Board's activities, we have implemented a number of practices designed to encourage effective corporate governance. These practices include:
    ·the requirement that at least a majority of the directors meet the standards of independence applicable to the Company;
    ·

    • the requirement that at least a majority of the directors meet standards of independence determined by NASDAQ and the Board;

    • holding regular executive sessions of the independent members of the Board of Directors and committee meetings which include individual sessions with representatives of the Company's independent registered public accounting firm, as well as the CFO and CEO; and

    ·completion of "360" performance evaluations of each Board members by the other members of the Board of Directors.
    Our management is primarily responsible to manage risk and inform the Board of Directors regarding the most material risks confronting us and our business. The Board of Directors has oversight responsibility of the processes established to monitor and manage such risks. The Board of Directors believes that such oversight function is the responsibility of the entire Board of Directors through frequent reports and discussions at regularly scheduled Board meetings. In addition, the Board has delegated specific risk management oversight responsibility to the Audit Committee and to the independent members of the Board;

  • holding committee meetings which include individual sessions with representatives of our independent registered public accounting firm, as well as with our Chief Financial Officer and our Chief Executive Officer; and

  • completion of "360" performance evaluations of each director by the other members of the Board.

  • The Board is actively involved in the oversight and management of Directors. In particular,the material risks that could affect us. The Board carries out its risk oversight and management responsibilities by monitoring risk directly as a full board and, where appropriate, through its committees. Effective risk oversight is a priority of the Board. These duties are accomplished through the effective use of Board committees that function under written charters adopted by the Board.

    Board Diversity Matrix

    The Company is committed to diversity and inclusion, and believes it is important that the Board is composed of individuals representing the diversity of the communities and customers we serve. The Nominating and Governance Committee seeks director nominees with a diverse range of experience, skills, knowledge and backgrounds. The Board Diversity Matrix set forth below reports self-identified diversity statistics for the current Board as of the date of this proxy statement in the format required by NASDAQ's rules.



    Board Diversity Matrix (As of October 10, 2023)

    Board Size:

    Total Number of Directors

      6


    Gender: Female  Male   Non-
    Binary
     
      Gender
    Undisclosed
     
     
    Number of Directors Based on Gender Identity 1  5       
    Number of Directors Who Identify in Any of the Categories Below:            
    African American or Black -  -  -  - 
    Alaskan Native or American Indian -  -  -  - 
    Asian -  -  -  - 
    Hispanic or Latinx -  -  -  - 
    Native Hawaiian or Pacific Islander -  -  -  - 
    White 1  5  -  - 
    Two or More Races or Ethnicities -  -  -  - 
    LGBTQ+ -  -  -  - 
    Demographic Background Undisclosed -  -  -  - 

    Audit Committee Report for Fiscal 2023

    The following is the report of the Audit Committee oversees management of risks related to accounting, auditing and financial reporting and maintaining effective internal controls for financial reporting. The independent members of the Board of Directors oversee risk management related to corporate governance practices and executive compensation plans and arrangements. These specific risk categories and our risk management practices are reviewed by the entire Board of Directors in the ordinary course of regular Board meetings.

    Communications with the Board of Directors
    Shareholders may communicate directly with our Board of Directors by writing to them at "Board of Directors, c/o Jim Ogilvie, Vice President of Business Development, Dynatronics Corporation, 7030 Park Centre Drive, Cottonwood Heights, Utah 84121." All communications received in this manner will be opened for the sole purpose of determining whether the contents represent a message to our directors, after which they will be forwarded to the director or directors to whom addressed, except for communications that are (1) advertisements, promotions of a product or service, patently offensive material or matters deemed inappropriate for the Board of Directors, (2) solely related to complaints with respect to ordinary course of business, customer service and satisfaction issues, or (3) clearly unrelated to our business, industry, management, Board of Directors, or related committee matters.
    10

    Code of Conduct and Ethics
    We have established a Code of Business Ethics that applies to our officers, directors and employees. The Code of Business Ethics contains general guidelinesthe audited consolidated financial statements for conducting our business consistent with the highest standards of business ethics, and is intended to qualify as a "code of ethics" within the meaning of the Exchange Act and as a "code of business conduct and ethics" within the meaning of the NASDAQ Rules.
    All of our directors, officers and employees must act in accordance with our Code of Business Ethics. Employees and directors are required to report any conduct that they believe in good faith to be an actual or apparent violation of the Code of Business Conduct and Ethics. In addition, our Audit Committee has established procedures to receive, retain and treat complaints received regarding accounting, internal accounting controls, or auditing matters, and to allow for the confidential and anonymous submission by employees of concerns regarding questionable accounting or auditing matters.
    The Code of Business Ethics is available on our website at www.dynatronics.com, in the "Investors, Corporate Policies" section. A copy may also be obtained by writing to the Vice President of Business Development, Dynatronics Corporation, 7030 Park Centre Drive, Cottonwood Heights, Utah 84121.
    DIRECTOR COMPENSATION
    During fiscal year 2017, each non-employee director was paid annual equity compensation having a fair value of $15,000, plus $2,000 for service on the Audit Committee, $1,000 for service on the Compensation Committee and $1,000 for service on the Nominating Committee. Committee chairs were paid $1,000 for service as chair. No additional compensation was paid to members of the Board of Directors who were also employed by the Company as executive officers for their service as directors. The following table summarizes the total compensation paid by us during the fiscal year ended June 30, 2017,2023 included in the Company's Annual Report on Form 10-K.

    REPORT OF THE AUDIT COMMITTEE OF THE BOARD

    Our management is responsible for preparing our financial statements and implementing our financial reporting process, including our system of internal controls over financial reporting pursuant to our non-employee directors.

    Director Compensation Fiscal Year 2017 (1)
     Stock awards Total 
    Name($) ($) 
    (a)
    (c) (h) 
         
    Erin S. Enright $20,000  $20,000 
    David B. Holtz $19,000  $19,000 
    Scott A. Klosterman $19,000  $19,000 
    Brian M. Larkin $17,000  $17,000 
    R. Scott Ward, PhD $17,000  $17,000 

    (1)Columns (b) and (d) through (g) are omitted from this table as no items of compensation referenced in those columns were paid to the directors during the period covered by the table. Total compensation paid to Mr. Cullimore, our Chief Executive Officers and Chairman, who also served as a director during fiscal year 2017, is detailed in the Summary Compensation Table under "Executive Compensation" on page 13 of this Proxy Statement. Executive officers serving as directors received no additional compensation for service as directors during fiscal year 2017.
    Fiscal Year 2018 Director Compensation
     In fiscal year 2018, each non-employee director will be paid an annual cash retainer of $15,000 and equity compensation under our 2015 Equity Incentive Award Plan consisting of 10,000 shares of Common Stock. Committee chairs will receive an additional cash payment of $10,000 for service as the chairsSection 404 of the respective Board committees.
     Family Relationships
    NoneSarbanes-Oxley Act of the directors or executive officers is related to any other director or executive officer of the Company by blood, marriage or adoption.
    11

    EXECUTIVE OFFICERS
    The following table sets forth information concerning our executive officers as of the date of this Proxy Statement. Similar information regarding Mr. Cullimore, who is also a member of our Board of Directors, may be found on page 5, above.
      OfficerPosition
    Name
    AgeSincewith Company
    Kelvyn H. Cullimore, Jr.611983President and CEO
    David A. Wirthlin562016Chief Financial Officer and Secretary
    James N. Ogilvie312016Vice President of Business Development
    Cynthia L. McHenry582017Vice President of Operations
    Bryan D. Alsop552011Vice President of Information Systems
    T. Jeff Gephart562016Senior Vice President of Sales
    Douglas G. Sampson632009Vice President of R&D, Quality and Regulatory
    Kelvyn H. Cullimore, Jr., is our President and Chief Executive Officer. Information regarding Mr. Cullimore's business and education background and experience is included under the heading "Business Experience and Qualifications of Nominees" on page 5 of this Proxy Statement.
    David A. Wirthlin joined Dynatronics and was appointed Chief Financial Officer in October 2016 and our Corporate Secretary in March 2017. He previously was with ArmorWorks Enterprises, LLC, a privately-held military armor technology company located in Arizona, where he served in several capacities. He served as Chief Financial Officer of ArmorWorks from June 2004 until January 2016, and was a consultant on a contract basis to ArmorWorks from January 2016 until his employment by Dynatronics. Mr. Wirthlin had previously served as Chief Financial Officer for Integrated Information Systems, Inc. and SkyMall, Inc., where he led the initial public offering process for each company and subsequently was directly responsible for all Commission related functions. He is a CPA (inactive status) and worked in public accounting and consulting for seven years at Arthur Andersen LLP. Mr. Wirthlin holds an MBA from the University of Chicago and a BS in Accounting from the University of Utah. He is a CPA in the State of Utah (inactive status).
    James N. Ogilvie was appointed Vice President of Business Development in December of 2016; he joined us in August 2015, initially as Director of Business Development. Mr. Ogilvie had previously been with Evolent Health, Inc. (NYSE:EVH), a start-up where he developed strategic business cases for hospital systems. He started his career in the investment banking division of Robert W. Baird where he provided analytical support on equity offerings, mergers and acquisitions and other financial advisory services. Mr. Ogilvie graduated from Brigham Young University, School of Accountancy, receiving an MS and BS in Accounting. His is also a CPA.
    Cynthia L. McHenry was appointed Vice President of Operations in March 2017. For nearly 20 years Ms. McHenry worked for St Jude Medical (now Abbott). She was their Sr. Director of Global Operations, Integration and Site Optimization from 2013 – 2015. Prior to that, she was Director of Product Development and Director of Engineering Operations and Services. Ms. McHenry earned her Master of Business Administration (MBA) degree from Claremont Graduate University, The Peter F. Drucker & Masatoshi Ito Graduate School of Management with additional certificates in Strategy and Leadership. Ms. McHenry received her BS in Business Management from the University of Redlands.
    Bryan D. Alsop was named Vice President of Information Systems in 2016. From July 2011, he served as Vice President of Information Technology. He was a consultant to Dynatronics in early 2009 and joined the Company later that year as the Director of Information Technology. From 2000 to 2008, Mr. Alsop was director of information technology at Bear River Mutual Insurance, where he was responsible for all aspects of the IT department as a member of the executive management team. Previously, he worked for such companies as Aetna Healthcare, McKesson, ITT Defense, Evans & Sutherland, and Sony Pictures Entertainment. He received his Bachelor of Science degree in Computer Science in 1991 from California State University - Northridge.
    T. Jeff Gephart was appointed Senior Vice President of Sales in March 2016. Mr. Gephart spent almost a decade as Vice President of Sales for Chattanooga Group, the Company's largest competitor, managing their extensive sales network. Subsequently, he worked as Director of Sales and Marketing in the US market for Zimmer MedizinSystems, a German manufacturer of rehabilitation products and, most recently, as Director of Sales and Marketing for Gebauer Corporation, where he supervised sales, marketing and customer service for their worldwide operations.
    Douglas G. Sampson was appointed Vice President of Research & Development, Quality and Regulatory in March 2017, and was Vice President of Production and Research and Development from September 2009 to 2017. Prior to joining Dynatronics, Mr. Sampson worked for Philips for 29 years. His positions included executive and management responsibilities in various Philips subsidiaries in Asia and the United States. From 2002, to 2007, he was Country Manager and Managing Director of NXP Semiconductor, Philips Semiconductor Thailand, where he was primarily responsible for all aspects of the manufacturing and sales operations of that subsidiary. Most recently, from 2007 to 2008, he served as Vice President of Outsourced Manufacturing for Fairchild Semiconductors in Singapore. Mr. Sampson earned a Master of Business Administration degree from the University of New Mexico, Anderson School of Management. He also holds a Bachelor of Science degree in electronics engineering technology from Brigham Young University, and an Associate's Degree in electronics engineering technology from Brigham Young University Idaho (formerly Ricks College).
    12

    EXECUTIVE COMPENSATION
    Employment Agreement and Potential Payments upon Termination or Change in Control
    Effective May 1, 2015, we entered into an employment agreement with Kelvyn H. Cullimore, Jr., our Chairman, President and Chief Executive Officer. The agreement was approved by the Compensation Committee of the Board. The compensation package underlying this agreement includes: (1) a base salary of $200,000 per year; (2) an automobile allowance; (3) a discretionary annual bonus (as determined by the Compensation Committee); (4) restricted stock awards and/or stock options granted under our equity compensation plan, as amended, and restated;has the primary responsibility for assuring their accuracy, effectiveness and (5)completeness. Our independent registered public accounting firm, Tanner, is responsible for performing an independent audit of our consolidated financial statements and issuing opinions on the conformity of those audited financial statements with United States generally accepted accounting principles ("GAAP") and the effectiveness of our internal control over financial reporting. The role and responsibility of the Audit Committee is to monitor and oversee these financial processes on behalf of the Board.

    The Audit Committee meets periodically with the independent registered public accountants, with and without management present, to discuss the results of the independent registered public accountants' examinations and evaluations of our internal controls and the overall quality of our financial reporting, and, as appropriate, initiates inquiries into various aspects of our financial affairs. The members of the Audit Committee are not our employees and are not, nor do they represent themselves to be, accountants or auditors by profession, and they do not undertake to conduct auditing or accounting reviews or procedures. Therefore, in performing the Audit Committee's oversight role, the Audit Committee necessarily must rely on management's representations that it has maintained appropriate accounting and financial reporting principles and policies, and appropriate internal control over financial reporting and disclosure controls and procedures designed to ensure compliance with accounting standards and applicable laws and regulations, and that our financial statements have been prepared with integrity and objectivity and in conformity with GAAP, and on the representations of our independent registered public accounting firm included in its reports on our financial statements.

    The Audit Committee currently consists of three directors, all of whom qualify as "independent" and meet the financial literacy and other employee benefitsrequirements under the current NASDAQ listing standards and SEC rules regarding audit committee membership: David B Holtz, Erin S. Enright, and Scott A. Klosterman.


    In this context, the Audit Committee hereby reports as follows:

    (1) The Audit Committee has reviewed and discussed our consolidated audited financial statements with our management.

    (2) The Audit Committee has discussed with Tanner the matters required to be discussed by Auditing Standard No. 1301, "Communications with Audit Committees," as adopted by the Public Company Accounting Oversight Board (the "PCAOB").

    (3) The Audit Committee has received the written disclosures and the letter from Tanner required by the applicable requirements of the PCAOB regarding Tanner's communications with the Audit Committee concerning independence, and the Audit Committee has discussed with Tanner its independence.

    (4) Based on the review and discussions referred to above in (1) through (3), the Audit Committee recommended to the Company's Board, and the Board approved, that are standardthe consolidated audited financial statements be included in such agreements, including, by way of example, life and disability insurance, health insurance, and paid vacation. our Annual Report on Form 10-K for the year ended June 30, 2023 for filing with the SEC.

    Respectfully Submitted by:

    MEMBERS OF THE AUDIT COMMITTEE

    David B. Holtz, Chair

    Erin S. Enright

    Scott A. Klosterman

    Dated: September 28, 2023

    The agreement also contains a provision granting Mr. Cullimore a single lump-sum cash payment of $500,000 within 30 days following a change of control event occurring after May 1, 2015. The agreement defines a "change of control" as an eventinformation contained in which:

    (a)any person or group of persons together with its affiliates, but excluding (i) the Company or any of its subsidiaries, (ii) any employee benefit plans of the Company or (iii) a corporation owned, directly or indirectly, by the shareholders of the Company in substantially the same proportions as their ownership of stock of the Company, is or becomes, directly or indirectly, the "beneficial owner" (as defined in Rule 13d-3 under the Exchange Act) of securities of the Company representing fifty percent (50%) or more of the combined voting power of the Company's then outstanding securities (not including in the securities beneficially owned by such person any securities acquired directly from the Company);
    (b)
     the following individuals cease for any reason to constitute a majority of the number of directors then serving: individuals who, on May 1, 2015, constitute the Board and any new director (other than a director whose initial assumption of office is in connection with an actual or threatened election contest, including but not limited to a consent solicitation, relating to the election of directors of the Company) whose appointment or election by the Board or nomination for election by the Company's shareholders was approved or recommended by a vote of at least two-thirds (2/3) of the directors then still in office who either were directors on the effective date of the agreement or whose appointment, election or nomination for election was previously so approved or recommended;
    (c)the consummation of a merger or consolidation of the Company or any direct or indirect subsidiary of the Company with any other corporation or entity regardless of which entity is the survivor, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or being converted into voting securities of the surviving entity) more than fifty percent (50%) of the combined voting power of the voting securities of the Company, such surviving entity or any parent thereof outstanding immediately after such merger or consolidation; or
    (d)the shareholders of the Company approve a plan of complete liquidation or winding-up of the Company or there is consummated an agreement for the sale or disposition by the Company of all or substantially all of the Company's assets.
    Notwithstanding the foregoing, a change of controlabove report shall not be deemed to have occurred by virtue of the consummation of any transactionbe "soliciting material" or series of integrated transactions immediately following which the holders of the Common Stock of the Company immediately prior to such transaction or series of transactions continue to have substantially the same proportionate ownership in an entity which owns all or substantially all of the assets of the Company immediately following such transaction or series of transactions, and a change of control shall not occur for purposes of the agreement as a result of any primary or secondary offering of Company Common Stock to the general public through a registration statement filedbe "filed" with the Commission.
    13

    In addition, notwithstandingSEC, nor shall such information be incorporated by reference into any future filing under the foregoing,Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except to the extent that any payment under the agreement is payable solely upon or following the occurrence of a change of control and such payment is treated as "deferred compensation" for purposes of §409A of the Internal Revenue Code, no event that would not qualify as a "change in the ownership of the Company," a "change in the effective control of the Company," or a "change in the ownership of a substantial portion of the assets of the Company" as such terms are defined in §1.409A-3(i)(5) of the Treasury Regulations, shall be treated as a change of control under the agreement.
    If a change of control occurs, Mr. Cullimore's stock options, stock awards, warrants and other similar rights granted to him prior to termination will immediately and entirely vest and will be immediately delivered to him without restriction or limitation of any kind (except for normal transfer restrictions requiredwe specifically incorporate it by law). In the event of termination prior to the expiration of the term of the agreement, we are also obligated to pay Mr. Cullimore a separation payment equal to 12 months' salary.
    The agreement also provides that upon termination of employment we will transfer to Mr. Cullimore title, free and clear of all encumbrances, to either the Company-owned vehicle used by him at the time of termination, or a vehicle of substantially similar market value. The agreement terminates upon Mr. Cullimore's death or disability or upon termination of his employment for cause. The agreement also contains covenants against competition during the term of his employment and for eighteen months after the termination.
    SUMMARY COMPENSATION TABLE
    The following table summarizes information concerning the compensation awarded to, earned by or paid to, our Chief Executive Officer and the two most highly paid executive officers of the Company other than our Chief Executive Officer who were serving as executive officers as of June 30, 2017, and one former executive officer of the Company who was not serving as of such date (collectively, our "Named Executive Officers") for the periods indicated:
    Name
    and
    Principal
    Position
    Year
    ended
    June 30,
     
    Salary
    ($)
      
    Bonus /
    Severance
    ($)
      All Other Compensation ($) (Note 1)  
    Total
    ($)
     
    (a)(b) (c)  (d)  (i)  (j) 
    Kelvyn H. Cullimore, Jr. 2017 $200,000  $0  $31,202  $231,202 
    Chairman, President/CEO2016 $200,000  $0  $28,106  $228,106 
                      
    T. Jeff Gehpart2017 $175,512  $19,732  $3,678  $198,922 
    Sr. VP Sales2016 $50,769  $10,511  $1,221  $62,501 
                      
    Bryan D. Alsop2017 $135,000  $0  $13,883  $148,883 
    VP Information Systems2016 $133,115  $0  $13,314  $146,429 

    (1)For each of the individuals listed in the table above, amounts indicated under "All Other Compensation" (column (i)) include but are not limited to perquisites including the dollar value of insurance premiums paid with respect to health and dental insurance, use of Company paid automobile, and cellular phone. No single item included in this column exceeds $25,000 or 10% of the total in the category. Columns (e) through (h) are omitted from this table, as no compensation of the types referred to in those columns was paid to the Named Executive Officers during the periods indicated.
    401(k) Plans
    We maintain three 401(k) plans for our employees at Dynatronics Corporation (the "Dynatronics Plan") and our subsidiaries, Hausmann Enterprises, LLC (the "Hausmann Plan") and Bird & Cronin, LLC (the "Bird & Cronin Plan).
    14

    Dynatronics Plan. Under the Dynatronics plan, employees who are 20 years of age or older and have completed at least one month of service with Dynatronics are eligible to participate. Eligible employees may contribute to the Dynatronics Plan in the form of salary deferrals of up to $18,000, the maximum allowable for calendar year 2017. Eligible employees who are over 50 years old may contribute an additional $6,000 in catchup contributions during calendar year 2017. We match annual employee contributions at 25% of employee contributions, up to a maximum of $500 per employee per year. Participants in the Dynatronics Plan are fully vested in their salary deferral contributions, and employer matching contributions vest at 20% per year after two years of service (100% vested after 6 years). Amounts deferred by Named Executive Officers in the Dynatronics Plan, along with the 25% matching contributions, are included under "All Other Compensation" in the "Summary Compensation Table".
    Hausmann Plan. Under the Hausmann Plan, employees who are 21 years of age or older and have completed a year of service with more than 1,000 hours of service with Hausmann are eligible to participate. Eligible employees may contribute to the Hausmann Plan in the form of salary deferrals of up to $18,000, the maximum allowable for calendar year 2017. Eligible employees who are over 50 years old may contribute an additional $6,000 in catchup contributions during calendar year 2017. We match employee contributions at 50% of up to the first 6% of employee compensation. Participants in the Hausmann Plan are fully vested in their salary deferral contributions, and employer matching contributions vest 10% after one year with more than 1,000 hours of service and 20% each year thereafter (100% vested after 6 years with more than 1,000 hours of service).
    Bird & Cronin Plan. Under the Bird & Cronin plan, employees who are 21 years of age or older and have completed six months of service with more than 500 hours of service with Bird & Cronin are eligible to participate. Eligible employees may contribute to the Bird & Cronin Plan in the form of salary deferrals of up to $18,000, the maximum allowable for calendar year 2017. Eligible employees who are over 50 years old may contribute an additional $6,000 in catchup contributions during calendar year 2017. We match employee contributions at 100% of up to the first 5% of employee compensation. Participants in the Bird & Cronin Plan are fully vested in their salary deferral contributions, and employer matching contributions vest 20% per year after two years of service with more than 1,000 hours of service (100% vested after 6 years with more than 1,000 hours of service).
    Section 162(m) Treatment Regarding Performance-Based Equity Awards
    Under Section 162(m) of the Internal Revenue Code, a public company is generally denied deductions for compensation paid to its chief executive officer and the next four most highly compensated executive officers to the extent the compensation for any such individual exceeds $1,000,000 for the taxable year. Our executive compensation programs are designed to preserve the deductibility of compensation payable to executive officers, although deductibility is just one among a number of factors considered in determining appropriate levels or types of compensation.
    OUTSTANDING EQUITY AWARDS AS OF FISCAL YEAR-END 2017
    The following table summarizes the outstanding equity awards held by our Named Executive Officers as of June 30, 2017:
         Stock Awards       
     
     
     
     
     
     
     
    Name
    (a)
     
    Number of
    securities
    underlying unexercised
    options
    (#) exercisable
    (b)
      
    Option
    exercise
    price
    ($)
    (e)
      
    Option
    expiration
    date
    (f)
      
    Number of
    shares
    or units
    of stock
    that have
    not
    vested (#)
    (g)
      
    Market value
    of shares
    or units of
    stock that
    have not
    vested ($)
    (h)
     
     
    Kelvyn H. Cullimore, Jr.
      10,000  $3.34  11/20/2025   102,000  $275,400 
                        
    Larry K. Beardall  0  $0.00   N/A   0  $0 
                         
    T. Jeff Gephart  3,750  $2.87  3/1/2026   11,250  $30,375 
                         
    Bryan D. Alsop  5,000  $4.15  7/28/2019   0  $0 

    15

    SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
    The following table sets forth information, as of October 16, 2017 (the "Table Date"), except as indicated in the footnotes below, for the following: (1) each person whom we know beneficially owns more than 5% of our Common Stock; (2) each of our directors and director nominees; (3) each of our Named Executive Officers; and (4) all of our executive officers and directors as a group. As of the Table Date, 4,823,694 shares of Common Stock were issued and outstanding. Unless otherwise indicated, the address of each beneficial owner listed in the table is c/o Dynatronics Corporation, 7030 Park Centre Drive, Cottonwood Heights, Utah 84121.
    We have determined beneficial ownership in accordance with the rules of the Commission. Except as indicated in the footnotes below, we believe, based on the information furnished to us, that the persons named in the table below have sole voting and investment power with respect to all shares of Common Stock that they beneficially own, subject to applicable community property laws. In computing the number of shares beneficially owned by each person or group as of the Table Date, we included shares of Common Stock that such person or group had the right to acquire on or within 60 days after the Table Date, including, but not limited to, shares issuable upon the exercise of options or warrants, conversion of preferred stock, or the vesting of restricted share awards that would vest or could settle on or within 60 days after the Table Date. We did not deem these shares outstanding, however, for the purpose of computing the percentage ownership of any other person. Beneficial ownership representing less than one percent is denoted with an asterisk (*).
    Principal Shareholders, Security Ownership of Holders of More than 5% of Voting Securities
     
    Name of Beneficial Owner
     
    Number
    of Shares
      
    Percent
     of Class
      
    Percent
     of Voting
     
    Stuart M. Essig  3,285,294
    (1) 
      42.8%   17.3% 
    174 Nassau Street #320            
    Princeton, NJ 08542            
                 
    Stuart M. Essig 2007 Family Trust   637,474
    (2) 
      11.8%   3.5% 
    174 Nassau Street #320            
    Princeton, NJ 08542            
                 
    Provco Ventures I LP  1,996,944
    (3) 
      30.6%   11.0% 
    795 E. Lancaster Ave. Suite 200            
    Villanova, PA 19085            
                 
    Brian Baker   255,607
    (4) 
      5.0%   1.2% 
    25251 Nueva Vista            
    Laguna Niguel, CA 92677            
                 
    John Henneman and Keryl Rowden   255,607
    (5) 
      5.0%   1.2% 
    c/o NewLink Genetics            
    2700 Via Fortuna Drive            
    Terrace II Suite 100            
    Austin, TX 78746            
                 
    David H. Hausmann  318,941
    (6)
      6.3%   2.3% 
    71 Briarwood Avenue            
    Norwood, NJ 07648            
                 
    Armistice Capital, LLC  1,771,891
    (7) 
      29.2%   12.5% 
    c/o Steven Boyd            
    510 Madison Ave, 22nd Floor            
    New York, NY 10022            
                 
    First Light Focus Fund LP  354,379
    (8)
      7.0%   2.5% 
    3300 Edinborough Way, Suite 201            
    Edina, MN 55435            
    16

    (1)Mr. Essig is an observer to our Board of Directors and the husband of Erin Enright, a Preferred Director and member of our Board of Directors. The amount indicated includes 880,000 shares of Common Stock issuable upon conversion of Series A Preferred Stock, 260,000 shares of Common Stock issuable upon conversion of Series B Preferred Stock, and 1,710,000 shares of Common Stock issuable upon the exercise of warrants beneficially owned by Mr. Essig. Amount indicated does not include 398,010 shares of Common Stock issuable upon conversion of Series C Preferred Stock following shareholder approval. Mr. Essig has sole voting and dispositive power over all shares of stock indicated; neither Ms. Enright nor the Essig Trust (see Note 2 to this table, below) has shared voting or dispositive power over the shares owned of record by Mr. Essig.
    (2)
    Mr. Essig is the Settlor/Grantor of The Stuart M. Essig 2007 Family Trust ("Essig Trust"). Mr. Essig's wife, Erin S. Enright, is Trustee of the Essig Trust and is a Preferred Director and member of our Board of Directors. Shares include 188,800 shares of Common Stock issuable upon conversion of Series A Preferred Stock, 40,000 shares issuable upon conversion of Series B Preferred Stock, and 343,200 shares issuable upon exercise of warrants owned of record by the Essig Trust. Ms. Enright and the Essig Trust have shared voting and dispositive power over all shares of stock held by the Essig Trust; Mr. Essig has no voting or dispositive power over such shares. Amount indicated also includes 15,456 shares of Common Stock held of record by Ms. Enright; however, Ms. Enright has sole voting and dispositive power over those shares of Common Stock owned of record by Ms. Enright and neither the Essig Trust nor Mr. Essig has shared voting or dispositive power over such shares. (See Note 2 to "Security Ownership of Management and Directors" table, below.)
    (3)The General Partner of Provco Ventures I, LP is Provco, LLC. The sole member of Provco, LLC is Richard E. Caruso, Ph.D. The amount indicated includes 484,000 shares of Common Stock issuable upon conversion of Series A Preferred Stock, 200,000 shares of Common Stock issuable upon conversion of Series B Preferred Stock, and 1,026,000 shares of Common Stock issuable upon the exercise of warrants held by Provco. Amount indicated does not include 300,000 shares of Common Stock issuable upon conversion of Series C Preferred Stock owned by Provco once shareholder approval is obtained at the Annual Meeting.
    (4)The amount indicated includes 96,000 shares of Common Stock issuable upon conversion of Series A Preferred Stock, and 144,000 shares of Common Stock issuable upon the exercise of warrants held by Mr. Baker.
    (5)The amount indicated includes 96,000 shares of Common Stock issuable upon conversion of Series A Preferred Stock, and 144,000 shares of Common Stock issuable upon the exercise of warrants held by John Henneman and Keryl Rowden.
    (6)The amount indicated includes 90,000 shares of Common Stock issuable upon conversion of Series B Preferred Stock, and 135,000 shares of Common Stock issuable upon the exercise of warrants held by Mr. Hausmann.
    (7)
    Amount indicated includes 500,000 shares of Common Stock issuable upon conversion of Series B Preferred Stock, and 750,000 shares of Common Stock issuable upon the exercise of warrants held by Armistice. Amount indicated does not include 760,000 shares of Common Stock issuable upon conversion of Series C Preferred Stock owned by Armistice once shareholder approval is obtained at the Annual Meeting.
    (8)Amount indicated includes 100,000 shares of Common Stock issuable upon conversion of Series B Preferred Stock, and 150,000 shares of Common Stock issuable upon the exercise of warrants held by First Light. Amount indicated does not include 680,000 shares of Common Stock issuable upon conversion of Series C Preferred Stock owned by First Light once shareholder approval is obtained at the Annual Meeting.

    17

    Security Ownership of Management and Directors
     Name of Beneficial Owner 
    Number
     of Shares
        
    Percent
    of Class
     
    Directors        
    Kelvyn H. Cullimore, Jr. (CEO/Director)  207,258  
    (1) 
      4.1%
    Erin S. Enright (Director)  3,922,768  
    (2) 
      47.6%
    David B. Holtz (Director)  14,684  
    (3) 
      * 
    Scott A. Klosterman (Director)  14,684     * 
    Brian M. Larkin (Director)  210,276  
    (4) 
      4.2%
    R. Scott Ward (Director)  14,991     * 
               
    Named Executive Officers          
    T. Jeff Gephart  22,956  
    (5) 
      * 
    Bryan D. Alsop  5,000  
    (6) 
      * 
    All executive officers and directors as a group (8 persons)  4,412,617     51.8%
    (1)Includes 72,000 shares of restricted Common Stock that vest upon retirement, change of control or death, 10,000 shares of Common Stock owned of record by Mr. Cullimore's wife, and options held by Mr. Cullimore for the purchase of 10,000 shares of Common Stock.
    (2)Ms. Enright is a Preferred Director and member of our Board of Directors; she is also a Managing Member of Prettybrook. The amount indicated includes 15,456 shares of Common Stock held of record by Ms. Enright. Neither Ms. Enright nor Prettybrook has shared voting or dispositive power over any other shares indicated, including: 880,000 shares of Common Stock issuable upon conversion of Series A Preferred Stock, 260,000 shares of Common Stock issuable upon conversion of Series B Preferred Stock, and 1,710,000 shares of Common Stock issuable upon the exercise of warrants beneficially owned by Mr. Essig as indicated in the table on page 17, above, for which Mr. Essig has sole voting and dispositive power. Amount indicated also includes 188,800 shares of Common Stock issuable upon conversion of Series A Preferred Stock, 40,000 shares issuable upon conversion of Series B Preferred Stock, and 343,200 shares issuable upon exercise of warrants beneficially owned by the Essig Trust, of which Ms. Enright is the Trustee.
    (3)Mr. Holtz is a Preferred Director and a member of our Board of Directors. Mr. Holtz is an executive officer of Provco, LLC, the general partner of Provco Ventures I LP.
    (4)Mr. Larkin is a Preferred Director and a member of our Board of Directors. The amount indicated includes 48,000 shares issuable upon conversion of shares of Series A Preferred Stock, 20,000 shares issuable upon conversion of Series B Preferred Stock, and 102,000 shares issuable upon the exercise of warrants beneficially owned by Mr. Larkin. Amount indicated excludes 40,000 shares of Common Stock issuable upon conversion of Series C Preferred Stock once shareholder approval of Proposal No. 3 is obtained.
    (5)Mr. Gephart is our Senior Vice President of Sales. The amount indicated includes 5,600 shares of Common Stock issuable upon conversion of Series A Preferred Stock and 8,400 shares underlying the warrants held by Mr. Gephart.
    (6)Mr. Alsop is our Vice President of Information Systems. The amount indicated includes 5,000 shares of Common Stock issuable upon exercise of options held by Mr. Alsop.

    18

    SECTION 16(A) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE
    Section 16(a) of the Exchange Act requires the Company's officers and directors, and persons who own more than 10% of a registered class of the Company's equity securities, to file reports of securities ownership and changesreference in such ownership with the Commission. Officers, directors and greater than ten percent shareholders also are required by Commission rules to furnish the Company with copies of all Section 16(a) forms they file.
    Based solely on review of the copies of the Forms 3, 4 and 5 (and amendments thereto) furnished to us during and with respect to the fiscal year ended June 30, 2017, we believe that during the fiscal year ended June 30, 2017, all Section 16(a) filings required to be made by these persons were filed and that such filings were timely except we understand that Provco Ventures I LP filed four late reports disclosing four transactions, Stuart M. Essig filed four late reports disclosing four transactions, and our director Brian M. Larkin filed on late report disclosing one transaction.
    Equity Compensation Plans
    As of June 30, 2017, we had equity awards outstanding under two plans: the 2005 Dynatronics Equity Incentive Award Plan ("2005 Plan") and the 2015 Dynatronics Equity Incentive Award Plan ("2015 Plan"). The 2015 Plan was approved by our shareholders on June 29, 2015. Outstanding awards under these plans expire (if not exercised) on the expiration date indicated in the respective awards, or, if no expiration date is indicated in such award, on the tenth anniversary of the grant date of the award. Nonqualified and incentive stock options and other awards have been granted to our employees, officers, directors and consultants under these plans. The Compensation Committee administers these plans.
    As of June 30, 2017, options for the purchase of 74,473 shares of Common Stock were exercisable and a total of 166,990 shares are subject to options outstanding under the 2005 Plan and 2015 Plan. As of June 30, 2017, a total of 299,549 shares were available for issuance through options or awards yet to be granted under the 2015 Plan. The following table sets forth information as of June 30, 2017 about our stock option plans and our non-plan options under which our equity securities are authorized for issuance.
    Equity Compensation Plan Information
    Plan Category 
    Number of
    securities to
    be issued upon exercise of outstanding
    options,
    warrants and
    rights
    (a)
      
    Weighted-
    average
    exercise
    price
    of outstanding
    options,
    warrants
    and rights
    (b)
      
    Number of
    securities
    remaining
    available for
    future
    issuance under
    equity
    compensation
    plans (excluding securities
    reflected in
    column
    (a))
    (c)
     
    Equity compensation plans approved by security holders  166,990  $3.14   299,549 
    Equity compensation plans not approved by security holders  72,000  $0.00   0 
    Total  238,990  $2.20   299,549 
    CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
    Review, Approval or Ratification of Transactions with Related Persons
    We have adopted a policy that any transactions with directors, executive officers or entities of which they are also officers or directors or in which they have a financial interest, will only be on terms consistent with industry standards and approved by a majority of the disinterested directors of our Board of Directors. Our bylaws provide that no such transactions by us shall be either void or voidable solely because of such relationship or interest of directors or officers or solely because such directors are present at the meeting of our Board of Directors or a committee thereof which approves such transactions, or solely because their votes are counted for such purpose if:
    19

    ·The fact of such common directorship or financial interest is disclosed or known by our Board of Directors or committee and noted in the minutes, and our Board of Directors or committee authorizes, approves or ratifies the contract or transaction in good faith by a vote for that purpose without counting the vote or votes of such interested directors; or
    ·The fact of such common directorship or financial interest is disclosed to or known by the shareholders entitled to vote, and they approve or ratify the contract or transaction in good faith by a majority vote or written consent of shareholders holding a majority of the shares of Common Stock entitled to vote (the votes of the interested directors or officers shall be counted in any such vote of shareholders); or
    ·The contract or transaction is fair and reasonable to us at the time it is authorized or approved.
    In addition, interested directors may be counted in determining the presence of a quorum at a meeting of our Board of Directors or a committee thereof that approves such transactions. If there are no disinterested directors, we shall obtain a majority vote of the shareholders approving the transaction.
    filing.

    PROPOSAL NO. 2

    RATIFICATION OF SELECTION OF

    TANNER LLC AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
    FOR FISCAL 2024

    General

    The Board of Directors is asking

    At the shareholdersAnnual Meeting, you will be asked to ratify the Audit Committee's appointment of Tanner LLC ("Tanner") as Dynatronics'our independent registered public accounting firm for the fiscal year ending June 30, 2018. While ratification of the selection of auditors by the shareholders is not required and is not binding upon the Audit Committee or the Company, in the event of a negative vote on such ratification, the Audit Committee might choose to reconsider its selection. Even if the appointment is ratified, the Audit Committee, in its discretion, may direct the appointment of a different independent registered public accounting firm at any time during the year if the Audit Committee determines that such a change would be in Dynatronics' and its shareholders' best interests.

    The Audit Committee is directly responsible for the appointment, determination of the compensation for, and retention and oversight of the work of the independent registered public accounting firm retained to audit Dynatronics' consolidated financial statements. The Audit Committee has appointed Tanner as our independent registered public accounting firm for fiscal 2018 and is responsible for pre-approving all audit and permissible non-audit services to be provided by Tanner.
    THE BOARD, UPON THE RECOMMENDATION OF THE AUDIT COMMITTEE, RECOMMENDS THAT THE SHAREHOLDERS VOTE "FOR" THE APPROVAL AND RATIFICATION OF TANNER LLC AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR FISCAL YEAR ENDING JUNE 30, 2018.
    CHANGES IN CERTIFYING ACCOUNTANT
    On October 24, 2016, the Audit Committee approved the engagement of Tanner as the Company's independent registered public accounting firm for the Company's fiscal year ending June 30, 2017. Also, the Audit Committee informed BDO USA, LLP ("BDO") that it had been dismissed, effective October 24, 2016, as the Company's independent registered public accounting firm. BDO had been engaged as our independent registered public accounting firm in July 2016, for the fiscal year ended June 30, 2016, when we dismissed Mantyla McReynolds LLC, which had been our independent registered public accounting firm for the two years ended June 30, 2015. Mantyla McReynolds LLC combined with BDO effective July 1, 2016.
    During the fiscal year ended June 30, 2016, and the subsequent interim period through October 24, 2016, the Company had (i) no disagreements within the meaning of Item 304(a)(1)(iv) of Regulation S-K and the instructions thereto with BDO on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, any of which that, if not resolved to BDO's satisfaction, would have caused it to make reference to the subject matter of any such disagreement in connection with its reports for such years and interim period and (ii) no reportable events within the meaning of Item 304(a)(1)(v) of Regulation S-K.
    20

    BDO's report on the Company's consolidated financial statements for the fiscal year ended June 30, 2016, did not contain any adverse opinion or disclaimer of opinion, nor was the report qualified or modified as to uncertainty, audit scope, or accounting principles.
    During the fiscal year ended June 30, 2016, and the subsequent interim period through October 24, 2016, neither the Company nor anyone on its behalf has consulted with Tanner regarding (i) the application of accounting principles to a specific transaction, either completed or proposed, (ii) the type of audit opinion that might be rendered on the Company's financial statements, (iii) any matter that was the subject of a disagreement within the meaning of Item 304(a)(1)(iv) of Regulation S-K and the instructions thereto, or (iv) any reportable event within the meaning of Item 304(a)(1)(v) of Regulation S-K.
    In accordance with Item 304(a)(3) of Regulation S-K, the Company provided BDO a copy of the disclosures made above, which were also made in the Company's Current Report on Form 8-K prior to filing such report with the Commission, and requested that BDO furnish the Company with a letter addressed to the Commission stating whether or not BDO agrees with the above statements. A copy of the letter was filed with the Current Report.
    Independence
    Tanner has advised us that it has no direct or indirect financial interest in the Company or in any of its subsidiaries and that during 2017 it had no connection with the Company or any of its subsidiaries, other than as its independent registered public accounting firm or in connection with certain other activities, as described below.
    2024. Representatives of Tanner are expected to be present at the Annual Meeting, and will have the opportunity to make a statementstatements if they desire to do so. It is also expected that those representatives will be availableso and to respond to appropriate questions. Tanner has served as our independent registered public accounting firm since 2016.

    Vote Required

    If a quorum is present, the affirmative vote of a majority of the votes cast on this proposal at the Annual Meeting is required for ratification of our independent registered public accounting firm.  Abstentions will be counted as present for purposes of determining the presence of a quorum, but will not be considered as votes cast either "FOR" or "AGAINST" the proposal and will therefore have no effect on the outcome of the vote.

    Neither our Bylaws nor other governing documents or law requires shareholder ratification of the selection of Tanner as our independent registered public accounting firm. However, the Audit Committee is submitting the selection of Tanner to the shareholders for ratification as a matter of good corporate practice. If the shareholders fail to ratify the selection, the Audit Committee will reconsider whether or not to retain that firm. Even if the shareholders ratify the selection, the Audit Committee in its discretion may direct the appointment of different independent auditors at any time during the year if they determine that such a change would be in our best interests and in the best interests of our shareholders.

    PRINCIPAL ACCOUNTANT FEES AND SERVICES

    Independence

    Tanner has advised us that it has no direct or indirect financial interest in us or in any of our subsidiaries and that during fiscal year 2023, it had no connection with us or any of our subsidiaries, other than as our independent registered public accounting firm or in connection with certain other services, as described below.

    Principal Accountant Fees and Services

    During fiscal year 2016, BDO provided2023, we entered into an engagement agreement with Tanner, which sets forth the terms by which Tanner agreed to perform audit services for us. Those services consisted of the audit of our annual consolidated financial statements and review of the quarterly financial statements.

    During fiscal year 2022, Tanner performed services consisting of the audit of theour annual consolidated financial statements and review of the Company for the fiscal year 2016. BDO did not perform anyquarterly financial information systems design and implementation services for the Company for fiscal year 2016.

    During fiscal year 2017, Tanner provided services consisting of the audit of the annual consolidated financial statements of the Company for the fiscal year ended June 30, 2017. statements.

    Tanner did not perform any financial information systems design and implementation services for us or our subsidiaries in fiscal years 2023 or 2022.

    The following table summarizes the Company forfees paid by us to Tanner during fiscal year 2017.

    years 2023 and 2022.

    Type of Service and Fee   2023   2022  
    Audit Fees (1)$239,100 $190,600 
    Audit Related Fees (2)$25,800 $9,560 
    Tax Fees    - 
    All Other Fees$1,791  - 
    Total Fees$266,691 $200,160 

    (1) Audit Fees

    The aggregate fees billed by BDOrepresent fees for professional services rendered for the fiscal year ended June 30, 2016,provided in connection with (i) the audit of our annual financial statements set forth in our Annual Report on Form 10-K forand internal control over financial reporting, the fiscal year then ended, and (ii) the reviewsreview of our quarterly financial statements, set forth in our Quarterly Reports on Form 10-Q for each of our fiscal quarters during the period then ended, totaled approximately $96,000.
    The fees billed by Tanner for professionaland audit services rendered for the fiscal year ended June 30, 2017provided in connection with (i) the audit of our annual financial statements set forth in our Annual Report on Form 10-K for the fiscal year then ended, and (ii) the reviews of our quarterly financial statements set forth in our Quarterly Reports on Form 10-Q for each of our fiscal quarters during the period then ended, totaled approximately $160,000.
    Audit-Related Fees
    No fees were billed by Tannerother statutory or BDO in each of the last two fiscal years for other assurance and related services.
    regulatory filings.

    (2) Audit-related fees paid to BDO in fiscal year 2016 totaled approximately $31,000 and were in connection with our private placement of Series A Preferred Stock in 2015, and our selling shareholder registration statementsprimarily included fees related to the 2015 offering of Series A Preferred Stockaccounting consultation and warrantsattestation services.

    Pre-approval Policies and underlying Common Stock. Audit-related fees paid to BDO in fiscal year 2017 totaled approximately $33,000 and were in connection with our selling shareholder registration statements related to our 2016 private placement of Series A Preferred Stock, and our 2017 private placement of units of Common Stock, Series B Preferred Stock and warrants ("Units"), and underlying Common Stock.

    21

    Audit-related fees paid to Tanner in fiscal year 2017 totaled approximately $5,000 and were in connection with the private placement of the Units, and our selling shareholder registration statements related to the 2016 private placements of our Series A Preferred Stock and the Units, as well as review of our Current Reports on Form 8-K associated with our acquisition of Hausmann.
    Other fees paid to Tanner for professional services rendered during the fiscal year ended June 30, 2017 in connection with our acquisition of Hausmann in April 2017, totaled approximately $120,000.
    All fees described above were approved by the Company's Audit Committee.
    Audit Committee Policy Regarding Pre-Approval of Audit and Permissible Non-Audit Services of the Company's Independent Registered Public Accounting Firm
    Procedures

    The Audit Committee has established a policy that all audit and permissible non-audit services provided by the independent registered public accounting firm will be pre-approved by the Audit Committee. These services may include audit services, audit-related services, tax services and other services. The Audit Committee considers whether the provision of each non-audit service is compatible with maintaining the independence of the independent registered public accounting firm. Pre-approval is detailed as to the particular service or category of services and is generally subject to a specific budget. The independent registered public accounting firm and our management are required to periodically report to the Audit Committee regarding the extent of services provided in accordance with this pre-approval, and the fees for the services performed to date.

    REPORT OF THE AUDIT COMMITTEE
    The following is the report of the Audit Committee with respect to the Company's audited financial statements for the year ended June 30, 2017. The information contained in this report shall not be deemed "soliciting material" or otherwise considered "filed" with the Commission, and such information shall not be incorporated by reference into any future filing under the Securities Act or the Exchange Act except to the extent that the Company specifically incorporates such information by reference in such filing.

    The Audit Committee has revieweddetermined that the rendering of services other than audit services by Tanner is compatible with maintaining the principal accountant's independence.

    Recommendation of the Board

    THE BOARD RECOMMENDS A VOTE "FOR" PROPOSAL NO. 2 RATIFYING THE SELECTION OF TANNER AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR FISCAL YEAR ENDING JUNE 30, 2024.


    PROPOSAL NO. 3 -APPROVAL OF A REVERSE STOCK SPLIT OF THE COMPANY'S COMMON STOCK

    General

    The Board has unanimously adopted a resolution approving, and discussedrecommending that our shareholders approve a resolution authorizing our Board to effect a reverse stock split of our outstanding common stock, at any time within one year from the date of shareholder approval, by a ratio of not less than 1-for-5 and not more than 1-for-10 shares (the "Exchange Ratio"), with Dynatronics' managementthe specific ratio, timing and Tanner LLC the audited consolidated financial statements of Dynatronics contained in Dynatronics' Annual Report on Form 10-K for the 2017 fiscal year. The Audit Committee has also discussed with Tanner LLC the matters requiredterms to be discusseddetermined by Auditing Standard No. 16, Communications with Audit Committees.

    The Audit Committee has received and reviewed the written disclosures and the letter from Tanner LLC required by applicable requirements of the Public Company Accounting Oversightour Board, regarding the independent accountant's communications with the Audit Committee concerning independence, and has discussed with Tanner LLCin its independence from Dynatronics.
    Based on the review and discussions referred to above, the Audit Committee recommended to the Board of Directors that the audited consolidated financial statements be included in Dynatronics' Annual Report on Form 10-K for its 2017 fiscal year for filing with the Securities and Exchange Commission.
    Respectfully submitted:
    THE AUDIT COMMITTEE
    David Holtz, Chairman
    Erin S. Enright
    Scott A. Klosterman
    22

    PROPOSAL NO. 3
    APPROVAL OF THE ISSUANCE OF COMMON STOCK (OR SECURITIES CONVERTIBLE
    INTO OR EXERCISABLE FOR COMMON STOCK) REPRESENTING MORE THAN 19.99% OF THE OUTSTANDING COMMON STOCK OR VOTING POWER OF THE COMPANY IN CONNECTION WITH THE ACQUISITION OF THE ASSETS OF BIRD & CRONIN
    The "NASDAQ Acquisition Rule" (NASDAQ Listing Rule 5635(a)) requires shareholder approval prior to the issuance of securities in connection with an acquisition of the stock or assets of another company where the total number of shares of common stock to be issued is or will be equal to or in excess of 20% of the total number of shares of common stock outstanding before the issuance of the stock or securities. We are seeking shareholder approval to allow conversion of the Series C Preferreddiscretion (the "Reverse Stock and the Series D Preferred Stock and for the exercise of the Warrants, in excess of 19.99% of our issued and outstanding Common Stock and the voting power of the Company, because the proceeds of the sale of the Series C Preferred Stock and the Warrants were used to finance the acquisition of the assets of Bird & Cronin as described in this Proxy Statement (the "Acquisition") and because the Series D Preferred Stock was issued as part of the consideration paid for the assets of Bird & Cronin.
    We are not seeking shareholder approval of the Acquisition or the use of proceeds from the sale of the Series C Preferred Stock or the Warrants. Shareholder approval of Dynatronics shareholders is not required under Utah law. For additional information about our acquisition of Bird & Cronin, including a detailed summary of the terms of the Asset Purchase Agreement entered into in connection with the Acquisition (the "Asset Purchase Agreement"), see the sections entitled "Background of the Acquisition" and "The Asset Purchase Agreement."
    Proposal No. 3 is not seeking authorization or approval of our shareholders to enter into the Securities Purchase Agreement among the Company and the purchasers of the Series C Preferred Stock and the related Warrants (the "Securities Purchase Agreement") described below, to enter into the Asset Purchase Agreement, to consummate the sale of the Series C Preferred Stock or to complete the Acquisition of Bird & Cronin. Securities Purchase Agreements for the sale of $7,000,000 of Series C Preferred Stock have already been executed and 2,800,000 shares of Series C Preferred Stock have been issued by the Company. In addition, in connection with the offer and sale of the Series C Preferred Stock, we have issued Warrants to purchase 1,400,000 shares of Common Stock. Upon approval of Proposal No. 3 at the Annual Meeting, the Series C Preferred Stock becomes convertible in an amount representing in excess of 19.99% of our Common Stock outstanding and the Warrants become exercisable. Immediately upon approval of Proposal No. 3, the Series C Preferred Stock will automatically convert to Common Stock, except to the extent, if any, that a shareholder of the Series C Preferred Stock has previously elected to be subject to the Beneficial Ownership Limitation (as defined below), in which case such shareholder's conversion will be restricted to the amount of the applicable Beneficial Ownership Limitation. Remaining, i.e., unconverted shares of Series C Preferred Stock will no longer have any preferences as to liquidation, redemption, or payment of dividends.
    If the Company does not receive approval of this Proposal No. 3, the Series C Preferred Stock will continue to be non-voting stock, entitled to payment of dividends quarterly at an annual rate of 6%, but will not be convertible until shareholder approval can be obtained at a future meeting of the shareholders. Similarly, the Warrants will not be exercisable until we have obtained shareholder approval.
    Background and Reasons for the Series C Financing
    On September 26, 2017, we entered into Securities Purchase Agreements with certain accredited investors (the "Preferred InvestorsSplit"), pursuant to which we agreedan amendment (the "Amendment") to (i) issueour Articles of Incorporation.

    If this proposal is approved by the shareholders, the Board will be granted the discretionary authority to select any ratio not less than 1 for 5 and sell an aggregate of 2,800,000 shares of Series C Preferrednot greater than 1 for 10, should it decide to proceed with the Reverse Stock Split, and Warrantswill be authorized to purchase an aggregate of 1,400,000 shares of Common Stock. The price per share of Series C Preferredfile the Amendment and effect the Reverse Stock with attached Warrant, was $2.50. Each Warrant, when exercisable, will entitle the holder to purchaseSplit at any time within one share of Common Stock for $2.75 per share. Gross proceedsyear from the saledate of these securities was $7.0 million. Closing of the offering and issuance of the shares of Series C Preferred Stock and Warrants took place on October 2, 2017.

    In connection with the offer and sale of the Series C Preferred Stock and the Warrants, we entered into a registration rights agreement (the "Registration Rights Agreement") with the Preferred Investors, obligating usshareholder approval. The Board's decision whether or not (and when) to file the Amendment and effect the Reverse Stock Split (and at what ratio to effect the Reverse Stock Split) will also be based on a registration statement withnumber of factors, as further explained herein.

    If the Commissionshareholders adopt the resolution and approve the Amendment, we reserve the right not to register all shares of Commonfile the Amendment and effect the Reverse Stock issuable upon conversion ofSplit if the Series C Preferred Stock and the exercise of the Warrants, within 45 days of the closing of the sale of the Series C Preferred Stock and Warrants. Proceeds of the offering were used for the purchase of the assets of Bird & Cronin, as described elsewhere in this Proxy Statement.

    23

     Our Board of Directors determined that the issuance of the Series C Preferred Stock and related Warrants was advisable and in our best interest anddoes not deem it to be in the best interestinterests of us and our shareholders. We entered into the financing transaction in order to raise funds necessary for the Acquisition and for general working capital purposes. 
    DescriptionThe form of the Series C Preferred Stock
    Amendment is provided in substantially the form attached hereto as Appendix A. The following is a summarytext of the terms ofAmendment is subject to modification to include such changes as may be required by the Certificate of Designations, Preferences and Rights of Series C Non-Voting Convertible Preferred Stock (the "Series C Designation of Rights") filed with the Utah Division of Corporations and Commercial Code of the State of Utah (the "Utah Division") and as the Board deems necessary and advisable to effect the Reverse Stock Split, including the Exchange Ratio.

    Vote Required

    If a quorum is present, the affirmative vote of a majority of the votes cast on September 29, 2017. We encourage you to readthis proposal at the Series C Designation of Rights thoroughly; the following summary is qualifiedAnnual Meeting by the terms contained in the Series C Designation of Rights.

    Each share of Series C Preferred Stock has no par value per share and a stated value equal to $2.50, with the aggregate stated value of all shares of Series D Preferred Stock being $7.0 million. The Series C Preferred Stock is non-voting. Prior to shareholder approval, Preferred Investors (excluding officers, directors, employees or consultants of the Company) may convert their shares of Series C Preferred Stock into shares of Common Stock at a conversion price of $2.50 per share; provided, however, that until shareholder approval has been obtained, such conversions cannot exceed, in the aggregate, 19.9% of the total issued and outstanding shares of Common Stock of the Company on the Issuance Date; and provided, further, that a shareholder that has elected to be subject to the Beneficial Ownership Limitation shall not convert above that Limitation.
    All shares of Series C Preferred Stock will convert automatically into shares of Common Stock, at the conversion price of $2.50 per share, immediately upon receipt of shareholder approval; provided, however, that a holder may make an election applicable to its beneficial ownership of common stock and restrict conversion of its shares of Series C Preferred Stock such that the Company shall not effect any conversion of such holder's shares of Series C Preferred Stock, and such holder shall not have the right to convert any portion of the Series C Preferred Stock, to the extent that, after giving effect to the conversion such holder or any of such holder's affiliates would beneficially own in excess of 4.99% (or, at the election of the holder, 9.99%, such amount, as elected, the "Beneficial Ownership Limitation") of the number of shares of Common Stock outstanding immediately after giving effect to the conversion of the holder's shares of Series C Preferred Stock. Shares of Series C Preferred Stock that are not automatically converted after shareholder approval are stripped of their dividend, liquidation preference and redemption rights, and remain subject to the Beneficial Ownership Limitation elected by the holder. The Series C Preferred Stock will accrue an annual dividend at a rate of 6.0% to be paid in cash, which dividends cease at the time of shareholder approval.
    At any time following the mandatory conversion upon shareholder approval, in the event of a fundamental transaction defined in the Series C Designation of Rights (such as a merger, consolidation, sale of all or substantially all of the Company's assets, etc.), the Company may force the conversion of the remaining Series C Preferred Stock by delivering a written notice to all holders of outstanding shares of Series C Preferred Stock at least 10 trading days prior to the date of consummation of the fundamental transaction; provided, however, that, if such forced conversion would result in the issuance of shares of Common Stock (or common stock of the successor or acquiring corporation in such fundamental transaction) to such holder in violation of the Beneficial Ownership Limitation, such forced conversion shall apply to the extent that, and only to the extent that, such issuance of shares of Common Stock (or common stock of the successor or acquiring corporation in such fundamental transaction) to the holder would not violate such Beneficial Ownership Limitation.
    Description of the Warrants
    Each Warrant entitles the holder thereof to purchase one share of Common Stock for cash at an exercise price of $2.75 per share, subject to customary anti-dilution adjustments. The Warrants become exercisable upon receipt of shareholder approval of this Proposal No. 3, for a period of 72 months.
    At the election of a particular Preferred Investor, the Warrants held by that Preferred Investor are subject to a provision prohibiting the exercise of such Warrants to the extent that, after giving effect to such exercise, the holder of such Warrant (together with the holder's affiliates, and any other persons acting as a group together with the holder or any of the holder's affiliates), would beneficially own in excess of 4.99% (or, at the election of the holder, 9.99%) of the outstanding Common Stock. Again, such restriction does not apply to a Preferred Investor unless that Preferred Investor elects to be bound by the limitation.
    Description of the Series D Preferred Stock
    In connection with the acquisition of Bird & Cronin, we issued 1,581,935 shares of Series D Preferred Stock. The rights and preferences of the Series D Preferred Stock are defined by the "Certificate of Designations, Preferences, and Rights of the Series D Non-Voting Convertible Preferred Stock" (the "Series D Designation of Rights") filed by us on September 29, 2017 with the Utah Division. We encourage you to read the Series D Designation of Rights thoroughly; the following summary is qualified by the terms contained in the Series D Designation of Rights.
    24

    Each share of Series D Preferred Stock has no par value per share and a stated value equal to $2.52855, with the aggregate stated value of all shares of Series D Preferred Stock being $4.0 million. The Series D Preferred Stock is non-voting. The Series D Preferred Stock accrues an annual dividend at a rate of 6.0% to be paid in cash. Upon receipt of shareholder approval of this Proposal No. 3, all shares of Series D Preferred Stock will be converted automatically into shares of our Common Stock, voting separately as a voting group, and by a majority of the votes cast on a one-for-one basis.
    Reasons for Shareholder Approval
    If our shareholders do not approve Proposal No. 3this proposal at the Annual Meeting shares of Series C Preferred Stock and Series D Preferred Stock may not be converted in excess of 19.99% of Common Stock outstanding and no Warrants may be exercised. Dividends on the Series C Preferred Stock and the Series D Preferred Stock would continue to accrue and be payable quarterly in cash. In addition, we have agreed to hold special meetings of shareholders and to seek approval of a similar proposal until the required approvals have been obtained to allow us to fulfill our obligations to the Preferred Investors under the Securities Purchase Agreement and to the seller under the Asset Purchase Agreement. Your approval of Proposal No. 3 will permit us to continue with the transition and integration of the Acquisition and assist us in meeting the obligations of the Company under our agreements with these parties and continue to pursue our growth strategy. Approval of Proposal No. 3 will constitute approval pursuant to the NASDAQ Listing Rule set forth above.
    Interests of Related Parties
    Certain of our officers, directors and affiliates hold shares of Series C Preferred Stock and will receive shares of Common Stock upon conversion of their shares of Series C Preferred Stock, one share of Common Stock for each share of Series C Preferred Stock held by such shareholder, immediately upon approval of Proposal No. 3 at the Annual Meeting, as indicated in the following table:
    Name of Shareholder No. of Shares of Series C Preferred Stock  
    No. of
    Common Stock Warrants
     
    Provco Ventures I, LP  300,000   150,000 
    Brian M. Larkin  40,000   20,000 
    Stuart M. Essig  398,010   199,005 
    David H. Hausmann  80,000   40,000 
    Potential Adverse Effects of Proposal No. 3
    The failure to approve Proposal No. 3 will mean that we will be obligated to continue to pay cash dividends to the holders of the Series C Preferred Stock and the Series D Preferred Stock. The Series C Preferred Stock and the Series D Preferred Stock would remain unconverted and outstanding, subject to their preferred liquidation and redemption provisions set forth in the Series C Designation of Rights and Series D Designation of Rights, respectively. In addition, the Warrants issued pursuant to the Securities Purchase Agreement will not be exercisable until approval has been obtained or the Company adopts alternative means to amend such Warrants.
    If Proposal No. 3 is approved, existing shareholders will suffer immediate substantial dilution in voting rights and in ownership interests upon the issuance of Common Stock upon conversion of the Series C Preferred Stock and Series D Preferred Stock and possible future dilution upon the exercise of the Warrants. The sale into the public market of these shares of Common Stock also could materially and adversely affect the market price of our Common Stock. The table below summarizes the dilution to our existing shareholders immediately following the approval of Proposal No. 3. Upon approval of Proposal No. 3 by the shareholders, the Series C Preferred Stock (subject to any applicable Beneficial Ownership Limitations elected by holders of the Series C Preferred Stock) will automatically convert into Common Stock, the Series D Preferred Stock will automatically convert into Common Stock, and the Warrants will become immediately exercisable. The table does not include or assume the exercise of the Warrants or other outstanding warrants or options and grants under the Company's incentive award plans as described below. Percentages in the table are approximate due to rounding.
    25

    Description of Securities Owned 
    No. Common
    Stock
    Equivalents
      
    Fully
    Diluted
    Percentage
    Ownership
     
    Common Stock/Existing Shareholders  4,823,694   38.0%
    Series A Preferred Stock (June 2015 Issuance)  1,610,000   12.7%
    Series A Preferred Stock (December 2016 Issuance)  390,000   3.1%
    Series B Preferred Stock  1,484,000   11.7%
    Series C Preferred Stock (after approval of Proposal No. 3) (1)  2,800,000   22.1%
    Series D Preferred Stock (after approval of Proposal No. 3) (2)  1,581,935   12.5%
    Totals  12,689,629   100.0%

    (1)Shares of Series C Preferred Stock will be converted automatically to the number of shares of Common Stock indicated upon approval of Proposal No. 3 at the Annual Meeting, subject, however, to the conversion limitations of the Beneficial Ownership Limitation applicable to those shareholders electing to be subject to such limitation as described on page 24 of this Proxy Statement.
    (2)All shares of Series D Preferred Stock will be converted automatically to the number of shares of Common Stock indicated upon approval of Proposal No. 3 at the Annual Meeting.
    In addition to the above securities, there are issued and outstanding or commitments to issue options and grants under the Company's incentive awards plans for the purchase of a total of 238,990 shares of Common Stock. The table does not give effect to the exercise of any of these options and grants or the potential exercise thereof. The number of shares of Common Stock described above also does not give effect to (i) the issuance of additional shares of Common Stock due to potential future anti-dilution adjustments on the Series A Preferred Stock or the Series B Preferred Stock, (ii) the issuance of additional shares of Common Stock in payment of Series A Dividends or Series B Dividends, (iii) the issuance of shares of Common Stock pursuant to other outstanding options and warrants or (iv) any other future issuances of our Common Stock including issuances in connection withand Voting Convertible Preferred Stock, voting together as a single voting group, is required for the possible redemptionapproval of a resolution authorizing the Board to effect the Reverse Stock Split.  Abstentions will be counted as present for purposes of determining the presence of a quorum, but will not be considered as votes cast either "FOR" or "AGAINST" the proposal and will therefore have no effect on the outcome of the Series A Preferred Stock orvote.

    Reasons for the Series B Preferred Stock.

    Required Vote
    Reverse Split Proposal No. 3 will be approved if the total votes cast on the proposal in person or by proxy voted "FOR" such approval exceed the number of votes cast against the proposal.
    THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS
    A VOTE "FOR" APPROVAL OF PROPOSAL NO. 3.
    INFORMATION ABOUT THE ACQUISITION

    The followingBoard believes that it is a summary of the material provisions of the Asset Purchase Agreement, dated September 26, 2017, by and between the Company and Bird & Cronin (the "Asset Purchase Agreement"), but does not purport to describe all of the terms of the Asset Purchase Agreement. The following summary is qualified in its entirety by reference to the complete text of the Asset Purchase Agreement, a copy of which is attached as an exhibit to our Current Report on Form 8-K filed with the Commission on September 27, 2017. This summary may not contain all of the information about the Asset Purchase Agreement that is important to you. You should refer to the full text of the Asset Purchase Agreement for details of the transaction and the terms and conditions of the Asset Purchase Agreement.

    Additionally, representations, warranties and covenants described in this section and contained in the Asset Purchase Agreement have been made only for the purpose of the Asset Purchase Agreement and, as such, are intended solely for the benefitbest interests of the Company and Bird & Cronin. In many cases, these representations, warranties and covenants are subjectour shareholders to limitations agreed upon byauthorize the parties and are qualified by certain disclosures exchanged byBoard, in its discretion, to effect a reverse stock split of our outstanding common stock for the parties in connection with the executionfollowing reasons:

    • The primary purpose of the Asset Purchase Agreement. Furthermore,Reverse Stock Split is to increase proportionately the representations and warranties inper share trading price of our common stock. Our common stock is listed for trading on NASDAQ under the Asset Purchase Agreement aresymbol "DYNT". On June 26, 2023, we were notified by NASDAQ (the "Deficiency Notice") that for 30 consecutive business days, the result of a negotiated allocation of contractual risk among the parties and, taken in isolation, do not necessarily reflect facts about the Company or Bird & Cronin, their respective subsidiaries and affiliates or any other party. Likewise, any references to materiality contained in the representations and warranties may not correspond to concepts of materiality applicable to investors or shareholders. Finally, information concerning the subject matterbid price of the representations and warranties may have changed sincecommon stock had closed below $1.00 per share, in violation of NASDAQ Listing Rule 5550(a)(2) (the "Minimum Bid Price Requirement"). Under NASDAQ Listing Rule 5810(c)(3)(A), if during the 180 calendar day period following the date of the Asset Purchase Agreement or may change inDeficiency Notice (the "Initial Compliance Period"), the future and these changes may not be fully reflected in the public disclosures made by the Company and/or Bird & Cronin.

    26

    Background of the Acquisition
    Discussions between Dynatronics and Bird & Cronin commenced in April of 2016. On May 1, 2017, the Company and Bird & Cronin executed a non-binding letter of intent for the purchase by the Company of substantially all of the assets of Bird & Cronin. The non-binding offer was conditioned upon, among other conditions, the completion of financial, legal and technical due diligence. On June 9, 2017, our Board of Directors met and discussed fully the potential Acquisition. At that meeting, Dynatronics' executive officers were authorized and instructed to pursue activities related to the Acquisition.
    On October 2, 2017, we closed on the Acquisition. Cash for the Acquisition was provided by proceeds from the offer and saleclosing bid price of our Series C Preferred Stock and the Warrants, and amounts borrowed pursuant to an asset-based credit facility with Bankcommon stock is at or above $1.00 for a minimum of the West, as amended pursuant to a Modification Agreement dated September 25, 2017 (the "Modification Agreement"). The closing of the Acquisition, the closing of the Modification Agreement and the financing under the Securities Purchase Agreement occurred simultaneously on October 2, 2017 (the "Closing").
    At the Closing, we paid Bird & Cronin cash of $9,066,666 and delivered 1,397,375 shares of Series D Preferred Stock valued at approximately $3,533,333. A holdback of cash totaling $933,334 and 184,560 shares of Series D Preferred Stock valued at approximately $466,666 will be retained for purposes of satisfying adjustments to the purchase price as may be required by the Asset Purchase Agreement and indemnification claims, if any. Subject to adjustments or claims as provided by the Asset Purchase Agreement, 50% of the holdback amount will be released to Bird & Cronin one year from the Closing, and the balance of the holdback amount will be released to Bird & Cronin 18 months after Closing. As part of the Acquisition,10 consecutive business days, we will payregain compliance with the Minimum Bid Price Requirement and discharge certain liabilities and obligations of Bird & Cronin relatedour common stock will continue to its ongoing business (primarily trade accounts and similar obligations inbe eligible for listing on The Nasdaq Capital Market, absent noncompliance with any other requirement for continued listing. The Deficiency Notice states that if compliance with the ordinary course).
    Bird & Cronin is a closely-held corporation founded in 1968 that prior to the Acquisition designed, manufactured, and distributed orthopedic soft goods and specialty patient care products to customers in the United States and internationally. Over 95% of Bird & Cronin's products were manufactured in an 85,000 square-foot manufacturing facility located at 1200 Trapp Road, Eagan, Minnesota (the "Facility") ownedMinimum Bid Price Requirement cannot be demonstrated by an affiliate of Bird & Cronin. The Acquisition does not include a purchase of the Facility. At the Closing, we entered into a lease ("Lease") with Trapp Road Limited Liability Company, a Minnesota limited liability company, to occupy the Facility for a term of three years at annual rental payments of $600,000, payable in monthly installments of $50,000. The Lease provides that the lease term will automatically be extended for two additional periods of two years each, without any increase in the lease payment, subject to our right to terminate the Lease or to provide notice not to extend the term of the Lease prior to the end of the term.
    EmployeesInitial Compliance Period, we may be eligible for a second 180-day period to regain compliance (the "Second 180 Day Compliance Period"). To be eligible for the Second 180 Day Compliance Period, (i) we must meet the market value of Bird & Cronin were offered employmentpublicly held shares requirement for continued listing and all other applicable standards for initial listing on The Nasdaq Capital Market set forth in Marketplace Rule 5505 (except the bid price requirement), (ii) we must provide NASDAQ with Dynatronics at Closing. In addition,written notice of our intention to cure the Co-Presidents of Bird & Cronin, Mike Cronindeficiency, through a reverse stock split, if necessary, and Jason Anderson, entered into employment agreements(iii) NASDAQ must determine that the Company will be able to cure the deficiency.

  • If we do not regain compliance with the Company (the "Employment Agreements") and serve as Co-Presidents of Bird & Cronin, LLC, our subsidiary and assignee ("Acquisition Subsidiary") that operates the business previously operated by Bird & Cronin, reporting to our CEO, Kelvyn Cullimore. Their annual salary is $175,000 and we will pay them each an annual bonus of up to $10,000, as determined by Mr. Cullimore. The Employment Agreements also provide them with other employee benefits as provided to our employees generally at their level of management at the Acquisition Subsidiary (including, e.g., paid time off and paid holidays, medical/dental/vision insurance, Section 125 Flexible Spending Account and 401(k)). In addition to the restrictive covenants applicable to them under the Asset Purchase Agreement, the Employment Agreements include restrictive covenants which limit the ability of Messrs. Anderson and Cronin to be employed by a competitor of, or otherwise to compete with, Dynatronics for, in Mr. Anderson's case, a two-year period, and, in Mr. Cronin's case, a one-year period following the later of (i) termination of employment and (ii) the latest date upon which Dynatronics makes any severance payment to such person.

  • The Asset Purchase Agreement contains customary representations, warranties and covenants by Bird & Cronin and the Company, as well as customary indemnification provisions among the parties. Post-closing covenants include a covenant that for a period of five years, Bird & Cronin and its shareholders (including Mr. Cronin) will refrain from, among other things, solicitation of employees, customers and business of Bird & Cronin or the Company and from other competitive activity as defined in the Asset Purchase Agreement, and requires them and their representatives (as defined in the Asset Purchase Agreement) to maintain (other than in connection with performing obligations pursuant to the Lease or the Employment Agreements, as applicable), the confidentiality of, and not use, confidential information relating to the acquired business or purchased assets, except as permittedMinimum Bid Price Requirement by the Asset Purchase Agreement.
    27

    The Asset Purchase Agreement contains limited representations and warranties of eachend of the Company and Bird & Cronin relating to, among other things,Initial Compliance Period (or the authorization of the parties to enter into and carry out the obligations in the Asset Purchase Agreement and the enforceability of the Asset Purchase Agreement.
    The Asset Purchase Agreement contains additional representations and warranties of Bird & Cronin which relate to, among other things, the following subject matters:
    ·Bird & Cronin's organization and qualifications to do business;
    ·Power and authorization to enter into the Asset Purchase Agreement and to consummate the transaction;
    ·The absence of conflicts or violations of Bird & Cronin's governing documents, contracts, applicable law or regulations;
    ·The accuracy of financial statements and their preparation in accordance with Bird & Cronin's historical accounting methodologies;
    ·Compliance with laws and statutes;
    ·Good and transferable title to the assets, free of encumbrances;
    ·The absence of legal proceedings and claims;
    ·The condition of the assets toSecond 180 Day Compliance Period as may be extended) our Common Stock will be acquired;
    ·Customers and suppliers;
    ·Material contracts;
    ·Intellectual property;
    ·Insurance;
    ·Regulatory matters;
    ·The absence of certain changes or events; and
    ·Solvency.
    All of the representations and warranties survive the closing and remain in full force and effect following the closing until September 30, 2018 (other than with respect to certain fundamental representations, which shall survive the closing and remain in full force and effect until 60 days after the expiration of the applicable statute of limitations).
    The Asset Purchase Agreement is governed by the laws of the state of Delaware, without giving effect to any conflict of law principles which would result in the application of the laws of any other jurisdiction.
    The business formerly operated by Bird & Cronin is now operated by Acquisition Subsidiary as a division of the Company. For convenience, reference to the "Company" in the following discussion of the post-closing operations of Bird & Cronin includes Acquisition Subsidiary unless otherwise indicated. This section of the Proxy Statement summarizes the material terms of the Acquisition.
    We have filed with the Commission Current Reports on Form 8-K disclosing terms and conditions of the Acquisition and related transactions. Those reports included or incorporated by reference as exhibits, transaction documents, including the Asset Purchase Agreement, the Modification Agreement and the Securities Purchase Agreement. The summary of the Asset Purchase Agreement in this Proxy Statement does not purport to be complete and is subject to and qualified in its entirety by, the full text of the Asset Purchase Agreement, a copy of which was filed as Exhibit 10.1 to the Company's Current Report on Form 8-K on September 27, 2017 and is incorporated herein by reference.
    28

    Bird & Cronin Description and Overview
    The following description of Bird & Cronin is as of thedelisting. At such time, of the Acquisition, except as indicated.
    Bird & Cronin is a family-owned Minnesota corporation founded in 1968. Bird & Cronin designs, manufactures, and distributes orthopedic soft goods and specialty patient care products to customers in the United States and internationally. Over 90% of Bird & Cronin's products are made in Bird & Cronin's 85,000 square-foot manufacturing facility located at 1200 Trapp Road, Eagan, Minnesota.
    Business Overview and Objectives
    Bird & Cronin has been family owned and operated for over 45 years and is proud of its tradition of manufacturing the industry's highest quality medical products with a special emphasis on customer care. Bird & Cronin's mission is to provide quality medical products and services to its customers, recognizing its obligation to be aware, informed and responsive to the changing needs of the health-care environment.
    Bird & Cronin has benefitted from strong, long-standing relationships with hospitals, orthopedic specialists, universities, research facilities, and other customers across the medical universe. Bird & Cronin sells products through direct sales as well as through distribution relationships. Additionally, Bird & Cronin holds a number of National Group Purchasing and Government Contracts, some of which include Intalere (formerly Amerinet), Department of Defense, and Department of Veterans Affairs.
    Gross sales for Bird & Cronin for the years ended September 30, 2015 and September 30, 2016 were $23.2 million and $24.0 million, respectively. Net income for the years ended September 30, 2015 and September 30, 2016 were approximately $1.1 million and $2.1 million, respectively.
    Employees
    Bird & Cronin currently has 109 employees. Bird & Cronin believes that the skills and dedication of its employees separate its products from those of its competitors.
    The Co-Presidents of Bird & Cronin, Michael Cronin and Jason Anderson continue to manage the business following the Acquisition. Mr. Cronin has over 25 years of experience leading sales, marketing, and customer service efforts. Prior to joining Bird & Cronin, Mr. Cronin owned and operated his own medical distribution business. Mr. Anderson has over 20 years of experience leading businesses, operations and technology. Prior to joining Bird & Cronin, Mr. Anderson was a partner and Chief Information Officer for Evercore Wealth Management (a leading national wealth management firm), the Director of Information Services at Varde Partners (an alternative asset manager), and both a partner and the Chief Technology Officer for Lowry Hill Private Asset Management (since restructured as Abbot Downing), a Minneapolis based high net worth advisory and proprietary asset management firm (and subsidiary of Wells Fargo).
    Products
    Approximately 90% of Bird & Cronin's revenues are generated from self‑manufactured products, with the remaining 10% generated from third party distributed products.
    Bird & Cronin's products include ankle walkers, wrist supports, ankle braces, abdominal binders, knee & leg supports, catheters, cervical collars, shoulder immobilizers, splints, extrication collars, and many other related products. All of Bird & Cronin's products fall under the FDA Class I distinction based on the risks associated with the manufactured products. Class I devices are deemed to be low risk and are therefore subject to the least regulatory controls. Bird & Cronin also has the capability to private label products for customers, which is a key differentiator in the market.
    A full listing of Bird & Cronin's products can be found in its online catalog located at: http://www.birdcronin.com. Reference to Bird & Cronin's website is not intended to incorporate by reference any of the material or information contained on such website in this Proxy Statement.
    29

    RISK FACTORS
    An investment in Dynatronics involves a high degree of risk and should not be made by persons who cannot afford the loss of their entire investment. Dynatronics' subsequent filings with the Commissionwe may contain amended and updated discussions of significant risks. Dynatronics cannot predict future risks or estimate the extent to which they may affect financial performance. Please also read carefully the section entitled "Special Note Regarding Forward-Looking Information" in this Proxy Statement at page 35.
    Certain risk factors relating to the business and industry of the Company and its securities can be found in Part I, Item 1A —"Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended June 30, 2017. In addition, you should carefully consider additional risks that relate to the Acquisition and the business of Bird & Cronin, including but not limited to, the risks set forth below.
    Risks Relating to the Acquisition
    Uncertainty about the proposed Acquisition may adversely affect relationships with our customers, suppliers and employees, whether or not the transaction is completed.
    In response to the announcement of the proposed Acquisition, Dynatronics' and/or Bird & Cronin's existing or prospective customers or suppliers may:
    ·delay, defer or cease purchasing products or services from us or the combined company, or providing products or services to us or the combined company;
    ·delay or defer other decisions concerning us or the combined company; or
    ·otherwise seek to change the terms on which they do business with us or the combined company.
    Any such delays or changes to terms could materially harm our business or the combined business. In addition, as a result of the proposed Acquisition, the employees acquired from Bird & Cronin could experience uncertainty about their future with us following the Closing. As a result, key employees may depart because of issues relating to such uncertainties, or a desire not to remain with us following the Acquisition. Losses of customers, employees or other important strategic relationshipsappeal NASDAQ's delisting determination. Delisting could have a material adverse effect on our business, operating results,liquidity and financial condition. Such adverse effectson the trading of our Common Stock. If our Common Stock were delisted, our Common Stock could be quoted on the OTCQB market or on the "pink sheets" maintained by the OTC Markets Group. However, such alternatives are generally considered to be less efficient markets. Further, delisting from NASDAQ could also have other negative effects, including potential loss of confidence by partners, lenders, suppliers and employees, and could also trigger various defaults under our lending agreements and other outstanding agreements. Delisting could make it more difficult for the Company to attract qualified Board candidates and potential strategic and collaborative partners. Finally, delisting could make it harder for us to raise capital and sell securities as we would no longer be exacerbated byeligible to use Form S-3 short form registration statements for such purposes.


    • The Board is asking the shareholders to grant it the authority, at its discretion, to effect a delayreverse stock split, which the Board believes is an effective way to increase the minimum bid price of our common stock proportionately and put us in a position to regain compliance with NASDAQ Listing Rule 5550(a)(2).

    • The Board believes that maintaining the listing of our common stock on NASDAQ is in the completionbest interests of us and our shareholders. The Board believes that the delisting of the Acquisitioncommon stock from NASDAQ would impair our ability to raise additional funds and result in lower prices and larger spreads in the bid and ask prices for any reason.

    We expectthe common stock, among other things. See "Certain Risk Factors Associated with the Reverse Stock Split" for more information.

  • If the common stock is delisted from NASDAQ, it will be subject to incur substantial expenses relatedSEC rules governing "penny stocks," which impose additional disclosure requirements on broker-dealers. The regulations relating to penny stocks, coupled with the typically higher cost per trade to the integrationinvestor of Bird & Cronin.

  • We expectpenny stocks due to incur substantial expensesfactors such as broker commissions generally representing a higher percentage of the price of a penny stock than of a higher-priced stock, will further limit the ability of investors to trade in connectionthe common stock and may limit the willingness of individual investors and institutions to purchase the common stock.

    Board Discretion to Implement the Reverse Stock Split

    The Board only intends to implement the Reverse Stock Split to the extent it believes necessary to maintain our listing on NASDAQ for the future. The Board believes that shareholder approval of a range of Exchange Ratios (rather than a single ratio) is in the best interests of our shareholders because it provides the Board with the integrationflexibility to achieve the desired results of the business, policies, procedures, operations, technologiesReverse Stock Split and systemsbecause it is not possible to predict market conditions at the time the Reverse Stock Split would be implemented. If shareholders approve this Proposal, the Board would carry out a Reverse Stock Split only upon the Board's determination that a Reverse Stock Split would be in the best interests of Bird & Cronin. There are a large number of systemsour shareholders at that time. The Board would then select the Exchange Ratio it determines to be advisable and functions that we may be required to integrate, including, for example, management information, accounting and finance, payroll and benefits and regulatory compliance. Acquisitions of privately held entities, such as Bird & Cronin, are particularly challenging because their prior practices may not meetin the requirementsbest interests of the Sarbanes-Oxley Act and/or generally accepted public accounting standards. While we have assumed that a certain levelshareholders considering relevant market conditions at the time the Reverse Stock Split is to be implemented. In determining the Exchange Ratio, following receipt of expenses would be incurred, there are a numbershareholder approval, the Board may consider numerous factors including:

    • the historical and projected performance of factors beyond our control that could affectcommon stock;

    • general economic and other related conditions prevailing in our industry and in the total amount or marketplace;

    • the timing of allprojected impact of the expected integration expenses. Moreover, many ofReverse Stock Split and the expenses that will be incurred, by their nature, are difficult to estimate accurately at the present time. These expenses could, particularlyExchange Ratio on trading liquidity in the near term, exceed the savings that we expect to achieve from the elimination of duplicative expenses, the realization of economies of scaleour common stock and cost savings, and other synergies related to the integration of the businesses following completion of the Acquisition.

    We may be unable to successfully integrate our business with the business of Bird & Cronin and realize the anticipated benefits of the Acquisition.
    The Acquisition involves the combination of the businesses of two companies that currently operate as independent companies. Although we recently acquired Hausmann Industries, Inc. ("Hausmann") in April 2017, our management has limited integration experience and will be required to devote significant attention and resources to integrating our business practices and operations with those of Bird & Cronin. Potential difficulties we may encounter as part of the integration process include, but are not limited to, the following:
    30

    ·inability to successfully combine our business with the business of Bird & Cronin in a manner that permits us to achieve the full synergies anticipated from the Acquisition;
    ·complexities associated with managing our business and the business of Bird & Cronin following the Acquisition, including the challenge of integrating the business and assets of each of the companies in a seamless manner that minimizes any adverse impact on customers, suppliers, employees and other constituencies;
    ·integrating the workforces of the two companies while maintaining focus on providing consistent, high quality customer service; and
    ·potential unknown liabilities and unforeseen increased expenses or delays associated with the Acquisition, including costs to integrate the two companies that may exceed anticipated costs.

    Any of the potential difficulties listed above could adversely affect our ability to maintain relationships with customers, suppliers, employees, lenderscontinued listing on The NASDAQ Capital Market;

  • our capitalization (including the number of shares of common stock issued and other constituencies oroutstanding);

  • the then-prevailing trading price and trading volume of our common stock;

  • the potential devaluation of our market capitalization as a result of the Reverse Stock Split;


    • the anticipated impact of the Reverse Stock Split on our ability to raise additional financing; and

    • business developments affecting us.

    The Board intends to select an Exchange Ratio that it believes would be most likely to achieve the anticipated benefits of the AcquisitionReverse Stock Split.

    If the Board determines that effecting the Reverse Stock Split is in our best interest, the Reverse Stock Split will become effective upon the filing of the Amendment with the Utah Division. (See, "Procedure for Effecting the Reverse Split," below.) The Amendment filed thereby will set forth the number of shares to be combined into one share of our common stock within the limits set forth in this proposal, but will not have any effect on the number of shares of common stock or preferred stock currently authorized, the ability of the Board to designate preferred stock, the par value of our common or preferred stock, or any series of preferred stock previously authorized (except to the extent such Reverse Stock Split adjusts the conversion ratio of such previously designated preferred stock).

    Effect of a Reverse Stock Split

    If approved by our shareholders and implemented by the Board, as of the effective time of the Amendment, each issued and outstanding share of our common stock would immediately and automatically be reclassified and reduced into a fewer number of shares of our common stock. However, except for adjustments that may result from the treatment of fractional shares, as described below, the Reverse Stock Split will not affect any shareholder's percentage ownership or proportionate voting power. Fractional shares will not be issued. All fractional shares that would otherwise result from the implementation of the Reverse Stock Split shall be automatically rounded up to the next whole share.

    Except to the extent that the Reverse Stock Split would result in any shareholder receiving an additional whole share of common Stock in connection with the rounding of fractional shares or any dilution to other shareholders in connection therewith, as described below, the Reverse Stock Split will not:

    • affect any shareholder's percentage ownership interest in us;

    • affect any shareholder's proportionate voting power;

    • substantially affect the voting rights or other privileges of any shareholder; or

    • alter the relative rights of common shareholders, preferred shareholders, warrant holders or holders of equity compensation plan awards and options.

    Depending upon the Exchange Ratio selected by the Board, the principal effects of the Reverse Stock Split are:

    • the number of shares of common stock issued and outstanding will be reduced by a factor ranging between 5 and 10, notwithstanding any rounding;

    • the per share exercise price will be increased by a factor from and including 5 and 10, and the number of shares issuable upon exercise or conversion shall be decreased by the same factor, for all outstanding options, warrants and other convertible or exercisable equity instruments entitling the holders to purchase or acquire shares of our common stock;

    • the number of shares authorized and reserved for issuance under our existing equity compensation plans will be reduced proportionately; and

    • the conversion rates for holders of our preferred stock and other outstanding securities will be adjusted proportionately.

    The bullets below contain approximate information relating to our outstanding common stock, Series A Preferred, and Series B Preferred (all of which Voting Convertible Preferred Stock, prior to the Reverse Stock Split, is convertible into shares of common stock on the basis of one share of common stock for each share of Voting Convertible Preferred Stock), outstanding debentures and warrants held by investors, and our outstanding warrants and options under our stock plans:


    Based on our capitalization as of October 10, 2023, the principal effect of the Reverse Stock Split (at a ratio between 1-for-5 and 1-for-10), not taking into account the treatment of fractional shares described above, would be that:

    • the number of shares of our authorized common stock would remain unchanged at 100,000,000 shares;

    • the number of shares of our common stock issued and outstanding would be reduced from 4,530,837 shares to between approximately 906,168 shares and 453,084 shares;

    • the 50,000,000 shares of our authorized preferred stock, 1,992,000 shares of which are designated as Series A Preferred and 1,359,000 shares of which are designated as Series B Preferred, would remain unchanged;

    • the number of shares of Series A Preferred issued and outstanding would remain unchanged, although the conversion price of the 1,992,000 outstanding shares of Series A Preferred would increase and the number of shares of common stock issuable upon conversion of such preferred stock would decrease in proportion to the Reverse Stock Split from 398,400 shares to between approximately 79,680 shares and 39,840 shares, subject to future adjustment as provided in the Certificate of Designation of Preferences;

    • the number of shares of our Series B Preferred issued and outstanding would remain unchanged, although the conversion price of the 1,359,000 outstanding shares of Series B Preferred would increase and the number of shares of common stock issuable upon conversion of such preferred stock would decrease in proportion to the Reverse Stock Split from 271,800 shares to between approximately 54,360 shares and 27,180 shares, subject to future adjustment as provided in the Certificate of Designation of Preferences, Rights and Limitations of the Series B Preferred;

    • the number of shares of our common stock issuable upon the exercise of outstanding stock options and restricted stock units would be reduced from 28,000 to between approximately 5,600 shares and 2,800 shares (and the respective exercise prices of the options would increase by a factor equal to the inverse of the Exchange Ratio);

    • the aggregate number of shares of our common stock reserved for issuance in connection with future awards under our 2020 Plan would be reduced from 200,906 to between approximately 40,182 shares and 20,091 shares; and

    • the par value of our common stock and preferred stock would remain unchanged at no par value per share,and the per-share net income or loss and net book value of our common stock would be restated because there would be fewer shares of common stock outstanding.

    The following table contains approximate information relating to our common stock immediately following the Reverse Stock Split under certain possible exchange ratios, based on share information as of October 10, 2023. All share numbers are rounded up to the nearest whole share.



     Pre-Reverse
    Split
    1-for-51-for-61-for-71-for-81-for-9 1-for-10
    Number of authorized shares of
    common stock
    100,000,000 100,000,000 100,000,000 100,000,000 100,000,000 100,000,000 100,000,000
                  
    Number of outstanding shares of common stock906,168 755,140 647,263 566,355 566,355 503,427 453,084
                  
    Number of authorized shares of
    preferred stock
    50,000,000 50,000,000 50,000,000 50,000,000 50,000,000 50,000,000 50,000,000
                  
    Number of shares
    of common stock
    issuable upon
    conversion of outstanding shares of preferred stock
    670,200 134,040 111,704 95,753 83,775 74,478 67,020
                  
    Number of shares of common stock issuable upon exercise of outstanding stock options and restricted stock units28,000 5,600 4,667 4,000 3,500 3,112 2,800
                  
    Number of shares of common stock reserved for issuance in connection with future awards under the 2020 Plan200,906 40,182 33,485 28,701 25,114 22,323 20,091

    See also "Certain Risks Associated with the Reverse Stock Split" below for additional information regarding the potential impact of the Reverse Stock Split.


    If the Reverse Stock Split is implemented, the Amendment will not reduce the number of shares of our common stock or preferred stock authorized under our Articles of Incorporation, as amended, the right of the Board to designate preferred stock, the par value of our common stock or preferred stock, or otherwise adversely affect our business and financial results following completiondesignated series of preferred stock, except to affect the conversion prices thereof.

    Our common stock is currently registered under Section 12(b) of the Acquisition.

    Our actual financialExchange Act, and operating resultswe are subject to the periodic reporting and other requirements thereof. We presently do not have any intent to seek any change in our status as a reporting company under the Exchange Act either before or after the Acquisition could differ materially fromReverse Stock Split.

    Additionally, as of the date of this Proxy Statement, we do not have any expectationscurrent plans, agreements, or guidance provided by us concerning future results, including (without limitation) expectations or guidanceunderstandings with respect to the financial impactadditional authorized shares that will become available for issuance after the Reverse Stock Split has been implemented.

    Anti-Takeover and Dilutive Effects

    The total number of any cost savingsauthorized shares of our common stock and other potential synergies.

    We currently expect to realize an increase in sales and other synergiespreferred stock will not be changed as a result of the proposed Acquisition. These expectations areReverse Stock Split. The common stock and preferred stock that is authorized but unissued provide the Board with flexibility to effect, among other transactions, public or private financings, acquisitions, stock dividends, stock splits and the granting of equity incentive awards. However, these authorized but unissued shares may also be used by the Board, consistent with and subject to numerous assumptions, however, including assumptions derived fromits fiduciary duties, to deter future attempts to gain control of us or make such actions more expensive and less desirable. The Reverse Stock Split is not being recommended in response to any specific effort to obtain control of us, nor does the Board have any present intent to use the authorized but unissued common stock or preferred stock to impede a takeover attempt.

    Except for our diligence efforts concerningobligation to issue common stock upon the statusexercise of outstanding options and prospects for Bird & Cronin's business, whichwarrants or the conversion of our outstanding shares of preferred stock, we do not currently control, and assumptions relatinghave no specific plan, commitment, arrangement, understanding or agreement, either oral or written, regarding the issuance of common stock subsequent to the near-term prospects Reverse Stock Split at this time, and we have not allocated any specific portion of the authorized number of shares to any particular purpose.

    Certain Risks Associated with the Reverse Stock Split

    Before voting on this Proposal No. 3, shareholders should consider the following risks associated with effecting a Reverse Stock Split:

    Areverse stock split may negatively impact the marketfor our industry generally andcommon stock. Although we expect that the markets for Bird & Cronin's productsReverse Stock Split will result in particular. Additional assumptions that we have made include, without limitation, the following:

    ·projections of Bird & Cronin's future revenues;
    ·anticipated financial performance of Bird & Cronin's products and products currently in development;
    ·anticipated cost savings and other synergies associated with the Acquisition, including potential revenue synergies;
    ·our expected capital structure after the Acquisition;
    ·amount of goodwill and intangibles that will result from the Acquisition;
    ·certain other purchase accounting adjustments that we expect to record in our financial statements in connection with the Acquisition;
    ·acquisition costs, including restructuring charges and transaction costs payable to our financial, legal and accounting advisors;
    ·our ability to maintain, develop and deepen relationships with Bird & Cronin's customers; and
    ·other financial and strategic risks of the Acquisition.
    We cannot provide any assurances with respect to the accuracy of our assumptions, including our assumptions with respect to future revenues or revenue growth rates, if any, of Bird & Cronin, and we cannot provide assurances with respect to our ability to realize any cost savings that we currently anticipate. Risks and uncertainties that could cause our actual results to differ materially from currently anticipated results include, but are not limited to, risks relating to our ability to integrate Bird & Cronin successfully; currently unanticipated incremental costs that we may incur in connection with integrating the two companies; risks relating to our ability to realize incremental revenues from the Acquisitionan increase in the amounts that we currently anticipate; risks relating to the willingness of Bird & Cronin's customers and other partners to continue to conduct business with us following the Acquisition; and numerous risks and uncertainties that affect our industry generally and the markets for our products and those of Bird & Cronin, specifically. Any failure to integrate Bird & Cronin successfully and to realize the financial benefits we currently anticipate from the Acquisition would have a material adverse impact on our future operating results and financial condition and could materially and adversely affect the trading price or trading volume of our Common Stock.
    31

    The combined businesses may not perform as we expect, or as the market expects, which could have an adverse effect on the price of our Common Stock.
    Risks associated with the combined company following the Acquisition include:
    ·integrating businesses is a difficult, expensive, and time-consuming process, and the failure to integrate successfully our business with the businesses of Bird & Cronin in the expected time frame would adversely affect our financial condition and results of operations;
    ·the Acquisition will significantly increase the size of our operations, and if we are not able to effectively manage our expanded operations, ourcommon stock, price may be adversely affected;
    ·the current sales rates of Bird & Cronin as combined with the Company may dilute the observed growth rates of the Company;
    ·the success of the Company following the Closing will also depend upon relationships with third parties and pre-existing customers of us and Bird & Cronin, which relationships may be affected by customer preferences or public attitudes about the Acquisition. Any adverse changes in these relationships could adversely affect our business, financial condition and results of operations; and
    ·the price of our Common Stock after the Acquisition may be affected by factors different from those currently affecting the price of our Common Stock.
    If any of these events were to occur, the price of our Common Stock could be adversely affected.
    Risks Related to the Operation of the Bird & Cronin Business Following the Acquisition
    Uncertain or weakened global economic conditions may adversely affect Bird & Cronin's industry, business and results of operations.
    The overall performance of the Bird & Cronin division will depend on domestic and worldwide economic conditions, which may remain challenging for the foreseeable future. Financial developments seemingly unrelated to Bird & Cronin or its industry may adversely affect it. The U.S. economy and other key international economies have been impacted by threatened sovereign defaults and ratings downgrades, falling demand for a variety of goods and services, restricted credit, threats to major multinational companies, poor liquidity, reduced corporate profitability, volatility in credit, equity and foreign exchange markets, bankruptcies, acts of terrorism and overall uncertainty. Healthcare reform in the United States has created a great deal of confusion for medical products such as those manufactured and distributed by Bird & Cronin. These conditions affect the rate of medical or therapeutic equipment spending and could adversely affect our ability to sell Bird & Cronin's products, or delay prospective purchasing decisions, any of which could adversely affect our operating results. We cannot predict the timing, strength or duration of the economic recovery or any subsequent economic slowdown worldwide, in the United States, or in Bird & Cronin's industry.
    Bird & Cronin's failure or inability to enforce its trademarks or other proprietary rights could adversely affect its competitive position or the value of its brand.
    Bird & Cronin owns certain federal trademark registrations but also relies on unregistered proprietary rights, including common law trademark protection. Third parties may oppose Bird & Cronin's trademark applications, or otherwise challenge its use of the trademarks, and may be able to use its trademarks in jurisdictions where they are not registered or otherwise protected by law. If Bird & Cronin's trademarks are successfully challenged or if a third party is using confusingly similar or identical trademarks in particular jurisdictions before Bird & Cronin, Bird & Cronin could be forced to rebrand its products, which could result in loss of brand recognition, and could require additional resources for marketing new brands. If others are able to use Bird & Cronin's trademarks, its ability to distinguish its products may be impaired, which could adversely affect its business. Further, we cannot assure you that competitorsa Reverse Stock Split, if effected, will increase the market price of our common stock in proportion to the reduction in the number of shares of our common stock outstanding, or result in a permanent increase in the market price. The effect that a Reverse Stock Split may have upon the market price of our common stock cannot be predicted with any certainty, and the history of similar reverse stock splits for companies in similar circumstances to ours is varied. The market price of our common stock is dependent on many factors, including our business and financial performance, general market conditions, prospects for future growth and other factors detailed from time to time in the reports we file with the SEC. Accordingly, the total market capitalization of our common stock after a Reverse Stock Split may be lower than the total market capitalization before a Reverse Stock Split and, in the future, the market price of our common stock following a Reverse Stock Split may not infringe upon Bird & Cronin's trademarks,exceed or remain higher than the market price prior to a Reverse Stock Split.

    NASDAQ may delist our common stock from its exchange which could limit your ability to make transactions in our securities and subject us to additional trading restrictions. Even if our shareholders approve a Reverse Stock Split and the Reverse Stock Split is effected, we cannot assure you that we will continue to meet the Minimum Bid Price Requirement. We have adequate resourcesbeen monitoring the closing bid price of our common stock through the 180 Day Compliance Period. We may request an extension of 180 days to enforce its trademarks.

    32

    Bird & Cronin mayregain compliance with the Minimum Bid Price Requirement under the NASDAQ Listing Rules, however there can be unable to effectively develop and market products against the products of its competitors in a highly competitive industry.
    The present or future products of Bird & Cronin could be rendered obsolete or uneconomical by technological advances by its competitors. Competitive factors include price, customer service, technology, innovation, quality, reputation and reliability. Bird & Cronin's competition may respond more quickly to new or emerging technologies, undertake more extensive marketing campaigns, have greater financial, marketing and other resources than Bird & Cronin, or be more successful in attracting potential customers, employees and strategic partners. Given these factors, we cannot guaranteeno assurance that we will be ablegranted an extension to continueregain compliance.


    If our common stock is delisted, our common stock would likely then trade only in the currentover-the-counter market. If our common stock were to trade on the over-the-counter market, selling our common stock could be more difficult because smaller quantities of shares would likely be bought and sold, transactions could be delayed, and we could face significant material adverse consequences, including: a limited availability of market quotations for our securities; reduced liquidity with respect to our securities; a determination that our shares are a "penny stock," which will require brokers trading in our securities to adhere to more stringent rules, possibly resulting in a reduced level of success of Bird & Cronintrading activity in the industry.

    The costsecondary trading market for our securities; a reduced amount of complying with complex governmental regulations applicablenews and analyst coverage for us; and a decreased ability to issue additional securities or obtain additional financing in the future. These factors could result in lower prices and larger spreads in the bid and ask prices for our common stock and would substantially impair our ability to raise additional funds and could result in a loss of institutional investor interest and fewer development opportunities for us.

    In addition to the Bird & Cronin business, sanctionsforegoing, if our common stock is delisted from NASDAQ and it trades on the over-the-counter market, the application of the "penny stock" rules could adversely affect the market price of our common stock and increase the transaction costs to sell those shares. The SEC has adopted regulations which generally define a "penny stock" as an equity security that has a market price of less than $5.00 per share, subject to specific exemptions. If our common stock is delisted from NASDAQ and it trades on the over-the-counter market at a price of less than $5.00 per share, our common stock would be considered a penny stock. The SEC's penny stock rules require a broker-dealer, before a transaction in a penny stock not otherwise exempt from the rules, to deliver a standardized risk disclosure document that provides information about penny stocks and the risks in the penny stock market. The broker-dealer must also provide the customer with current bid and offer quotations for the penny stock, the compensation of the broker-dealer and the salesperson in the transaction, and monthly account statements showing the market value of each penny stock held in the customer's account. In addition, the penny stock rules generally require that before a transaction in a penny stock occurs, the broker-dealer must make a special written determination that the penny stock is a suitable investment for the purchaser and receive the purchaser's agreement to the transaction. If applicable in the future, these rules may restrict the ability of brokers-dealers to sell our common stock and may affect the ability of investors to sell their shares, until our common stock no longer is considered a penny stock.

    You may end up holding an "odd lot" or less than 100 shares of common stock as a result of the Reverse Stock Split, making it more difficultfor you to sell your shares. A Reverse Stock Split may result in some shareholders owning "odd lots" of less than 100 shares of common stock on a post-split basis. A purchase or sale of less than 100 shares of common stock (an "odd lot" transaction) may result in incrementally higher trading costs through certain brokers, particularly "full service" brokers, and generally may be more difficult than a "round lot" sale. Therefore, those shareholders who own less than 100 shares of common stock following the Reverse Stock Split may be required to pay somewhat higher transaction costs and may experience some difficulties or delays should they then determine to sell their shares of common stock.

    The market price of our common stock may not rise after the Reverse Stock Split. It is possible that the per share price of our common stock after the Reverse Stock Split will not rise in proportion to the reduction in the number of shares of our common stock outstanding resulting from non-compliance,the Reverse Stock Split, and the market price per post-Reverse Stock Split share may not exceed or remain in excess of the $1.00 minimum bid price for a sustained period of time, and the Reverse Stock Split may not result in a per share price that would attract brokers and investors who do not trade in lower priced stocks. Even if we effect the Reverse Stock Split, the market price of our common stock may decrease due to factors unrelated to the Reverse Stock Split. In any case, the market price of our common stock may also be based on other factors which may be unrelated to the number of shares outstanding, including our future performance. If the Reverse Stock Split is consummated and the trading price of the common stock declines, the percentage decline as an absolute number and as a percentage of our overall market capitalization may be greater than would occur in the absence of the Reverse Stock Split. Even if the market price per post-Reverse Stock Split share of our common stock remains in excess of $1.00 per share, we may be delisted due to a failure to meet other continued listing requirements, including NASDAQ requirements related to the minimum shareholders' equity, the minimum number of shares that must be in the public float, the minimum market value of the public float and the minimum number of round lot holders.


    The Reverse Stock Split may decrease the liquidity of our common stock. The liquidity of our common stock may be harmed by the Reverse Stock Split given the reduced demand resultingnumber of shares of common stock that would be outstanding after the Reverse Stock Split, particularly if the stock price does not increase as a result of the Reverse Stock Split. In addition, investors might consider the increased proportion of unissued authorized shares of common stock to issued shares to have an anti-takeover effect under certain circumstances, because the proportion allows for dilutive issuances which could prevent certain shareholders from changing the composition of the Board or render tender offers for a combination with another entity more difficult to successfully complete. The Board does not intend for the Reverse Stock Split to have any anti-takeover effects.

    The number of authorized but unissued shares will not change, while the number of issued shares decreases, effectively increasing the number of shares of common stock availablefor future issuance and potential dilution to existing shareholders. Our Articles of Incorporation presently authorize 100,000,000 shares of common stock and 50,000,000 shares of blank check preferred stock, no par value per share. The Reverse Stock Split would not change the number of authorized shares of the common stock, although the Reverse Stock Split would decrease the number of issued and outstanding shares of common stock. Therefore, because the number of issued and outstanding shares of common stock would decrease, the number of shares of common stock remaining available for issuance by us in the future would increase.

    Such additional shares of common stock would be available for issuance from time to time for corporate purposes such as issuances of common stock in connection with capital-raising transactions and acquisitions of companies or other assets, as well as for issuance upon conversion or exercise of securities such as convertible preferred stock, convertible debt, warrants or options convertible into or exercisable for common stock. We believe that the availability of the additional shares of common stock will provide us with the flexibility to meet business needs as they arise, to take advantage of favorable opportunities and to respond effectively in a changing corporate environment. For example, we may elect to issue shares of common stock to raise equity capital, to make acquisitions through the use of stock, to establish strategic relationships with other companies, to adopt additional employee benefit plans or reserve additional shares of common stock for issuance under such plans, where the Board determines it advisable to do so, without the necessity of soliciting further shareholder approval, subject to applicable shareholder vote requirements under Utah law and NASDAQ rules. If we issue additional shares of common stock for any of these purposes, the aggregate ownership interest of our current shareholders, and the interest of each such existing shareholder, would be diluted, possibly substantially.

    The additional shares of our common stock that would become available for issuance upon an effective Reverse Stock Split could also be used by us to oppose a hostile takeover attempt or delay or prevent a change of control or changes in or removal of our management, including any transaction that may be favored by a majority of our shareholders or in which our shareholders might otherwise receive a premium for their shares of common stock over then-current market prices or benefit in some other manner. Although the increased proportion of authorized but unissued shares of common stock to issued shares of common stock could, under certain circumstances, have an anti-takeover effect, the Reverse Stock Split is not being proposed in order to respond to a hostile takeover attempt or to an attempt to obtain control of us.

    Fractional Shares

    We will not issue fractional certificates for post-Reverse Stock Split shares of common stock in connection with the Reverse Stock Split. To the extent any holders of pre-Reverse Stock Split shares of common stock are entitled to fractional shares of common stock as a result of the Reverse Stock Split, we will issue an additional share to all holders of fractional shares of common stock.

    No Dissenters' Rights

    Under Utah law, our shareholders would not be entitled to dissenters' rights or rights of appraisal in connection with the implementation of the Reverse Stock Split, and we will not independently provide our shareholders with any such rights.


    U.S. Federal Income Tax Considerations

    The following is a summary of certain United States federal income tax consequences of the Reverse Stock Split. It does not address any state, local or foreign income or other tax consequences, which, depending upon the jurisdiction and the status of the shareholder/taxpayer, may vary from the United States federal income tax consequences. It applies to you only if you held pre-Reverse Stock Split shares of common stock as capital assets for United States federal income tax purposes. This discussion does not apply to you if you are a member of a class of our shareholders subject to special rules, such as (a) a dealer in securities or currencies, (b) a trader in securities that elects to use a mark-to-market method of accounting for your securities holdings, (c) a bank, (d) a life insurance company, (e) a tax-exempt organization, (f) a person that owns shares of common stock that are a hedge, or that are hedged, against interest rate risks, (g) a person who owns shares of common stock as part of a straddle or conversion transaction for tax purposes or (h) a person whose functional currency for tax purposes is not the U.S. dollar. The discussion is based on the Internal Revenue Code of 1986, as amended (the "Internal Revenue Code"), its legislative history, existing, temporary and proposed regulations could affect our operating results.

    Bird & Cronin's operationsunder the Internal Revenue Code, published rulings and facilitiescourt decisions, all as of the date hereof. These laws, regulations and other guidance are subject to change, possibly on a retroactive basis. We have not sought and will not seek an opinion of counsel or a ruling from the Internal Revenue Service regarding the United States federal income tax consequences of the Reverse Stock Split.

    PLEASE CONSULT YOUR OWN TAX ADVISOR CONCERNING THE CONSEQUENCES OF THE REVERSE STOCK SPLIT IN YOUR PARTICULAR CIRCUMSTANCES UNDER THE INTERNAL REVENUE CODE AND THE LAWS OF ANY OTHER TAXING JURISDICTION.

    Tax Consequences to United States Holders of Common Stock.

    A United States holder, as used herein, is a shareholder who or that is, for United States federal income tax purposes: (a) a citizen or individual resident of the United States, (b) a domestic corporation, (c) an estate whose income is subject to United States federal income tax regardless of its source, or (d) a trust, if a United States court can exercise primary supervision over the trust's administration and one or more United States persons are authorized to control all substantial decisions of the trust. This discussion applies only to United States holders.

    Except for adjustments that may result from the treatment of fractional shares of common stock as described above, no gain or loss should be recognized by a shareholder upon such shareholder's exchange of pre-Reverse Stock Split shares of common stock for post-Reverse Stock Split shares of common stock pursuant to the Reverse Stock Split, and the aggregate adjusted basis of the post-Reverse Stock Split shares of common stock received will be the same as the aggregate adjusted basis of the common stock exchanged for such new shares. The shareholder's holding period for the post-Reverse Stock Split shares of common stock will include the period during which the shareholder held the pre-Reverse Stock Split shares of common stock surrendered.

    Accounting Consequences

    Following the Effective Date of the Reverse Stock Split (as defined below under "Procedure for Effecting the Reverse Stock Split"), if any, the net income or loss and net book value per share of common stock will be increased because there will be fewer shares of the common stock outstanding. We do not anticipate that any other accounting consequences would arise as a result of the Reverse Stock Split.

    Procedure for Effecting the Reverse Stock Split

    When and if the Board decides to implement the Reverse Stock Split, we will promptly file the Amendment with the Utah Division. The Reverse Stock Split will become effective on the date of filing the Amendment, which is referred to as the "Effective Date." Beginning on the Effective Date, each certificate representing pre-Reverse Stock Split shares will be deemed for all corporate purposes to evidence ownership of post-Reverse Stock Split shares.

    After the Effective Date, our common stock will have a new CUSIP number, which is a number used to identify our securities, and any stock certificates with the old CUSIP number will need to be exchanged for stock certificates with the new CUSIP number using the procedures described below.


    Exchange of Stock Certificates

    As of the Effective Date, each certificate representing shares of our common stock outstanding before the Reverse Stock Split will be deemed, for all corporate purposes, to evidence ownership of the reduced number of shares of our common stock resulting from the Reverse Stock Split. All shares underlying options, warrants and other securities exchangeable or exercisable for or convertible into common stock also automatically will be adjusted on the Effective Date.

    Our transfer agent, Colonial Stock Transfer Company, Inc., will act as the exchange agent for purposes of exchanging stock certificates subsequent to the Reverse Stock Split. Shortly after the Effective Date, shareholders of record will receive written instructions requesting them to complete and return a letter of transmittal and surrender their old stock certificates for new stock certificates reflecting the adjusted number of shares as a result of the Reverse Stock Split. Certificates representing shares of common stock issued in connection with the Reverse Stock Split will continue to bear the same restrictive legends, if any, set forth in the surrendered certificates representing the shares of common stock outstanding prior to the Reverse Stock Split. No new certificates will be issued until such shareholder has surrendered any outstanding certificates, together with the properly completed and executed letter of transmittal, to the exchange agent. Until surrendered, each certificate representing shares of common stock outstanding before the Reverse Stock Split would continue to be valid and would represent the adjusted number of shares of common stock, based on the Exchange Ratio.

    Any shareholder whose stock certificates are lost, destroyed or stolen will be entitled to a new certificate or certificates representing post-Reverse Stock Split shares of common stock upon compliance with the requirements that we and our transfer agent customarily apply in connection with lost, destroyed or stolen certificates. Instructions as to lost, destroyed or stolen certificates will be included in the letter of instructions from the exchange agent.

    Upon the Reverse Stock Split, we intend to treat shareholders holding our common stock in "street name", through a bank, broker or other nominee, in the same manner as registered shareholders whose shares of common stock are registered in their names. Banks, brokers and other nominees will be instructed to effect the Reverse Stock Split for their beneficial holders holding our common stock in "street name". However, such banks, brokers and other nominees may have different procedures than registered shareholders for processing the Reverse Stock Split. If you hold your shares in "street name" with a bank, broker or other nominee, and if you have any questions in this regard, we encourage you to contact your bank, broker or nominee.

    YOU SHOULD NOT DESTROY YOUR STOCK CERTIFICATES AND YOU SHOULD NOT SEND THEM NOW. YOU SHOULD SEND YOUR STOCK CERTIFICATES ONLY AFTER YOU HAVE RECEIVED INSTRUCTIONS FROM THE EXCHANGE AGENT AND IN ACCORDANCE WITH THOSE INSTRUCTIONS.

    If any certificates for shares of common stock are to be issued in a name other than that in which the certificates for shares of common stock surrendered are registered, the shareholder requesting the reissuance will be required to pay to us any transfer taxes or establish to our satisfaction that such taxes have been paid or are not payable and, in addition, (a) the transfer must comply with all applicable federal and state securities laws, and (b) the surrendered certificate must be properly endorsed and otherwise be in proper form for transfer.

    Book-Entry

    Our registered shareholders may hold some or all of their shares electronically in book-entry form with our transfer agent. These shareholders do not have stock certificates evidencing their ownership of common stock. They are, however, provided with a statement reflecting the number of shares of common stock registered in their accounts.

    • If you hold registered shares of common stock in book-entry form, you do not need to take any action to receive your post-Reverse Stock Split shares of common stock in registered book-entry form.

    • If you are entitled to post-Reverse Stock Split shares of common stock, a transaction statement will automatically be sent to your address of record by our transfer agent as soon as practicable after the Effective Date indicating the number of shares of common stock that you hold.


    Interests of Directors and Executive Officers

    Our directors and executive officers have no substantial interests, directly or indirectly, in the matters set forth in this proposal except to the extent of their ownership of shares of our common stock, preferred stock, warrants, or equity awards granted to them under our equity incentive plans.

    Recommendation of the Occupational Safety and Health Act and comparable state statutes that regulate the protectionBoard

    THE BOARD RECOMMENDS THAT YOU VOTE "FOR" PROPOSAL NO. 3.

    EXECUTIVE COMPENSATION

    Executive Officers

    The following table sets forth certain information with respect to our executive officers as of the healthdate of this Proxy Statement:

    NameAgePosition
    John A. Krier(1)46Interim Chief Financial Officer
    Brian Baker(2)57President, Chief Executive Officer, and Director

    (1) Mr. Krier resigned as our President effective May 17, 2023 and safetyas Chief Executive Officer effective October 1, 2023 and was engaged to provide services as our Interim Chief Financial Officer effective October 1, 2023.

    (2) Mr. Baker resigned as our Chief Operating Officer effective October 1, 2023 and was appointed as our President effective May 18, 2023 and Chief Executive Officer effective October 1, 2023.

    John A. Krier. Mr. Krier currently serves as our acting Principal Financial Officer, a position he has held since July 2022.  He also served as our President from July 2020 until May 2023 and Chief Executive Officer from July 2020 until his resignation effective October 1, 2023.  Prior to his appointment as Chief Executive Officer, he served as our Chief Financial Officer from March 2020 until July 2020.  Prior to joining us, Mr. Krier was Vice President of workers,Marketing and Commercial Operations at Breg, Inc., a significant customer of ours, where his work included executive leadership for Breg's bracing product and technology marketing teams, including integrated applications with healthcare systems, service solutions with third-party payer reimbursement, and customer experience. Mr. Krier received a B.S. degree in Business Administration from the proper design, operationUniversity of South Dakota. He is a Certified Public Accountant (inactive), and maintenancea member of equipment. Additionally, certain productsthe American Institute of Bird & Cronin are subjectCertified Public Accountants and Minnesota Society of Public Accountants.

    Brian D. Baker. Mr. Baker is a nominee for director at the Annual Meeting. His personal information is detailed above on page 5 of this Proxy Statement.

    Our Compensation Objectives

    The Compensation Committee operates under a written charter that establishes its responsibilities. The Compensation Committee reviews the charter annually to ensure that its scope is consistent with the Compensation Committee's expected role and meets regulatory requirements. Under the charter, the Compensation Committee is charged with general responsibility for the oversight and administration of our executive compensation program. The charter gives the Compensation Committee the sole responsibility for determining the compensation of the Chief Executive Officer based on the Committee's evaluation of his performance. The charter also authorizes the committee to engage consultants and other professionals without management approval to the requirementsextent deemed necessary to discharge its responsibilities.

    Decisions regarding other executives are made by the Compensation Committee considering recommendations from the Chief Executive Officer and with input from other executive officers and management. Decisions by the Compensation Committee with respect to compensation of the Food, Drug, and Cosmetic Act andChief Executive Officer are ratified by the oversightnon-executive members of the FoodBoard.


    The compensation of our executive officers includes base salary and Drug Administration ("FDA").

    Failureequity components. The ultimate goal of our compensation philosophy is to complycreate long-term shareholder value by rewarding performance that furthers our strategic goals and growth. At the same time, the Compensation Committee seeks to maintain an executive compensation program that is competitive with these requirements, including general industry standards, record keeping requirements and monitoring and control requirements, may result incomparably-sized organizations within our industry.

    We do not target a specific pay mix; however, each Named Executive Officer has a significant fines or compliance costs, which could have a material adverse effect on our resultspercentage of operations, financial condition and cash flows.

    ADDITIONAL INFORMATION ABOUT BIRD & CRONIN
    Historical Financial Information
    This Summary Information should be read in conjunction with the historical financial information preparedtheir bonus determined by performance goals established by the managementCompensation Committee. Each executive's compensation opportunity is designed to provide pay below targeted pay levels if annual and/or long-term performance goals are not achieved. The compensation program is designed to provide pay at or above targeted pay levels if performance meets or exceeds goals. The Company provides a competitive base salary and benefits with limited equity awards. There is not an expectation of Bird & Cronin, including Bird & Cronin's audited Balance Sheetsfuture equity awards for our executives, beyond the Chief Executive Officer.

    The following table summarizes information concerning the compensation paid to our Named Executive Officers for the last two fiscal years (columns (g) and Income Statements as(h) have been intentionally omitted):

    2023 Summary Compensation Table

    The following table shows information regarding the compensation of September 30, 2016 and September 30, 2015, and historical nine-month financial information (unaudited), consisting of Bird & Cronin's Balance Sheet and Income Statement as ofour Named Executive Officers for services performed in the fiscal years ended June 30, 2017, attached2023 and 2022.

    Name and principal
    position

    (a)
     Year
    (b)
          Salary
    ($) (c) 
        Bonus
    ($) (d) 
        Stock
    awards
    ($) (e)
     
          Option
    awards
    ($) (f) 
          All other
    compensation
    ($) (i) (1) 
              Total  
    John A. Krier 2023 $275,577 $46,383 $46,383 $- $18,480 $386,823 
    Chief Financial Officer(3) 2022 $274,481 $56,250 $56,250 $- $26,338 $413,319 
    Brian D. Baker 2023 $248,582 $11,290 $9,284 $- $13,123 $282,279 
    President and Chief Executive Officer (2) 2022 $90,644 $- $- $- $144,179 $234,824 
    Norman Roegner III 2023 $23,077 $- $- $- $- $23,077 
    Chief Financial Officer (4) 2022 $239,690 $19,354 $19,354 $- $27,093 $305,491 

    __________________

    (1) Except as otherwise set forth below, "All other compensation" includes employer contributions to this Proxy Statement as Attachment C (referred to herein as the "Bird & Cronin Financial Statements"). Financial information about Dynatronics for401K, medical, dental, and life insurance benefits.

    (2) Mr. Baker has been our President since May 2023, Chief Executive Officer since October 1, 2023 and was our Chief Operating Officer through October 1, 2023. Mr. Baker was also a non-employee member of our Board from October 2020 through January 2022. During the year ended June 30, 2017, including2022, "All other compensation" includes $15,500 for director fees paid in cash, $11,000 for director fees paid in stock awards, and $108,933 for consulting fees.

    (3) Mr. Krier is our audited financial statementsacting Principal Financial Officer and was our President through May 2023 and our Chief Executive Officer through October 1, 2023. 

    (4) Mr. Roegner was our Chief Financial Officer through July 2022. 

    Outstanding Equity Awards at June 30, 2023

    The following table presents information regarding outstanding equity awards held by each of the Named Executive Officers as of June 30, 2023.



        Option awards         Stock awards                
    Name Number of securities
    underlying
    unexercised options (#)
    exercisable
     
      Number of securities
    underlying
    unexercised options
    (#) unexercisable
     
      Option
    exercise
    price ($)
     
      Option
    expiration
    date
     
      Number
    of shares
    or units of
    stock that
    have not
    vested (#)
     
      Market
    value of
    shares or
    units of
    stock that
    have not
    vested
    ($)
     
     
    (a)     (b)       (c)     (e)     (f)     (g)     (h)  
    John A. Krier 6,750  3,250 $4.64 to 5.60  3/22/2027 to
    7/6/2027
      14,359  10,769 
    Brian D. Baker 18,000  - $6.95 to 13.50  2/26/2026 to
    8/25/2027
      4,374  3,280 
    Norman Roegner III -  -  -  -  -  - 

    Employment

    John A. Krier. On July 7, 2020, we entered into an employment agreement with John Krier as our President and Chief Executive Officer. Pursuant to the agreement, we paid Mr. Krier an annual base salary of $250,000 per year and he was eligible for an annual bonus targeted at a maximum payout of $75,000, and an annual equity award of restricted stock units, or RSUs, up to a maximum value of $75,000, which amount was to be determined by the Compensation Committee of the Board, based on results of operations and Mr. Krier's performance against goals established by the Compensation Committee. On the date of his appointment, Mr. Krier received a grant of 50,000 RSUs under the 2018 Plan, vesting in four equal annual installments commencing on the first anniversary of the grant date. Upon vesting, Mr. Krier was to receive a number of shares of common stock equal to the number of RSUs that have vested. Also, upon his appointment date, the Company granted Mr. Krier a stock option under the 2018 Plan for the two years then ended,purchase of 15,000 shares of common stock, vesting over a four-year period with one-fourth of the shares vesting annually on the anniversary of the grant date. The exercise price of the stock option is the market price of the common stock on the date of grant. We also entered into an indemnification agreement with Mr. Krier on the same terms as the agreements entered into with our other directors and executive officers.

    Mr. Krier's employment agreement was mutually terminated by the notes thereto, is available on our Annual Report on Form 10-K, filed September 26, 2017, incorporated herein by reference.

    As discussed above,Company and Mr. Krier in connection with his resignation as Chief Executive Officer and as a director, effective October 1, 2023.  Notwithstanding such termination, Mr. Krier remains subject to a non-solicitation, non-competition and confidentiality agreement with post-termination restrictive covenants.

    As referenced above, effective October 1, 2023, the Company accepted Mr. Krier's resignation as Chief Executive Officer and member of its Board of Directors and in connection with Mr. Krier's appointment as the Company's Interim Chief Financial Officer, the Company entered into a Consulting Agreement with JKrier LLC, pursuant to which Mr. Krier will provide such services to the Company, which also became effective October 1, 2023 (the "Consulting Agreement"). Pursuant to the Consulting Agreement, the Company will pay to Mr. Krier consulting fees in the amount of $2,500 per week. Mr. Krier will not be eligible to participate in any employee benefits programs offered by the Company, but will receive reimbursement of reasonable and necessary out-of-pocket expenses. The Consulting Agreement will terminate on December 31, 2023, unless earlier terminated in accordance with its terms.


    Brian D. Baker. On October 1, 2023, the Company and Mr. Baker entered into an Employment Agreement effective as of October 1, 2023 (the "Employment Agreement").  Pursuant to the Employment Agreement, the Company will pay Mr. Baker an annual base salary of $212,000 per year and he will be eligible for an annual equity award of restricted stock units, or RSUs, valued at $75,000, with such grants vesting fifty percent (50%) on the date of grant and fifty percent (50%) on the first anniversary of the date of grant, subject to applicable terms and conditions determined by the Compensation Committee of the Board (the "Compensation Committee"). Additionally, at the next regularly scheduled meeting of the Compensation Committee following Mr. Baker's appointment date, the Compensation Committee will consider a grant (the "Initial Awards") to Mr. Baker of (i) 50,000 RSUs, which, upon vesting, will entitle Mr. Baker will to a number of shares of common stock equal to the number of RSUs that have vested, and (ii) a stock option for the purchase of 15,000 shares of the Company's common stock at an exercise price equal to the market price of the Company's common stock on the date of grant.  If granted, such Initial Awards will vest in four equal annual installments commencing on the first anniversary of the grant date.  All equity grants awarded to Mr. Baker in accordance with the terms of the Employment Agreement will be subject to the terms and conditions of the Company's applicable equity incentive plans. 

    Any incentive-based or other compensation paid to Mr. Baker under the Employment Agreement or any other agreement or arrangement with the Company will be subject to deductions and clawbacks to the extent required to be made under applicable laws and/or stock exchange listing requirements (whether currently in existence or later adopted) or any policy established by the Company pursuant to such laws or listing requirements.

    Under the Employment Agreement, Mr. Baker is eligible to participate in the employee benefit plans and programs generally available to the Company’s senior executives and entitled to the fringe benefits and perquisites they may be made available from time to time to other top executives of the Company at the discretion of the Compensation Committee, in accordance with and subject to the terms and conditions of such plans and programs.

    Mr. Baker is also subject to a non-solicitation, non-competition and confidentiality agreement with post-termination restrictive covenants. The Company has also entered into an indemnification agreement with Mr. Baker on the same terms as it has with its other directors and executive officers.

    Payments upon Termination

    Mr. Baker's Employment Agreement continues until terminated by the Company or by Mr. Baker in accordance with its terms. If the Company terminates Mr. Baker's employment during the first 12 months without cause as defined under the Employment Agreement, the Company must pay Mr. Baker an amount equal to ninety (90) days' base salary. In addition, in such event and to the extent applicable, one-half of the Initial Awards granted to him at the as contemplated above will automatically vest, subject to his execution of a release of all claims against the Company.

    Norman Roegner III. On July 6, 2022, the Company announced that the Company and Norman Roegner mutually determined that Mr. Roegner's services as Chief Financial Officer (Principal Financial Officer) of the Company would be terminated, effective July 22, 2022. In connection with Mr. Roegner's termination, the Company and Mr. Roegner entered into a Separation and Release Agreement (the "Roegner Separation Agreement"). The Roegner Separation Agreement provided that Mr. Roegner received separation pay equal to eight (8) weeks of his annual base salary. In addition, the Roegner Separation Agreement provides for the accelerated vesting of 15,180 shares of Restricted Stock Units, the vesting of which occurred on July 22, 2022. The Roegner Separation Agreement included a general release of claims and waivers customary in such agreements.

    Retirement Benefits

    We do not provide pension arrangements or post-retirement health coverage for executive officers or employees. Our executive officers and other eligible employees may participate in one of our Annual Meeting,401(k) defined contribution plans depending on the location of their employment. In fiscal year 2023, we maintained two separate 401(k) plans for our employees: (1) the Dynatronics Corporation Plan (the "Dynatronics Plan") covers its Bird & Cronin, LLC and Dynatronics Corporation employees; and (2) the Hausmann Enterprises, LLC Plan (the "Hausmann Plan") covers employees at our New Jersey location.


    Dynatronics Plan. Under the Dynatronics Plan, employees who are 21 years of age or older are eligible to participate on the first day of the month following their hire date. Eligible employees may contribute to the Dynatronics Plan in the form of salary deferrals of up to $22,500, the maximum allowable for calendar year 2023. Eligible employees who are over 50 years old may contribute an additional $7,500 in catchup contributions during calendar year 2023. We match employee contributions at 50% of the first 6% of employee compensation, up to a maximum of $3,000 per employee per year. Participants in the Dynatronics Plan are fully vested in their salary deferral contributions, and employer matching contributions vest 25% after year one, 25% each year thereafter (100% vested after four years).

    Hausmann Plan. Under the Hausmann Plan, employees who are 21 years of age or older are eligible to participate on the first day of the month following their hire date. Eligible employees may contribute to the Hausmann Plan in the form of salary deferrals of up to $22,500, the maximum allowable for calendar year 2023. Eligible employees who are over 50 years old may contribute an additional $7,500 in catchup contributions during calendar year 2023. We match employee contributions at 50% of the first 6% of employee compensation, up to a maximum of $3,000 per employee per year. Participants in the Hausmann Plan are fully vested in their salary deferral contributions, and employer matching contributions vest 25% after year one, 25% each year thereafter (100% vested after four years).

    SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDERS MATTERS

    Security Ownership of Certain Beneficial Owners and Management

    The following table sets forth certain information regarding the ownership of our voting securities as of October 10, 2023, for:

    • each shareholder known by us to be the beneficial owner of more than 5% of any class of our voting securities;

    • each of our directors;

    • each of our Named Executive Officers; and

    • all of our directors and executive officers as a group.

    Applicable ownership is based on 4,530,837 shares of common stock outstanding at October 10, 2023. In computing the percentage of shares of common stock beneficially owned, we deemed to be outstanding all shares of common stock subject to options, warrants or other equity awards and all shares of our Series A Preferred, and Series B Preferred held by that person or entity that are currently exercisable or exchangeable or that will become exercisable or convertible within 60 days.

    Under SEC rules, "Named Executive Officers" or "NEO" include (i) all persons who served as principal executive officer during the last completed fiscal year, regardless of compensation level; (ii) our two most highly compensated executive officers other than the principal executive officer who were serving as executive officers as of the end of the last completed fiscal year; and (iii) up to two additional individuals who would have been deemed to be Named Executive Officers except that they were not serving as officers at the end of the fiscal year. Pursuant to these rules, we have identified as our Named Executive Officers for purposes of this Proxy Statement the following: (1) Mr. Krier, who was our Chief Executive Officer during fiscal 2023 and is currently our Chief Financial Officer; (2) Mr. Baker, who was our Chief Operating Officer during fiscal 2023 and is our current President and Chief Executive Officer; and (3) Mr. Roegner, who was our Chief Financial Officer at the end of fiscal 2022. Unless otherwise indicated in the notes below the table, the address of each beneficial owner listed in the table below is c/o Dynatronics Corporation, 1200 Trapp Road, Eagan, Minnesota 55121.



    Beneficial Ownership Table

    Name/Address of
    Beneficial Owner
    (1)
     

    Title of
    Class
      No. of Shares
    of each
    Class
    Beneficially
    Owned
      Percent of Class
    Beneficially Owned
      Total No. of Shares
    Beneficially Owned
      Percent of
    Total
    Voting Power
     
    Greater than 5% Shareholders:               
    Stuart M. Essig (2) Common  628,490  13.9%  856,490  18.9% 
      Series A  880,000  44.2%       
      Series B  260,000  19.1%       
    Stuart M. Essig 2007 Family Trust (3) Common  107,299  2.4%  153,059  3.4% 
      Series A  188,800  9.5%       
      Series B  40,000  2.9%       
    Provco Ventures I, LP (4) Common  396,792  8.8%  533,592  11.8% 
      Series A  484,000  24.3%       
      Series B  200,000  14.7%       
    Armistice Capital, LLC(5) Common  199,401  4.4%  299,401  6.6% 
      Series B  500,000  36.8%       
                    
    Directors and Named Executive Officers:               
    Brian D. Baker (CEO/ President/Director) (6) Common  53,797  1.2%  90,997  2.0% 
      Series A  96,000  4.8%       
    John A. Krier (CFO) (7) Common  31,469  *  41,469  * 
    Erin S. Enright (Director)(8) Common  25,124  *  178,183  3.9% 
      Series A  188,800  9.5%       
      Series B  40,000  2.9%       
    David B. Holtz (Director) (9) Common  24,968  *  24,968  * 
    Scott A. Klosterman (Director) (10) Common  24,968  *  24,968  * 
    Brian M. Larkin (Director) (10) Common  62,257  1.4%  75,857  1.7% 
      Series A  48,000  2.4%       
      Series B  20,000  1.5%       
    R. Scott Ward (Director) (11) Common  21,416  *  21,416  * 
    Norman Roegner III (Former CFO)(12) Common  *  *  *  * 
    All executive officers and directors as a group (8 persons) Common  243,999  5.4%  457,858  10.1% 
      Series A  332,800  16.7%       
      Series B  60,000  4.4%       

    (1) The table assumes 4,530,837 shares of common stock issued and outstanding as of October 10, 2023. The amount in the "Percent of Total Voting Power" column includes the impact of any applicable Voting Cutback as to the indicated beneficial owner. Subject to the Voting Cutback, the Series A Preferred and the Series B Preferred vote on an as-converted basis one vote per share with the common stock. For purposes of the table, we determined the number of shares of each class as beneficially owned by each person under Rule 13d-3(d)(1) of the Exchange Act. Under this rule, shares of voting stock not outstanding that are subject to issuance pursuant to options, warrants, rights or conversion privileges exercisable by a person within 60 days of the date indicated are deemed outstanding for the purpose of calculating the number and percentage beneficially owned by such person, but are not seekingdeemed outstanding for the purpose of calculating the number or percentage beneficially owned by any other person listed in the table. Except where otherwise noted, we believe that each individual or entity named has sole investment and voting power with respect to the shares beneficially owned by such person, subject to community property laws, where applicable. Beneficial ownership representing less than one percent of the outstanding shares of a class is denoted with an asterisk (*). If an individual or person disclaims beneficial ownership, that is noted in the notes below the table.


    (2) Mr. Essig is an observer to our Board and the husband of Erin Enright, a Preferred Director and the Chairman of our Board. Mr. Essig has sole voting and dispositive power over the shares of stock indicated. He has no voting or dispositive power over securities that are beneficially owned of record by The Stuart M. Essig 2007 Family Trust ("Essig Trust," see, Note (3), below) or by Ms. Enright (see, Note (8), below). The address for this beneficial owner is 512 West MLK Jr. Blvd #320, Austin, Texas 78701.

    (3) Mr. Essig is the settlor/grantor of the Essig Trust. His wife, Ms. Enright, is Trustee of the Essig Trust. Ms. Enright and the Essig Trust have shared voting and dispositive power over the shares of stock owned of record by the Essig Trust. The address for this beneficial owner is 512 West MLK Jr. Blvd #320, Austin, Texas 78701.

    (4) The address of this beneficial owner is 795 E. Lancaster Ave. Suite 200, Villanova, PA 19085. The general partner of this shareholder is Provco, LLC. The sole member of Provco, LLC is Gerald N. Holtz.

    (5) The address for this beneficial owner is c/o Steven Boyd, 510 Madison Ave, 22nd Floor, New York, New York 10022. With respect to information relating to Armistice Capital, LLC, we have relied solely on information supplied by such entity on a Schedule 13G/A filed with the SEC on February 14, 2023. Per the Schedule 13G/A, Armistice Capital, LLC held shared voting power over 199,401 shares and shared dispositive power over 199,401 shares.

    (6) Amount of common stock beneficially owned includes (a) 18,000 exercisable options, and (b) 53,797 shares of common stock owned of record.

    (7) Amount of common stock beneficially owned includes (a) 10,000 exercisable options and (b) 31,469 shares of common stock owned of record.

    (8) The amount of common stock beneficially owned includes: (a) 25,124 shares of common stock owned of record and (b) 107,299 shares of common stock beneficially owned by the Essig Trust (see, Note (3), above). Ms. Enright has no voting and dispositive power over the shares beneficially owned by her husband; she has shared voting and dispositive power as Trustee over the shares beneficially owned by the Essig Trust.

    (9) Mr. Holtz is an executive officer of Provco, LLC, the general partner of Provco Ventures I LP. He does not have sole voting or dispositive power of shares beneficially owned by Provco.

    (10) All amounts indicated are shares of common stock owned of record by Mr. Klosterman.

    (11) All amounts indicated are shares of common stock owned of record by Dr. Ward.

    (12) All amounts indicated are shares of common stock owned of record by Mr. Roegner.

    Securities Authorized for Issuance Under Equity Compensation Plans

    Equity Grants

    As of June 30, 2023, options to purchase a total of 28,000 registered shares of our common stock were outstanding at a weighted average exercise price of $7.79 per share, of which options to purchase 22,500 shares of our common stock were vested and exercisable at a weighted average exercise price of $8.26 per share and options to purchase 5,750 shares were unvested and not exercisable at a weighted average exercise price of $1.19 per share. These options were issued under Dynatronics 2018 Equity Incentive Award Plan (the "2018 Plan"). At June 30, 2023, an additional 198,406 shares remained available for future equity grants under our 2020 Plan, and no shares remained available for future equity grants under our 2018 Plan.


    The following table summarizes awards outstanding under the 2018 Plan and the 2020 Plan as of June 30, 2023. The following information does not reflect issuances or exercises under the 2018 Plan or the 2020 Plan subsequent to June 30, 2023.1

    Plan category 

    Number of
    securities
    to be issued
    upon
    exercise of
    outstanding
    options,
    warrants
    and rights
    (a)
      

    Weighted-
    average
    exercise
    price of
    outstanding
    options,
    warrants
    and rights
    (b)
      Number of
    securities
    remaining
    available
    for
    future
    issuance
    under
    equity
    compensation
    plans
    (excluding
    securities
    reflected in
    column (a))
    (c)
     
    Equity compensation plans approved by security holders         
    2020 Plan 20,371 $0.75  178,305 
    2018 Plan 28,000 $7.79  - 
                    Total 48,371     178,305 

    Description of the 2018 Plan

    Our Board unanimously approved the 2018 Plan on September 10, 2018, and the 2018 Plan was approved by our shareholders at our 2018 annual meeting of shareholders on December 3, 2018. The Board also determined to keep the 2018 Plan in effect upon adoption of the 2020 Plan, and to grant awards under the 2018 Plan until the remaining shares available for awards and issuance under the 2018 Plan have been exhausted. The 2018 Plan reserved for issuance pursuant to awards under the 2018 Plan, 600,000 shares of common stock, plus the number of shares of common stock reserved and available for issuance under our prior plan (the 2015 Plan) as of the date of shareholder approval of the Acquisition2018 Plan. For purposes of this limitation, the shares of stock underlying any awards that are forfeited, are canceled, expire or are terminated (other than by exercise) under (i) the 2018 Plan or (ii) from and there are no regulatory requirements that we obtainafter shareholder approval of the Acquisition. We are seeking shareholder approval, in accordance with2018 Plan, the NASDAQ Listing Rules,shares remaining available under our 2015 Equity Incentive Award Plan (the "2015 Plan") were added to the shares of stock available for issuance under the 2018 Plan. Shares tendered or held back upon exercise of an option or settlement of an award to cover the exercise price or tax withholding were not be available for future issuance under the 2018 Plan.

    As of June 30, 2023, no shares remain authorized for issuance under the 2018 Plan and awards covering 28,000 shares of common stock remain outstanding as of June 30, 2023 and remain operative under the terms of the issuance of securities in excess of 19.99%respective grants.

    Description of the outstanding Common Stock2020 Plan

    The maximum number of the Company in connection with the Acquisition. The risksshares of stock reserved and uncertainties described above are not the only ones related to the Acquisition. Additional risks and uncertainties regarding Bird & Cronin not presently known to us or that our management currently deems immaterial also may impair our business operations. Following the closing of the Acquisition, the business of Bird & Cronin is now the business of the Company, operated by Acquisition Subsidiary as a division of Dynatronics. If any of the risks described above were to occur, our business, financial condition, operating results and cash flows could be materially adversely affected. In such an event, the trading price of our Common Stock could decline and you could be materially and adversely impacted. The risks discussed above also include forward-looking statements and our actual results may differ substantially from those discussed in these forward-looking statements.

    MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
    AND RESULTS OF OPERATIONS OF BIRD & CRONIN
    Set forth below is our management discussion and analysis of financial condition and results of operationsavailable for Bird & Cronin for the year ended September 30, 2016 compared to the year ended September 30, 2015, and the nine months ended June 30, 2017 compared to the nine months ended June 30, 2016.
    The following discussion and analysis of Bird & Cronin's financial condition and results of operations should be read in conjunction with the audited financial statements of Bird & Cronin, as of and for the years ended September 30, 2016 and 2015 and the notes thereto, and the unaudited financial information for the nine months ended June 30, 2017, provided to Dynatronics in connection with the Acquisition by Bird & Cronin.
    Critical Accounting Policies and Estimates
    Bird & Cronin makes judgments, estimates and assumptions concerning the future when preparing its financial statements. Actual results may differ from these estimates. Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimates are revised and in any future periods affected. The accounting policies and estimates below involve a high degree of judgment and complexity. See Note 1 of the Bird & Cronin Financial Statements for a complete discussion of Bird & Cronin's significant accounting policies and estimates.
    33

    Revenue Recognition
    Bird & Cronin recognizes revenue from the sale of a product when products are shipped to the customer. Amounts billed for shipping and handling are recorded as costs of sales.
    Accounts Receivable
    Accounts receivable are due from dealers and distributors. Customer accounts receivable are recorded at the amounts Bird & Cronin expects to collect on balances outstanding, which are net of allowances for doubtful accounts. Management provides for probable uncollectible amounts and estimated rebates and returns through charges to earnings and credits to valuation allowances based on its assessment of the current status of individual accounts and estimates of sales levels. In addition, Bird & Cronin closely monitors outstanding balances and charges off all balances when Bird & Cronin management determines the probability of collection is remote. Generally, accounts receivable are due within 30 to 60 days. Accounts receivable balances outstanding longer than the contractual payment terms are considered past due.
    Inventories
    Inventories consist of raw materials (including work in process) and finished goods, and are stated at the lower of cost or market. Cost is recorded using the weighted-average method.
    Income Taxes
    Bird & Cronin, with the consent of its stockholders, has electedissuance under the Internal Revenue Code to be an S Corporation. In lieu2020 Plan is 1,000,000 shares of corporate income taxes, the individual stockholders of an S Corporation are taxed on their proportionate share of the corporation's taxable income. The guidance followed by Bird & Cronin on accounting for uncertainty in income taxes recognized in financial statements prescribes a more likely than not recognition threshold for financial statement recognition and measurement of a tax position taken, or expected to be taken, in a tax return and also provides guidance on various related matters such as interest and penalties and disclosure. Under Section 7519 of the Internal Revenue Code, Bird & Cronin is required to make income tax deposits to maintain its fiscal year end for the amount of deferred income from October 1 through December 31 of each year.
    Nine Months Ended June 30, 2017 Compared to Nine Months Ended June 30, 2016
    Net sales for the nine months ended June 30, 2017 were $17,923,262, compared to $17,659,221 for the nine months ended June 30, 2016. Cost of sales for the nine-month period in 2017 were $11,342,431 and gross profit was $6,580,831 for the period, compared to cost of sales of $11,337,934 and gross profit of $6,321,287 in 2016. The improvement in gross profit was due primarily to greater operational efficiencies, increased sales of higher margin products and price increases in 2017.
    Selling, general and administrative ("SG&A") expense for the nine months ended June 30, 2017 were $5,177,464 or 28.8% of net sales, compared to $4,966,780, or 28.1% of net sales for the same period in 2016. The increase in SG&A expense in 2017 was due to employee bonuses and increased executive compensation expense. Net income for the nine months ended June 30, 2017, was $1,403,470, compared to net income of $1,340,071 for the nine months ended June 30, 2016.
    Net cash provided by operating activities during the nine months ended June 30, 2017 was $387,122, compared to $1,223,483 during the same period in 2016. Capital expenditures used net cash during the nine months ended June 30, 2017 of $76,190 and $6,840 during the same period in 2016. Distributions to stockholders during the nine months ended June 30, 2017 totaled $1,235,250, compared to $1,180,000 during the nine months ended June 30, 2016.
    34

    Year Ended September 30, 2016 Compared to Year Ended September 30, 2015
    Results of Operations
    Net Sales
    The increase in net sales during the year ended September 30, 2016 from 2015 is due to increased focus on sales management and improved market conditions. Bird & Cronin management anticipate sales to stay within historical ranges.
    Cost of Sales
    Cost of sales consists of certain labor costs, payments to raw materials suppliers, vendors and others that are directly related to a revenue-generating event. Cost of sales also includes shipping and handling charges.  During the year ended September 30, 2016, cost of sales as a percent of total revenue decreased to 63.8% as compared to 65% for the year ended September 30, 2015. This decrease was primarily the result of improved operating efficiencies. Bird & Cronin management anticipates cost of sales as a percentage of total revenue to stay within its historical range.
    Operating Expense
    SG&A expense decreased in 2016 compared to the year ended September 30, 2015, from $7,067,142 (30.2% of net sales) to $6,581,001 (27.2% of net sales). The primary reason for the decrease in SG&A is due to the implementation of a new sales commission structure, key performance indicators across the organization, and retirement of a senior executive. Bird & Cronin management anticipates that operating costs will continue at similar levels.
    Research and Development
    Research and development ("R&D") expense is related primarily to the development of new products and improvement of existing products. Bird & Cronin management has not historically reported R&D costs separately. Its management anticipates that certain R&D costs will be incurred and that they will continue at similar historical levels.
    Interest Expense
    Interest expense for the years September 30, 2016 and 2015 was immaterial and represents interest paid on a revolving line of credit with a financial institution. The borrowing capacity under the line of credit was $4,000,000. No borrowings were outstanding at September 30, 2016 and 2015. Subsequent to the year end, prior to the closing of the Acquisition, Bird & Cronin closed the line of credit and the agreement with the bank was terminated.
    Liquidity and Capital Resources
    Bird & Cronin has historically met its working capital and capital expenditure requirements by using net cash flow from operations and by drawing on its line of credit. The principal source of liquidity is Bird & Cronin's operating cash flow.
    Cash Flows from Operating Activities
    Net cash provided by operating activities totaled $2,041,409 in 2016, compared with $969,143 in 2015. Cash flow improvement from 2015 to 2016 was directly related to the improvement in net income.
    Cash Flows from Investing Activities
    For the year ended September 30, 2016, Bird & Cronin used $6,840 for the purchase of property and equipment, compared to cash provided from the sale of assets in 2015 (offset by capital expenditures of $10,463) net, of $20,350 for the year ended September 30, 2015.
    Cash Flows from Financing Activities
    Distributions to stockholders in 2016 totaled $1,790,000, compared to distributions to stockholders in 2015 of $338,938.
    35

    UNAUDITED PRO FORMA FINANCIAL INFORMATION
    Unaudited Pro Forma Condensed Combined Statements of Operations for the year ended June 30, 2017 (the "Pro Forma Statements"), which combine the historical consolidated statements of operations of Dynatronics and Bird & Cronin for those periods,common stock (without giving effect to any subsequent adjustments resulting from stock splits or other transactions), plus the Acquisition as if it had been consummated on July 1, 2016,number of shares of common stock underlying any award granted under our 2018 Plan that are forfeited, are canceled, expire or are terminated (other than by exercise). Shares tendered or held back upon exercise of an option or settlement of an award to cover the beginningexercise price or tax withholding shall not be available for future issuance under the 2020 Plan.

    ___________________________

    1 NTD: Table to be updated.


    The 2020 Plan provides for the grant of various types of awards, including, for example: (i) incentive stock options; (ii) nonqualified stock options; (iii) stock appreciation rights; (iv) restricted stock awards; (v) deferred stock awards; and (vi) other stock-based and cash-based awards to eligible individuals. The terms of the full year period presented are includedawards will be set forth in an award agreement, consistent with this Proxy Statement as Attachment D. The Pro Forma Statements were derived from, and should be read in conjunction with:

    The audited consolidated financial statements of Dynatronics as of and for the year ended June 30, 2017, as contained on Form 10-K filed on September 27, 2017;
    The audited financial statements of Bird & Cronin as of and for the years ended September 30, 2016 and 2015, and the unaudited financial statements of Cronin as of and for the nine-months ended June 30, 2017.
    SPECIAL NOTE REGARDING FORWARD-LOOKING INFORMATION
    This Proxy Statement includes "forward-looking statements" within the meaning of Section 27Aterms of the Securities Act2020 Plan.

    As of 1933,June 30, 2023, 198,406 shares remain authorized for issuance under the 2020 Plan and no awards remain outstanding as amended,of June 30, 2023.

    Certain Relationships and Section 21ERelated Transactions

    We have adopted a policy that any transactions with directors, executive officers or entities of which they are also officers or directors or in which they have a financial interest, will only be on terms consistent with industry standards and approved by a majority of the Exchange Act. These statementsdisinterested members of our Board. In addition, interested directors may be counted in determining the presence of a quorum at a meeting of our Board or a committee thereof that approves such transactions. If there are often identified by the use of words such as "may," "expect," "believe," "anticipate," "intend," "could," "estimate," or "continue," and similar expressions or variations and other matters that do not relate strictly to historical facts. Such forward-looking statements are subject to risks, uncertainties and other factors that could cause actual results and the timing of certain events to differ materially from future results expressed or implied by such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those discussed under the heading "Risk Factors" in our filings with the Commission pursuant to Sections 13(a), 13(c), 14 or 15(d)no disinterested directors, we shall obtain a majority vote of the Exchange Act. The forward-looking statements in this Proxy Statement represent our views as ofshareholders approving the date such statements are made. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change. These forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date such statements are made. The forward-looking statements contained herein speak only as of the date on which they were made, and, except as required by law, we disclaim any obligation to update any forward-looking statements to reflect events or circumstances after the date of this Proxy Statement.

    transaction.

    SHAREHOLDER PROPOSALS FOR 20182024 ANNUAL MEETING OF SHAREHOLDERS

    Requirements for Shareholder Proposals to Be Considered for Inclusion in Dynatronics' Proxy Materials

    Shareholders of Dynatronics may submit proposals on matters appropriate for shareholder action at meetings of Dynatronics'our shareholders in accordance with Rule 14a-8 promulgated under the Exchange Act. For such proposals to be included in Dynatronics'our proxy materials relating to its 2018 Annual Meetingour 2024 annual meeting of Shareholders,shareholders, all applicable requirements of Rule 14a-8 must be satisfied and such proposals must be received by Dynatronicsus no later than June 2, 2018.26, 2024. Such proposals should be delivered to Dynatronics Corporation, 7030 Park Centre Drive, Cottonwood Heights, Utah 84121,1200 Trapp Road, Eagan, Minnesota 55121, Attention: Jim Ogilvie, Vice President of Business Development,Legal Department, telephone (801) 727-1755.

    Requirements for Shareholder Proposals to be Brought Before the Annual Meeting
    Dynatronics' bylaws provide568-7000.

    Our Board has determined that, except in the case of proposals made in accordance with Rule 14a-8, for shareholder nominations to the Board of Directors or other proposals to be considered at an annual meeting of shareholders, the shareholder must have given timely notice thereof in writing to theour Corporate Secretary of Dynatronics not less than 60 nor more than 90 calendar days prior to the anniversary of the date on which Dynatronicswe first mailed itsour proxy materials for itsour immediately preceding annual meeting of shareholders (as specified in Dynatronics'the proxy materials for itsthe immediately preceding annual meeting of shareholders). To be timely for the 2018 Annual Meeting2024 annual meeting of Shareholders,shareholders, a shareholder's notice must be delivered or mailed to and received by Dynatronics'our Corporate Secretary at theour principal executive offices of Dynatronics between July 2, 2018,26, 2024 and August 1, 2018.25, 2024. However, in the event that the 2024 annual meeting of shareholders is called for a date that is not within 30 calendar days of the anniversary of the date on whichthat the immediately preceding2024 annual meeting of shareholders was called, to be timely, notice by the shareholder must be so received by us not later than the close of business on the tenth calendar day following the date on which public announcement of the date of the 2024 annual meeting of shareholders is first made. In no event will the public announcement of an adjournment of an annual meeting of shareholders commence a new time period for the giving of a shareholder's notice as provided above. A shareholder's notice to Dynatronics'our Corporate Secretary must set forth the information required by Dynatronics' bylawsthe Bylaws with respect to each matter the shareholder proposes to bring before the annual meeting.

    Annual Meeting.

    In addition, the proxy solicited by the Board of Directors for the 2018 Annual Meeting2024 annual meeting of Shareholdersshareholders will confer discretionary authority to vote on (i) any proposal presented by a shareholder at that meeting for which Dynatronics haswe have not been provided with notice on or prior to August 1, 2018,25, 2024, and (ii) any proposal made in accordance with the bylawBylaw provisions, if the 2018 proxy statement2024 Proxy Statement briefly describes the matter and how management's proxy holders intend to vote on it, if the shareholder does not comply with the requirements of Rule 14a-4(c)(2) under the Exchange Act.

    36

    SHAREHOLDERS SHARING THE SAME ADDRESS

    HOUSEHOLDING OF PROXY MATERIALS

    The CommissionSEC has adopted rules that permit companies and intermediaries (such as(e.g., brokers) to implement asatisfy the delivery procedure called "householding." Under this procedure, multiplerequirements for Notices of Internet Availability of Proxy Materials or other Annual Meeting materials with respect to two or more shareholders who reside atsharing the same address may receiveby delivering a single copy of our annual report and proxy materials, including any Notice of Internet Availability of Proxy Materials unless the affected shareholder has provided contrary instructions.or other Annual Meeting materials addressed to those shareholders. This procedure reduces printing costsprocess, which is commonly referred to as "householding," potentially means extra convenience for shareholders and postage fees.cost savings for companies.

    Once again this

    This year, a number of brokers with account holders who beneficially own our Common Stockare Dynatronics shareholders will be "householding"householding our annual report and proxy materials. A single setNotice of annual report and other proxy materialsInternet Availability of Proxy Materials will be delivered to multiple shareholders sharing an address unless contrary instructions have been received from the affected shareholders. Once you have received notice from your broker that itthey will be "householding"householding communications to your address, "householding"householding will continue until you are notified otherwise or until you revoke your consent. Shareholders with shares held in street name may revoke their consentIf, at any time, by contacting Broadridge Financial Solutions, either by calling toll-free (800) 542-1061, or by writingyou no longer wish to Broadridge Financial Solutions, Householding Department, 51 Mercedes Way, Edgewood, New York, 11717.

    Upon written or oral request, Dynatronics will promptly deliver a separate copy of the annual reportparticipate in householding and other proxy materialswould prefer to any beneficial owner at a shared address to which a single copy of any of those documents was delivered. To receive a separate copyNotice of Internet Availability of Proxy Materials, please notify your broker. Shareholders who currently receive multiple copies of the annual reportNotices of Internet Availability of Proxy Materials at their addresses and would like to request householding of their communications should contact their brokers.

    OTHER MATTERS

    The Board knows of no other matters that will be presented for consideration at the Annual Meeting. If any other matters are properly brought before the meeting, it is the intention of the persons named in the accompanying proxy materials, you may write or call Dynatronics' Investor Relations Department at Dynatronics Corporation, 7030 Park Centre Drive, Cottonwood Heights, Utah 84121, Attention: Jim Ogilvie, Vice to vote on such matters in accordance with their best judgment.

    By Order of the Board of Directors

    /s/ Brian Baker

    Brian Baker

    President of Business Development, telephone (801) 727-1755.

    ANNUAL REPORT ON FORM 10-K
    We are furnishing aand Chief Executive Officer

    October 24, 2023

    A copy of our Annual Report on Form 10-K for the fiscal year ended June 30, 2017, including2023, is available without charge upon written request to: Attn: Corporate Secretary, Dynatronics Corporation, 1200 Trapp Road, Eagan, Minnesota 55121.

    To the Financial Statements forextent the year then ended, as filed withrules and regulations adopted by the Commission, to each shareholder to whomSEC state that certain information included in this Proxy Statement is delivered.

    OTHER BUSINESS
    We knownot deemed "soliciting material" or "filed" with the SEC or subject to Regulation 14A promulgated by the SEC or to the liabilities of no other matters thatSection 18 of the Exchange Act, such information shall not be deemed incorporated by reference by any general statement incorporating by reference this Proxy Statement into any filing under the Securities Act of 1933, as amended, or under the Exchange Act.


    Appendix A to Proxy Statement

    ARTICLES OF AMENDMENT

    TO THE

    AMENDED AND RESTATED ARTICLES OF INCORPORATION OF

    DYNATRONICS CORPORATION

    Pursuant to and in accordance with the provisions of Section 16-10a-1006 of the Utah Revised Business Corporation Act, as amended (the "Act"), the undersigned, Dynatronics Corporation (the "Corporation") hereby declares and certifies the following Articles of Amendment ("Articles of Amendment") to its Amended and Restated Articles of Incorporation (as previously amended, "Articles of Incorporation").

    1. The name of the Corporation is Dynatronics Corporation.

    2. The text of the amendment to the Articles of Incorporation adopted is as follows:

    Following the final paragraph of ARTICLE III of the Articles of Incorporation, the following text is inserted (the "Amendment"):

    "Upon the filing of these Articles of Amendment to the Articles of Incorporation, each share of Common Stock of the Corporation issued and outstanding immediately prior to the filing of these Articles of Amendment, without further action, will be presentedautomatically split and converted into one-[__________] ([_____]) of one (1) share of fully paid and nonassessable shares of Common Stock of the Corporation (the "Reverse Stock Split"). No fractional shares shall be issued upon the Reverse Stock Split; rather, each fractional share resulting from the Reverse Stock Split shall be rounded up to the nearest whole number. Each outstanding stock certificate of the Corporation, which prior to the filing of these Articles of Amendment represented one or more shares of Common Stock, shall immediately after such filing represent that number of shares of Common Stock equal to the product of (i) the number of shares of Common Stock represented on such certificates divided by (ii) [__________] ([_____]) (such adjusted shares, the "Reclassified Shares"), with any resulting fractional shares rounded up to the nearest whole share as set forth above. Any options, warrants, conversion, or other purchase or conversion rights, which prior to the filing of these Articles of Amendment represented the right to acquire one or more shares of the Corporation's Common Stock, shall immediately after such filing represent the right to acquire one-[__________] ([_____]) of one (1) share of the Corporation's Common Stock for each share of the Corporation's Common Stock that such option, warrant, conversion or other purchase or conversion right previously represented the right to acquire. The exercise or conversion price of such options, warrants or conversion rights shall be adjusted by multiplying the existing exercise or conversion price by [__________] ([___]).

    The number of authorized shares of Common Stock of the Corporation and the par value of such shares will not be affected by these Articles of Amendment.

    The Corporation shall, upon the request of each record holder of a certificate representing shares of Common Stock issued and outstanding immediately prior to the filing of these Articles of Amendment to the Articles of Incorporation, issue and deliver to such holder in exchange for such certificate a new certificate or certificates representing the Reclassified Shares."

    3. The general form of the Articles of Amendment was adopted as of [__________, 20___] by Written Action of the Board of Directors of the Corporation, and was finalized by the Board of Directors [at a meeting of the Board held on __________, 20___,] and in accordance with the requirements of the Act and the Bylaws of the Corporation. The Board of Directors unanimously recommended approval of the Amendment by the shareholders of the Corporation.

    4. The Amendment was authorized and approved pursuant to sections 16-10a-1003 and 1004 of the Act by: (i) a majority of the votes cast at the meeting by the holders of shares of Common Stock voting separately as a voting group and entitled to vote at [the Annual Meeting of the shareholders of the Corporation held on __________, 20___,] (the "Annual Meeting"), and (ii) a majority of the votes cast at the Annual Meeting. If, however, any further business should properly come beforeMeeting by the holders of shares of Common Stock, Series A Preferred Stock, and Series B Preferred Stock, voting together as a voting group and entitled to vote at the Annual Meeting:


    (a) The number of voting shares held by the holders of the issued and outstanding shares of Common Stock, voting separately as a voting group and entitled to vote on the foregoing Amendment, was [__________], of which [__________] (or approximately [_____]%) of such voting shares were represented in person or by proxy at the Annual Meeting, constituting a quorum of such voting shares.  Such voting shares present at the persons namedAnnual Meeting in person or by proxy with respect to the Amendment and voting separately as proxiesa voting group were voted as set forth in the accompanying form willtable below.

    (b) The number of voting shares held by the holders of the issued and outstanding shares of Common Stock, Series A Preferred Stock, and Series B Preferred Stock, voting together as a single voting group and entitled to vote on the foregoing Amendment, was [__________], of which [__________] (or approximately [_____]%) of such businessvoting shares were represented in accordanceperson or by proxy at the Annual Meeting, constituting a quorum of such voting shares.  Such voting shares present at the Annual Meeting in person or by proxy with their best judgment.

    respect to the Amendment and voting together as a single voting group were voted as set forth in the table below.

    DESIGNATION
    OF STOCK
    NO. OF VOTING
    SHARES
    REPRESENTED AT
    THE ANNUAL
    MEETING AND
    ENTITLED TO
    VOTE
    VOTES CAST IN
    FAVOR OF
    AMENDMENT
    VOTES CAST
    AGAINST
    AMENDMENT
    VOTES ABSTAINING

    common stock voting separately as a voting group
    [__________][__________][__________][__________]

    common stock,
    Series A Preferred, and
    Series B Preferred voting together as a voting group
    [__________][__________][__________][__________]

    (c) Such votes cast were sufficient for approval of the Amendment and the filing of these Articles of Amendment.

    IN WITNESS WHEREOF, these Articles of Amendment are executed as of [__________], 20[___].

     DYNATRONICS CORPORATIONDynatronics Corporation,
     By order of the Board of Directorsa Utah corporation
      
     
    /s/ Kelvyn H. Cullimore, Jr.
    Kelvyn H. Cullimore, Jr.
    Chairman, President and CEO
    37

    ATTACHMENT A

    Dynatronics Corp.
    Compensation Committee Charter


    Purpose

    The purpose of the Compensation Committee (the "Committee") of the Board of Directors (the "Board") of Dynatronics Corp. (the "Company") is to:
    ·oversee the Company's employee benefit plans, including its incentive compensation and equity compensation plans;
    ·
    oversee the Company's compensation policies, plans and programs for its executive officers, including, without limitation, the compensation of the Company's Chief Executive Officer (the "CEO") and other executive officers (including officers reporting under Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"));
    ·approve and evaluate director compensation; and
    ·oversee the management of risks associated with the Company's compensation policies and programs
    The compensation programs for the Company's executive officers shall be (i) designed to attract, motivate and retain talented executives responsible for the success of the Company, (ii) determined within a competitive framework and (iii) based on the achievement of the Company's overall financial results, individual contributions and a compensation philosophy of "pay for performance."  In furtherance of these purposes, the Compensation Committee will undertake those specific duties and responsibilities listed below and such other duties as the Board may from time to time prescribe.

    Membership

    The Committee shall be composed of no more than four (4) members.
    Committee members shall be appointed by, and shall serve at the discretion of, the Board. Each member of the Committee shall be appointed by the Board to serve until such member's successor is duly appointed or until such member's earlier retirement, resignation or removal. The Board may remove any member of the Committee at any time with or without cause. The Committee shall consist of no fewer than three members of the Board. The Board may designate one member of the Committee as its chair. The Committee may form and delegate authority to subcommittees when appropriate.  All members of the Committee will meet the independence requirements set forth in Rule 10C-1(b)(1) under the Exchange Act and the rules of Nasdaq Stock Market, Inc. (the "Nasdaq Rules"); the non-employee director definition of Rule 16b-3 promulgated under Section 16 of the Securities Exchange Act of 1934, as amended; and the outside director definition of Section 162(m) of the Internal Revenue Code of 1986, as amended.
    1

    Responsibilities and Duties
    Executive and Other Compensation
    The responsibilities and duties of the Compensation Committee shall include:
    ·Annually reviewing and approving for the CEO and the executive officers of the Company, including: (i) annual base salary, (ii) annual incentive bonus, including the specific goals and amount, (iii) equity compensation, (iv) any employment agreement, severance arrangement and change in control agreement/provision, (v) any signing bonus or payment of relocation costs and (vi) any other significant benefits, compensation or arrangements not available to employees generally. One of the Committee's objectives shall be to use compensation to align the interests of the executive officers with the long-term interests of the Company's shareholders, thereby incentivizing management to increase shareholder value.  In evaluating and determining CEO and other executive officer compensation, the Committee shall consider the results of the most recent shareholder advisory vote on executive compensation ("Say on Pay Vote"), as required by Section 14A of the Exchange Act;
    ·Reviewing and approving corporate goals and objectives relevant to the compensation of the CEO and the executive officers of the Company, evaluating performance in the light thereof, and considering factors related to the performance of the Company, including accomplishment of the Company's long-term business and financial goals;
    ·Acting as Administrator of the Company's equity compensation plans for its employees, directors and other service providers;
    ·Providing oversight of the Company's overall compensation plans and benefits programs and making recommendations to the Board with respect to improvements or changes to such plans or the adoption of new plans when appropriate;
    ·Evaluating, on a periodic basis, the competitiveness of (i) the compensation of the CEO and the executive officers of the Company and (ii) the Company's overall compensation plans;
    ·Reviewing and discussing with management the risks arising from the Company's compensation policies and practices related to all employees that are reasonably likely to have a material adverse effect on the Company and making recommendations to the Board with respect to such policies and practices to mitigate such risks;
    ·Evaluating director compensation, consulting with outside consultants and/or with the Human Resources department when appropriate, and making recommendations to the Board regarding director compensation;
    ·Reviewing and making recommendations to the Board with respect to directors' stock option grants or other equity awards under the Company's equity incentive plans;
    ·Reviewing and recommending to the Board for approval any equity award granting policy; and
    ·Reviewing and recommending to the Board for approval the frequency with which the Company will conduct Say-on-Pay votes, taking into account the results of the most recent shareholder advisory vote on the frequency of Say-on-Pay votes required by Section 14A of the Exchange Act, and reviewing and approving the proposals regarding the Say-on-Pay Vote and the frequency of the Say-on-Pay vote to be included in the Company's annual proxy statement.
    2

    Authority to Engage Advisors
    In addition to the responsibilities and duties described above, the Committee has the authority, in its sole discretion, to retain or obtain the advice of a compensation consultant, legal counsel or other advisor. The Committee shall be directly responsible for the appointment, compensation and oversight of the work of any such compensation consultant, legal counsel or other advisor retained by the Committee. The Committee shall receive appropriate funding from the Company, as determined by the Committee in its capacity as a committee of the Board, for the payment of reasonable compensation to its compensation consultants, legal counsel or other advisors and to otherwise perform its duties and responsibilities under this Charter.
    The Committee may select, or receive advice from, a compensation consultant, legal counsel or other advisor to the Committee (other than in-house legal counsel) only after taking into consideration the factors specified in Nasdaq Rule 5605(d)(3)(D). The Committee may retain, or receive advice from, any compensation consultant, legal counsel or other advisor that it prefers, including advisors that are not deemed independent, after considering the factors specified in Nasdaq Rule 5605(d)(3)(D).
    Notwithstanding the foregoing, the Committee is not required to conduct an independence assessment for a compensation consultant, legal counsel or other advisor that acts in a role limited to the following activities for which no disclosure is required under Item 407(e)(3)(iii) of Regulation S-K: (i) consulting on any broad-based plan that does not discriminate in scope, terms, or operation in favor of executive officers or directors of the Company and that is available generally to all salaried employees and/or (ii) providing information that either is not customized for the Company or that is customized based on parameters that are not developed by the advisor and about which the advisor does not provide advice.
    The Committee shall not be required to implement or act consistently with the advice or recommendations of any compensation consultant, legal counsel or other advisor to the Committee, and the authority granted to the Committee pursuant to this Charter shall not affect the ability or obligation of the Committee to exercise its own judgment in fulfillment of its duties under this Charter. Any advisors retained by the Committee will report directly to the Committee and may be terminated in the discretion of the Committee.

    Compliance and Governance

    The Committee shall annually review this Charter and recommend any proposed changes to the Board.  To the extent required by the Exchange Act and the rules and regulations of the SEC, the Committee will review the Company's Compensation Discussion and Analysis ("CD&A") and related executive compensation information, recommend that the CD&A and related executive compensation information be included in the Company's annual report on Form 10-K or proxy statement, as applicable, and produce the Committee report on executive officer compensation required to be included in the Company's annual report on Form 10-K or proxy statement, as applicable.
    3

    Meetings

    The Committee shall meet as often as may be deemed necessary or appropriate, in its judgment, in order to fulfill its responsibilities, but at least once annually.  The affirmative vote of a majority of the members present at a meeting at which a quorum is present shall constitute action of the Committee.

    Subject to the foregoing, the Committee may meet either in person or telephonically, and at such times and places as the Committee determines. The Committee may establish its own meeting schedule, which it will provide to the Board. The Committee may seek any information it requires from employees of the Company, all of whom shall be directed to cooperate with the Committee's requests, and from external parties.  The Company may invite to its meetings other Board members, members of the Company's management team and such other persons as the Committee deems appropriate in order to carry out its responsibilities. Neither the CEO nor any other officer of the Company may be present during deliberations of the Committee regarding the compensation of the CEO or such other officer, as applicable. The Committee is governed by the same rules regarding meetings (including meetings in person, by telephone, or by electronic communications), action without meetings, notice, waiver of notice, and quorum and voting requirements as are applicable to the Board.

    Reports

    The Committee shall make regular reports to the full Board on the actions and recommendations of the Committee.

    Compensation

    Members of the Committee shall receive such fees, if any, for their service as Committee members as may be determined by the Board in its sole discretion.
    4

    ATTACHMENT B

    AUDIT COMMITTEE CHARTER
    OF DYNATRONICS CORPORATION
    Organization
    There shall be a committee of the board of directors to be known as the Audit Committee. The Audit Committee shall be composed of directors who are independent of the management of the corporation and are free of any relationship that, in the opinion of the board of directors, would interfere with their exercise of independent judgment as a committee member.
    Statement of Policy
    The Audit Committee shall provide assistance to the directors of the corporation in fulfilling their responsibility to the shareholders, potential shareholders and investment community relating to corporate accounting, reporting practices of the corporation and the quality and integrity of the financial reports of the corporation. In so doing, it is the responsibility of the Audit Committee to maintain free and open means of communication between the directors, the independent auditors, and the financial management of the corporation.
    Responsibilities
    In carrying out its responsibilities, the Audit Committee believes its policies and procedures should remain flexible, in order to best react to changing conditions and to ensure to the directors and shareholders that the corporate accounting and reporting practices of the corporation are in accordance with all requirements and are of the highest quality.
    In carrying out these responsibilities, the Audit Committee will:
    Review and recommend to the directors the independent auditors to be selected to audit the financial statements of the corporation and its divisions and subsidiaries.
    Meet with the independent auditors and management of the corporation at the conclusion of the fiscal year to review the audit, including any comments or recommendations of the independent auditors.
    Review with the independent auditors and the corporation's financial and accounting personnel, the adequacy and effectiveness of the accounting and financial controls of the corporation, and elicit any recommendations for the improvement of such internal control procedures or particular areas where new or more detailed controls or procedures are desirable. Particular emphasis should be given to the adequacy of such internal controls to expose any payments, transactions or procedures that might be deemed illegal or otherwise improper. Further, the committee periodically should review the corporation's policy statements to determine their adherence to the code of conduct.
    Review the financial statements contained in the annual report to shareholders with management and the independent auditors to determine that the independent auditors are satisfied with the disclosure and content of the financial statements to be presented to the shareholders. Any changes in accounting principles should be reviewed.
    Provide sufficient opportunity for the independent auditors to meet with the members of the Audit Committee without members of management present. Among the items to be discussed in these meetings are the independent auditors' evaluation of the corporations' financial and accounting personnel, and the cooperation that the independent auditors received during the course of the audit.
    Review accounting and financial human resources and succession planning within the corporation.
    Submit the minutes of all meetings of the Audit Committee to, or discuss the matters discussed at each committee meeting with, the board of directors.
    Investigate any matter brought to its attention within the scope of its duties, with the power to retain outside counsel for this purpose if, in its judgment, it is appropriate.

    1

    ATTACHMENT C

    FINANCIAL STATEMENTS OF BIRD & CRONIN


    BIRD & CRONIN, INC.

    FINANCIAL STATEMENTS

    SEPTEMBER 30, 2016 AND 2015


    BIRD & CRONIN, INC.

    CONTENTS
    SEPTEMBER 30, 2016 AND 2015
    Page
    INDEPENDENT AUDITOR'S REPORT1
    FINANCIAL STATEMENTS
         Balance Sheets2-3
         Statements of Income4
         Statements of Retained Earnings5
         Statements of Cash Flows6
         Notes to Financial Statements7-10



    INDEPENDENT AUDITOR'S REPORT


    Board of Directors and Management
    Bird & Cronin, Inc.
    Eagan, Minnesota

    We have audited the accompanying financial statements of Bird & Cronin, Inc. (an S Corporation), which comprise the balance sheets as of September 30, 2016 and 2015 and the related statements of income, retained earnings, and cash flows for the years then ended, and the related notes to the financial statements.

    Management's Responsibility for the Financial Statements

    Management is responsible for the preparation and fair presentation of these financial statements in accordance with accounting principles generally accepted in the United States of America; this includes the design, implementation, and maintenance of internal control relevant to the preparation and fair presentation of financial statements that are free from material misstatement, whether due to fraud or error.

    Auditor's Responsibility

    Our responsibility is to express an opinion on these financial statements based on our audits.  We conducted our audits in accordance with auditing standards generally accepted in the United States of America.  Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free from material misstatement.

    An audit involves performing procedures to obtain audit evidence about the amounts and disclosures in the financial statements.  The procedures selected depend on the auditor's judgment, including the assessment of the risks of material misstatement of the financial statements, whether due to fraud or error.  In making those risk assessments, the auditor considers internal control relevant to the entity's preparation and fair presentation of the financial statements in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the entity's internal control.  Accordingly, we express no such opinion.  An audit also includes evaluating the appropriateness of accounting policies used and the reasonableness of significant accounting estimates made by management, as well as evaluating the overall presentation of the financial statements.

    We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.

    Opinion

    In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of Bird & Cronin, Inc. as of September 30, 2016 and 2015 and the results of its operations and its cash flows for the years then ended in conformity with accounting principles generally accepted in the United States of America.

    /s/ CUMMINGS, KEEGAN & CO., P.L.L.P.

    December 7, 2016
    St. Louis Park, Minnesota
    1

    BIRD & CRONIN, INC. 
                 
    BALANCE SHEETS 
    SEPTEMBER 30, 2016 AND 2015 
                 
                 
    ASSETS
     
                 
      2016  2015 
    Current assets
                
    Cash and cash equivalents    $2,289,493     $2,044,924 
    Accounts receivable, trade  2,261,380       2,230,978     
     Less allowance for rebates  (157,000)      (164,000)    
      Less allowance for doubtful accounts  (8,000)  2,096,380   (8,000)  2,058,978 
      Inventories:                
    Finished goods  1,886,387       1,492,176     
    Raw materials  2,485,044   4,371,431   2,274,214   3,766,390 
     Prepaid expenses      121,055       162,653 
                     
    Total current assets      8,878,359       8,032,945 
                     
    Property and equipment
                    
    Furniture and equipment      2,983,202       2,980,949 
    Leasehold improvements      741,458       741,458 
           3,724,660       3,722,407 
    Less accumulated depreciation      (2,813,963)      (2,664,268)
                     
    Property and equipment - net      910,697       1,058,139 
                     
    Other assets
                    
    Federal tax deposit to retain fiscal year   109,693       64,979 
                     
    Total other assets      109,693       64,979 
                     
    Total assets     $9,898,749      $9,156,063 
    See Notes to Financial Statements.
    2

    LIABILITIES AND STOCKHOLDERS' EQUITY
      2016  2015 
    Current liabilities
          
    Accounts payable - trade $823,869  $566,630 
    Accrued salaries and vacation  391,399   182,998 
             
    Total current liabilities  1,215,268   749,628 
             
    Stockholders' equity
            
    Common stock, stated value $50 per share, 2,500 shares authorized, 217.5 shares issued and outstanding - stated value  10,875   10,875 
    Capital paid in excess of stated value  46,278   46,278 
    Retained earnings  8,626,328   8,349,282 
             
    Total stockholders' equity  8,683,481   8,406,435 
             
    Total liabilities and stockholders' equity $9,898,749  $9,156,063 
    See Notes to Financial Statements.
    3

    BIRD & CRONIN, INC. 
                 
    STATEMENTS OF INCOME 
    FOR THE YEARS ENDED SEPTEMBER 30, 2016 AND 2015 
                 
      2016  2015 
         % of     % of 
      Amount  Sales  Amount  Sales 
                 
    Sales - net
     $24,005,306   100.0% $23,201,757   100.0%
                     
    Cost of sales
      15,357,454   63.8   15,084,837   65.0 
                     
    Gross profit  8,647,852   36.2   8,116,920   35.0 
                     
    Operating expenses                
    Selling  2,223,511   9.3   2,588,136   11.0 
    General and administrative  4,357,490   17.9   4,479,006   19.2 
                     
    Total operating expenses  6,581,001   27.2   7,067,142   30.2 
                     
       2,066,851   9.0   1,049,778   4.8 
                     
    Other income
                    
    Miscellaneous income  248   -   44,485   0.2 
    Interest income  -   -   28   - 
                     
    Total other income  248   -   44,513   0.2 
                     
    Other expenses
                    
    Interest  53   -   -   - 
                     
    Total other expenses  53   -   -   - 
                     
    Net income $2,067,046   8.9% $1,094,291   5.0%
    See Notes to Financial Statements.
    4

    BIRD & CRONIN, INC. 
           
    STATEMENTS OF RETAINED EARNINGS 
    FOR THE YEARS ENDED SEPTEMBER 30, 2016 AND 2015 
           
      2016  2015 
           
    Balance - beginning of year $8,349,282  $7,593,929 
             
    Add net income for the year  2,067,046   1,094,291 
             
    Less distributions to stockholders  (1,790,000)  (338,938)
             
    Balance - end of year 
    $
    8,626,328  
    $
    8,349,282 
    See Notes to Financial Statements.
    5

    BIRD & CRONIN, INC. 
           
    STATEMENTS OF CASH FLOWS 
    FOR THE YEARS ENDED SEPTEMBER 30, 2016 AND 2015 
           
      2016  2015 
           
    Cash flows from operating activities:      
    Net income $2,067,046  $1,094,291 
    Adjustments to reconcile net income to net cash provided by operating activities:        
    Depreciation and amortization  154,482   193,760 
    Net gain on disposal of assets  (200)  (12,911)
    Provision for rebates and doubtful accounts  (7,000)  32,000 
     Changes in:        
    Accounts receivable  (30,402)  (150,855)
    Inventories  (605,041)  (379,447)
    Federal tax deposit to retain fiscal year  (44,714)  (23,944)
    Prepaid expenses  41,598   (1,414)
    Accounts payable  257,239   194,564 
    Accrued liabilities  208,401   23,099 
    Total adjustments  (25,637)  (125,148)
             
    Net cash provided by operating activities  2,041,409   969,143 
             
    Cash flows from investing activities:        
    Proceeds from sale of assets  200   20,350 
    Capital expenditures  (7,040)  (10,463)
             
    Net cash provided by (used in) investing activities  (6,840)  9,887 
             
    Cash flows from financing activities:        
    Distributions to stockholders  (1,790,000)  (338,938)
             
    Net cash used in financing activities  (1,790,000)  (338,938)
             
    Net increase in cash and cash equivalents  244,569   640,092 
             
    Cash and cash equivalents at beginning of year  2,044,924   1,404,832 
             
    Cash and cash equivalents at end of year $2,289,493  $2,044,924 
    See Notes to Financial Statements.
    6

    BIRD & CRONIN, INC.

    NOTES TO FINANCIAL STATEMENTS
    SEPTEMBER 30, 2016 AND 2015


    1.   Summary of Significant Accounting Policies
    Nature of Business - Bird & Cronin, Inc. (the "Company") manufactures and sells medical supplies and equipment on credit terms to medical and health care facilities throughout the United States and Canada.

    Cash and Cash Equivalents - For purposes of the statements of cash flows, the Company considers all highly liquid debt instruments purchased with a maturity of three months or less to be cash equivalents.

    Customer Accounts Receivable - Customer accounts receivable is stated at the amount management expects to collect from outstanding balances.  Management provides for probable uncollectible amounts and estimated rebates and returns through charges to earnings and credits to valuation allowances based on its assessment of the current status of individual accounts and estimates of sales levels.  Balances that are still outstanding after management has used reasonable collection efforts are written off.  There were no accounts receivable balances over 90 days old for either of the years ended September 30, 2016 and 2015.

    Inventories - Inventories are valued at the lower of cost (weighted average) or market, and consist of raw materials and finished goods.  Work in process is insignificant and is included in raw materials.

    Property and Equipment - Property and equipment, including significant renewals and betterments, are capitalized at cost.  The costs of property, equipment and leasehold improvements are depreciated over the estimated useful lives of the related assets.  Depreciation is computed using straight-line and accelerated methods over the estimated useful lives of the assets.

    When property and equipment is sold or retired, its cost and related accumulated depreciation allowance are removed from the accounts and any gain or loss from disposition is reflected in income.  Maintenance and repairs are charged to operations when incurred.

    The estimated useful lives of the various classifications of property and equipment are as follows:

    Classification of Assets
    Estimated Useful Lives
    Furniture and equipment3-10 years
    Leasehold improvements7-40 years

    Depreciation expense for the years ended September 30, 2016 and 2015 was $154,482 and $193,760, respectively.
    7

    BIRD & CRONIN, INC.

    NOTES TO FINANCIAL STATEMENTS
    SEPTEMBER 30, 2016 AND 2015
    (Continued)

    1.Summary of Significant Accounting Policies (continued)

    Accumulated depreciation for the years ended September 30, 2016 and 2015, by category, is as follows:

      2016  2015 
    Classification of Assets
          
    Furniture and equipment $2,467,805  $2,341,393 
    Leasehold improvements  346,158   322,875 
             
    Total $2,813,963  $2,664,268 

    Use of Estimates - The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions.  These estimates and assumptions affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from their estimates.

    Shipping and Handling - The Company includes shipping and handling costs in cost of sales.

    Advertising Costs - Advertising costs consist of general advertising costs which are expensed as incurred and printing of catalogs and product information which are expensed as the supply is used.  Prepaid advertising costs included in prepaid expenses were $5,545 and $8,190 as of September 30, 2016 and 2015, respectively, and advertising expense was $29,328 and $30,805 for the years ended September 30, 2016 and 2015, respectively.

    Revenue Recognition - Sales are recognized when products are shipped to customers and includes amounts billed to customers for shipping.

    Sales Tax - The Company excludes from its revenues all sales taxes assessed to its customers.  Sales taxes assessed on sales are recorded as accrued liabilities until remitted to state agencies.

    Income Taxes - The Company has elected to be taxed under the provisions of the S-Corporation Act of the Internal Revenue Code and similar provisions of Minnesota law.  Under those provisions the Company does not pay federal or state corporate taxes on its income.  Instead, the stockholders are liable for individual federal and state income taxes on their respective shares of the Company's taxable income.

    Under Section 7519 of the Internal Revenue Code, the Company is required to make income tax deposits to maintain its fiscal year end for the amount of deferred income from October 1 through December 31.  For the years ended September 30, 2016 and 2015, the amount on deposit was $109,693 and $64,979, respectively.
    8

    NOTES TO FINANCIAL STATEMENTS
    SEPTEMBER 30, 2016 AND 2015
    (Continued)


    1.Summary of Significant Accounting Policies (continued)

    Subsequent Events - The Company has evaluated subsequent events through December 7, 2016, which is the date the financial statements were available to be issued.

    Accounting Standards Not Yet Adopted - Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers, as revised by ASU No. 2015-14, Revenue from Contracts with Customers: Deferral of the Effective Date, will be effective for the Company for the year ending September 30, 2020.  This standard update requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects consideration to which the entity expects to be entitled in exchange for those goods or services.  The Company has not yet determined the effect this ASU will have on the Company's financial statements.

    2.Line of Credit

    The Company has a loan agreement with its bank for advances under a revolving line of credit of up to $4,000,000.  The line is secured by the Company's assets and expires February 28, 2017.  Interest is charged at the prime rate as published by the Wall Street Journal (3.5% at September 30, 2016).  There were no amounts outstanding at September 30, 2016 or 2015.  The line of credit agreement contains working capital, tangible net worth and other customary covenants.

    3.Operating Lease and Related Party Transaction

    The Company leases its warehouse and sales facilities from a limited liability company related through common control under an agreement expiring March 2019. The lease requires monthly lease payments of $50,000.  The lease agreement allows for an additional five year term.  In addition to the minimum rental payments, the agreement provides the Company pay real estate taxes, utilities, insurance, and maintenance.  Total rent expense (including real estate taxes) under the building operating lease for the years ended September 30, 2016 and 2015 was $719,858 and $718,579, respectively.

    Future minimum obligations, not including real estate taxes, utilities, insurance or maintenance for the years ending September 30 are as follows:

    Year
       
    2017 $600,000 
    2018  600,000 
    2019  300,000 
         
      $1,500,000 


    9

    NOTES TO FINANCIAL STATEMENTS
    SEPTEMBER 30, 2016 AND 2015
    (Continued)


    4.Profit Sharing and 401(k) Plans

    The Company has a profit sharing plan covering all employees who meet the Plan's eligibility requirements.  Contributions are made at the discretion of the management. No contributions were made for the years ended September 30, 2016 or 2015.

    The Company also has a 401(k) plan for all eligible employees.  The Company will match employee contributions up to 5% of eligible compensation.  Employees are allowed to contribute up to 75% of compensation to the plan.  For the years ended September 30, 2016 and 2015, employer contributions were $217,031 and $243,630, respectively.

    5.Concentrations

    The Company maintains checking balances at two banks in the Minneapolis area.  Accounts at the institutions are insured by the Federal Deposit Insurance Corporation up to $250,000.  At September 30, 2016, the Company's uninsured cash and deposit balances totaled approximately $1,880,000.

    The Company has concentrations of credit risk as a result of sales to two significant customers.  During the year ended September 30, 2016, these customers represented approximately 30% of total sales and 21% of total receivables at year end.  During the year ended September 30, 2015, these customers represented approximately 29% of total sales and 20% of total receivables at year end.

    The Company has concentrations as a result of purchases from one major vendor for the year ended September 30, 2016 and two major vendors for the year ended September 30, 2015.  Purchases from these vendors as a percentage of total purchases for the years ended September 30, 2016 and 2015 represented approximately 10% and 26%, respectively.  These customers represented approximately 1% or less of accounts payable for each of the years ended September 30, 2016 and 2015.

    6.Income Tax

    Management has evaluated the Company's tax positions for all open tax years.  Currently, the 2013, 2014 and 2015 tax years are open and subject to examination by the Internal Revenue Service, Iowa Department of Revenue, North Dakota Department of Revenue and Minnesota Department of Revenue.  However, the Company is not currently under audit nor has the Company been contacted by any of these jurisdictions.

    Based on the evaluation of the Company's tax positions, management believes all positions taken would be upheld under an examination.  Therefore, no provision for the effects of uncertain tax positions has been recorded for the year ended September 30, 2016.
    10

    BIRD & CRONIN, INC.

    FINANCIAL STATEMENTS

    JUNE 30, 2017 AND 2016


    BIRD & CRONIN, INC.

    CONTENTS
    JUNE 30, 2017 AND 2016
     
     Page
    INDEPENDENT ACCOUNTANT'S REVIEW REPORT1
    FINANCIAL STATEMENTSBy:  
     Balance Sheets2-3Name: Brian Baker
     Statements of Income4
         Statements of Retained Earnings5
         Statements of Cash Flows6
         Notes to Financial Statements7- 10Title: President and Chief Executive Officer


    INDEPENDENT ACCOUNTANT'S REVIEW REPORT


    Board of Directors and Management
    Bird & Cronin, Inc.
    Eagan, Minnesota

    We have reviewed the accompanying financial statements of Bird & Cronin, Inc. (an S Corporation), which comprise the balance sheets as of June 30, 2017 and 2016 and the related statements of income, retained earnings, and cash flows for the nine months then ended, and the related notes to the financial statements.  A review includes primarily applying analytical procedures to management's financial data and making inquiries of management.  A review is substantially less in scope than an audit, the objective of which is the expression of an opinion regarding the financial statements as a whole.  Accordingly, we do not express such an opinion.

    Management's Responsibility for the Financial Statements

    Management is responsible for the preparation and fair presentation of these financial statements in accordance with accounting principles generally accepted in the United States of America; this includes the design, implementation, and maintenance of internal control relevant to the preparation and fair presentation of financial statements that are free from material misstatement, whether due to fraud or error.

    Accountant's Responsibility

    Our responsibility is to conduct the review engagement in accordance with the Statements on Standards for Accounting and Review Services promulgated by the Accounting and Review Services Committee of the AICPA.  Those standards require us to perform procedures to obtain limited assurance as a basis for reporting whether we are aware of any material modifications that should be made to the financial statements for them to be in accordance with accounting principles generally accepted in the United States of America.  We believe that the results of our procedures provide a reasonable basis for our conclusion.

    Accountant's Conclusion

    Based on our reviews, we are not aware of any material modifications that should be made to the accompanying financial statements in order for them to be in accordance with accounting principles generally accepted in the United States of America.

    Emphasis of Matter

    As more fully described in Note 7 to the financial statements, subsequent to issuance of the Company June 30, 2017 financial statements and our review report thereon, dated September 13, 2017, we became aware that those financial statements overstated certain inventory purchases and accounts payable.  In our original report, we concluded that we were not aware of any material modifications that should be made to the financial statements in order for them to be in conformity with accounting principles generally accepted in the United States of America. Our conclusion on the accompanying revised financial statements remains unchanged.

    /s/ CUMMINGS, KEEGAN & CO., P.L.L.P.

    September 13, 2017 (except for Note 7, as to which the date is October 5, 2017)
    St. Louis Park, Minnesota
    1

    BIRD & CRONIN, INC. 
                  
    BALANCE SHEETS 
    JUNE 30, 2017 AND 2016 
                  
    ASSETS
     
                  
       2017  2016 
    Current assets
                
     Cash and cash equivalents    $1,365,175     $2,081,567 
     Accounts receivable, trade  2,115,957       2,013,202     
     Less allowance for rebates  (157,030)      (164,016)    
     Less allowance for                
     doubtful accounts  (8,000)  1,950,927   (8,000)  1,841,186 
     Inventories:                
     Finished goods  2,304,717       2,174,101     
     Raw materials  3,265,465   5,570,182   2,539,356   4,713,457 
     Prepaid expenses      10,033       80,194 
                      
     Total current assets      8,896,317       8,716,404 
                      
    Property and equipment
                    
     Furniture and equipment      3,005,988       2,983,202 
     Leasehold improvements      741,458       741,458 
            3,747,446       3,724,660 
     Less accumulated depreciation      (2,860,064)      (2,778,576)
                      
     Property and equipment - net      887,382       946,084 
                      
    Other assets
                    
     Federal tax deposit to retain fiscal year   227,358       64,979 
                      
     Total other assets      227,358       64,979 
                      
     Total assets     $10,011,057      $9,727,467 
    2

    BIRD & CRONIN, INC.
    BALANCE SHEETS
    LIABILITIES AND STOCKHOLDERS' EQUITY
     
           
      2017  2016 
    Current liabilities
          
    Accounts payable - trade $948,868  $1,047,801 
    Accrued salaries and vacation  210,488   113,160 
             
    Total current liabilities  1,159,356   1,160,961 
             
    Stockholders' equity        
    Common stock, stated value $50 per share, 2,500 shares authorized, 217.5 shares issued and outstanding - stated value  10,875   10,875 
    Capital paid in excess of stated value  46,278   46,278 
    Retained earnings  8,794,548   8,509,353 
             
    Total stockholders' equity  8,851,701   8,566,506 
            
    Total liabilities and stockholders' equity $10,011,057  $9,727,467 
    See Independent Accountant's Review Report and Notes to Financial Statements.
    3

    BIRD & CRONIN, INC. 
                 
    STATEMENTS OF INCOME 
    FOR THE NINE MONTHS ENDED JUNE 30, 2017 AND 2016 
                 
      2017  2016 
         % of     % of 
      Amount  Sales  Amount  Sales 
                 
    Sales - net
     $17,923,262   100.0% $17,659,221   100.0%
                     
    Cost of sales  11,342,431   62.9   11,337,934   64.1 
                     
    Gross profit  6,580,831   37.1   6,321,287   35.9 
                     
    Operating expenses                
      Selling  1,514,024   8.4   1,731,497   9.8 
    General and administrative  3,663,440   20.4   3,235,283   18.3 
                     
    Total operating expenses  5,177,464   28.8   4,966,780   28.1 
                     
       1,403,367   8.3   1,354,507   7.8 
                     
    Other income                
    Gain on sale of assets  100   -   200   - 
    Interest income  3   -   -   - 
                     
    Total other income  103   -   200   - 
                     
    Other expenses                
    Bonuses  -   -   14,583   0.1 
    Interest  -   -   53   - 
                     
    Total other expenses  -   -   14,636   0.1 
                     
    Net income $1,403,470   8.3% $1,340,071   7.7%
    See Independent Accountant's Review Report and Notes to Financial Statements.
    4

    BIRD & CRONIN, INC. 
              
    STATEMENTS OF RETAINED EARNINGS 
    FOR THE NINE MONTHS ENDED JUNE 30, 2017 AND 2016 
              
         Capital Paid    
      Common  In Excess of  Retained 
      Stock  Stated Value  Earnings 
              
    Balance - October 1, 2015 $10,875  $46,278  $8,349,282 
                 
    Add: net income for the nine months ended June 30, 2016  -   -   1,340,071 
                 
    Less: distributions  -   -   (1,180,000)
                 
    Balance - June 30, 2016 $10,875  $46,278  $8,509,353 
                 
    Balance - October 1, 2016 $10,875  $46,278  $8,626,328 
                
    Add: net income for the nine months ended June 30, 2017  -   -   1,403,470 
                 
    Less: distributions  -   -   (1,235,250)
                 
    Balance - June 30, 2017 $10,875  $46,278  $8,794,548 
    See Independent Accountant's Review Report and Notes to Financial Statements.
    5

    BIRD & CRONIN, INC. 
           
    STATEMENTS OF CASH FLOWS 
    FOR THE NINE MONTHS ENDED JUNE 30, 2017 AND 2016 
           
      2017  2016 
           
    Cash flows from operating activities:      
    Net income $1,403,470  $1,340,071 
    Adjustments to reconcile net income to net cash provided by operating activities:        
    Depreciation  99,605   119,095 
    Net gain on sale of assets  (100)  (200)
    Net change in assets and liabilities:        
    Accounts receivable  145,453   217,792 
    Inventories  (1,198,752)  (947,067)
    Prepaid expenses and other assets  (6,643)  82,459 
    Accounts payable  125,000   528,120 
    Accrued salaries and vacation  (180,911)  (116,787)
             
    Net cash provided by operating activities  387,122   1,223,483 
             
    Cash flows from investing activities:        
    Proceeds from sale of assets  100   200 
    Capital expenditures  (76,290)  (7,040)
             
    Net cash used in investing activities  (76,190)  (6,840)
             
    Cash flows from financing activities:        
    Distributions to stockholders  (1,235,250)  (1,180,000)
             
    Net cash used in financing activities  (1,235,250)  (1,180,000)
             
    Net increase (decrease) in cash and cash equivalents  (924,318)  36,643 
             
    Cash and cash equivalents at beginning of year  2,289,493   2,044,924 
             
    Cash and cash equivalents at end of year $1,365,175  $2,081,567 
    See Independent Accountant's Review Report and Notes to Financial Statements.
    6

    BIRD & CRONIN, INC.

    NOTES TO FINANCIAL STATEMENTS
    JUNE 30, 2017 AND 2016


    1.   Summary of Significant Accounting Policies

    Nature of Business - Bird & Cronin, Inc. (the "Company") manufactures and sells medical supplies and equipment on credit terms to medical and health care facilities throughout the United States and Canada.

    Cash and Cash Equivalents - For purposes of the statements of cash flows, the Company considers all highly liquid debt instruments purchased with a maturity of three months or less to be cash equivalents.

    Customer Accounts Receivable - Customer accounts receivable is stated at the amount management expects to collect from outstanding balances.  Management provides for probable uncollectible amounts and estimated rebates and returns through charges to earnings and credits to valuation allowances based on its assessment of the current status of individual accounts and estimates of sales levels.  Balances that are still outstanding after management has used reasonable collection efforts are written off.  There were no accounts receivable balances over 90 days old for either of the nine months ended June 30, 2017 and 2016.

    Inventories - Inventories are valued at the lower of cost (weighted average) or market, and consist of raw materials and finished goods.  Work in process is insignificant and is included in raw materials.

    Property and Equipment - Property and equipment, including significant renewals and betterments, are capitalized at cost.  The costs of property, equipment and leasehold improvements are depreciated over the estimated useful lives of the related assets.  Depreciation is computed using straight-line and accelerated methods over the estimated useful lives of the assets.

    When property and equipment is sold or retired, its cost and related accumulated depreciation allowance are removed from the accounts and any gain or loss from disposition is reflected in income.  Maintenance and repairs are charged to operations when incurred.

    The estimated useful lives of the various classifications of property and equipment are as follows:

    Classification of Assets
    Estimated Useful Lives
    Furniture and equipment3-10 years
    Leasehold improvements7-40 years

    Depreciation expense for the nine months ended June 30, 2017 and 2016 was $99,605 and $119,095, respectively.
    7

    BIRD & CRONIN, INC.

    NOTES TO FINANCIAL STATEMENTS
    JUNE 30, 2017 AND 2016


    1.Summary of Significant Accounting Policies (continued)

    Accumulated depreciation for the periods ended June 30, 2017 and 2016, by category, is as follows:

      2017  2016 
    Classification of Assets
          
    Furniture and equipment $2,498,156  $2,437,681 
    Leasehold improvements  361,908   340,895 
             
    Total $2,860,064  $2,778,576 

    Use of Estimates - The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions.  These estimates and assumptions affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from their estimates.

    Shipping and Handling - The Company includes shipping and handling costs in cost of sales.

    Advertising Costs - Advertising costs consist of general advertising costs which are expensed as incurred and printing of catalogs and product information which are expensed as the supply is used.  Prepaid advertising costs included in prepaid expenses were $4,207 and $6,072 as of June 30, 2017 and 2016, respectively, and advertising expense was $17,463 and $21,990 for the nine months ended June 30, 2017 and 2016, respectively.

    Revenue Recognition - Sales are recognized when products are shipped to customers and includes amounts billed to customers for shipping.

    Sales Tax - The Company excludes from its revenues all sales taxes assessed to its customers.  Sales taxes assessed on sales are recorded as accrued liabilities until remitted to state agencies.

    Income Taxes - The Company has elected to be taxed under the provisions of the S-Corporation Act of the Internal Revenue Code and similar provisions of Minnesota law.  Under those provisions the Company does not pay federal or state corporate taxes on its income.  Instead, the stockholders are liable for individual federal and state income taxes on their respective shares of the Company's taxable income.

    Under Section 7519 of the Internal Revenue Code, the Company is required to make income tax deposits to maintain its fiscal year end for the amount of deferred income from October 1 through December 31.  For the periods ended June 30, 2017 and 2016, the amount on deposit was $227,358 and $64,979, respectively.
    8

    BIRD & CRONIN, INC.

    NOTES TO FINANCIAL STATEMENTS
    JUNE 30, 2017 AND 2016


    1.Summary of Significant Accounting Policies (continued)

    Subsequent Events - The Company has evaluated subsequent events through September 13, 2017, which is the date the financial statements were available to be issued.

    Accounting Standards Not Yet Adopted - Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers, as revised by ASU No. 2015-14, Revenue from Contracts with Customers: Deferral of the Effective Date, will be effective for the Company for the year ending September 30, 2020.  This standard update requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects consideration to which the entity expects to be entitled in exchange for those goods or services.  The Company has not yet determined the effect this ASU will have on the Company's financial statements.

    2.Line of Credit

    The Company had a loan agreement with its bank for advances under a revolving line of credit of up to $4,000,000.  During the nine months ended June 30, 2017 this was amended to $1,000,000.  The line is secured by the Company's assets and expires February 28, 2018.  Interest is charged at the prime rate as published by the Wall Street Journal (4.25% at June 30, 2017).  There were no amounts outstanding at June 30, 2017 or 2016.  The line of credit agreement contains working capital, tangible net worth and other customary covenants.

    3.Operating Lease and Related Party Transaction

    The Company leases its warehouse and sales facilities from a limited liability company related through common control under an agreement expiring March 2019. The lease requires monthly lease payments of $50,000.  The lease agreement allows for an additional five year term.  In addition to the minimum rental payments, the agreement provides the Company pay real estate taxes, utilities, insurance, and maintenance.  Total rent expense (including real estate taxes) under the building operating lease for the nine months ended June 30, 2017 and 2016 was $566,839 and $570,158, respectively.

    Future minimum obligations, not including real estate taxes, utilities, insurance or maintenance for the years ending June 30 are as follows:

    2018 $600,000 
    2019  450,000 
         
      $1,050,000 


    9

    BIRD & CRONIN, INC.

    NOTES TO FINANCIAL STATEMENTS
    JUNE 30, 2017 AND 2016



    4.Profit Sharing and 401(k) Plans

    The Company has a profit sharing plan covering all employees who meet the Plan's eligibility requirements.  Contributions are made at the discretion of the management. No contributions were made for the nine months ended June 30, 2017 or 2016.

    The Company also has a 401(k) plan for all eligible employees.  The Company will match employee contributions up to 5% of eligible compensation.  Employees are allowed to contribute up to 75% of compensation to the plan.  For the nine months ended June 30, 2017 and 2016, employer contributions were $163,501 and $167,709, respectively.

    5.Concentrations

    The Company maintains checking balances at two banks in the Minneapolis area.  Accounts at the institutions are insured by the Federal Deposit Insurance Corporation up to $250,000.  At June 30, 2017, the Company's uninsured cash and deposit balances totaled approximately $1,192,000.

    The Company has concentrations of credit risk as a result of sales to two significant customers.  These customers represented approximately 31% of total sales and 19% of total receivables for each of the nine months ended June 30, 2017 and 2016.

    The Company has concentrations as a result of purchases from one major vendor which represented approximately 1% or less of accounts payable for each of the nine months ended June 30, 2017 and 2016. Purchases from these vendors as a percentage of total purchases for the periods ended June 30, 2017 and 2016 represented approximately 24% and 10%, respectively.

    6.Income Tax

    Management has evaluated the Company's tax positions for all open tax years.  Currently, the 2013, 2014 and 2015 tax years are open and subject to examination by the Internal Revenue Service, Iowa Department of Revenue, North Dakota Department of Revenue and Minnesota Department of Revenue.  However, the Company is not currently under audit nor has the Company been contacted by any of these jurisdictions.

    Based on the evaluation of the Company's tax positions, management believes all positions taken would be upheld under an examination.  Therefore, no provision for the effects of uncertain tax positions has been recorded for the period ended June 30, 2017.

    7.Restatement

    Our financial statements issued on September 13, 2017 overstated inventory and accounts payable on the Balance Sheet by $491,589 each.  These reissued financial statements have corrected this error.  The error has no impact on the Statement of Income or Statement of Retained Earnings.
    10
    ATTACHMENT D

    PROFORMA FINANCIAL STATEMENTS


    UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS
    On September 26, 2017, Dynatronics Corporation ("Dynatronics" or the "Company") entered into an agreement (the "Asset Purchase Agreement") to acquire substantially all the assets of Bird & Cronin, Inc. ("Cronin"). At the time of Closing (the "Closing") on October 2, 2017, the purchase price for the Company's acquisition of Cronin's assets (the "Acquisition") totals approximately $15,500,000 with the final purchase price subject to adjustments as the result of an $1,000,000 earn-out provision and as may otherwise be required by the Asset Purchase Agreement and indemnification claims, if any (the "Purchase Price").
    The following Unaudited Pro Forma Condensed Combined Statements of Operations for the year ended June 30, 2017, combine the historical consolidated statements of operations of Dynatronics and Cronin for those periods, giving effect to the Acquisition as if it had been consummated on July 1, 2016, the beginning of the full year period presented. The following Unaudited Pro Forma Condensed Combined Balance Sheet combines the consolidated balance sheets of Dynatronics and Cronin, giving effect to the Acquisition as if it had been consummated on June 30, 2017.
    The Unaudited Pro Forma Condensed Combined Financial Statements were prepared using the acquisition method of accounting in accordance with Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") Topic 805, Business Combinations, with Dynatronics considered as the accounting acquirer and Cronin as the accounting acquiree. Accordingly, consideration paid by Dynatronics to complete the Acquisition will be allocated to identifiable assets and liabilities of Cronin based on their estimated fair values as of the closing date of the Acquisition.
    As of the date of this Form 8-K filing to which these Pro Forma Condensed Combined Financial Statements are attached (the "Form 8-K"), Dynatronics has not completed the detailed valuation analysis necessary to arrive at the required estimates of the fair value of Cronin's assets acquired and the liabilities assumed and the related allocations of purchase price, nor has it identified all adjustments necessary to conform Cronin's accounting policies to Dynatronics' accounting policies. A final determination of the fair value of Cronin's assets and liabilities, including intangible assets with both indefinite or definite lives, will be based on the actual net tangible and intangible assets and liabilities of Cronin that existed as of the closing date of the Acquisition and, therefore, cannot be made prior to the preparation of the financial statements of Cronin after Closing. As a result of the foregoing, the pro forma adjustments are preliminary and are subject to change as additional information becomes available and as additional analyses are performed. Dynatronics has prepared preliminary estimates of the fair value of Cronin's assets and liabilities based on discussions with Cronin's management, preliminary valuation analyses and due diligence which are reflected in the Unaudited Pro Forma Condensed Combined Financial Statements. Any increases or decreases in the fair value of relevant balance sheet amounts upon completion of the final valuations will result in differences from the Unaudited Pro Forma Condensed Combined Balance Sheet and Statements of Operations and these differences may be material.
    Assumptions and estimates underlying the unaudited adjustments to the pro forma condensed combined financial information (the "pro forma adjustments") are described in the accompanying notes. The historical consolidated financial statements have been adjusted in the unaudited pro forma condensed combined financial information to give effect to pro forma events that are: (1) directly attributable to the Acquisition; (2) factually supportable; and (3) with respect to the Unaudited Pro Forma Condensed Combined Statement of Operations, expected to have a continuing impact on the combined results following the Acquisition. The unaudited pro forma condensed combined financial information has been presented for illustrative purposes only and is not necessarily indicative of the operating results and financial position that would have been achieved had the Acquisition occurred on the date indicated. Further, the unaudited pro forma condensed combined financial information does not purport to project the future operating results or financial position of the combined company following the Acquisition.
    1

    These Unaudited Pro Forma Condensed Combined Financial Statements have been derived from, and should be read in conjunction with:
    The audited consolidated financial statements of Dynatronics as of and for the year ended June 30, 2017, as contained on Form 10-K filed on September 27, 2017;
    The audited financial statements of Cronin as of and for the years ended September 30, 2016 and 2015, and the unaudited financial statements of Cronin as of and for the nine-months ended June 30, 2017 and 2016, attached as an exhibit to this Form 8-K of Dynatronics filed on October 6, 2017.

    The Unaudited Pro Forma Condensed Combined Financial Statements do not reflect the costs of any integration activities or any future cost savings from combined operations pursuant to the Acquisition. Although Dynatronics believes that there will be integration costs and that cost savings will be realized following the Acquisition, there can be no assurance that these costs savings will be achieved in full or at all. In addition, the Unaudited Pro Forma Condensed Combined Statements of Operations do not include other one-time costs directly attributable to the Acquisition or professional fees incurred by Dynatronics or Cronin pursuant to provisions contained in the Asset Purchase Agreement as those costs are not considered part of the purchase price nor are they expected to have a continuing impact on the combined company.
    To effect this transaction the sellers received, or may receive at a future date, 1,581,935 shares of Series D 6% Non-Voting Convertible Preferred Stock ("Series D Preferred") valued at $4,000,000 and approximately $11,500,000 in cash, with approximately $4,900,000 of the cash provided from a loan facility and approximately $7,000,000 ($6,600,000, net of issuance costs) provided through the issuance of 2,800,000 units, with each unit comprised of one share of Series C 6% Non-Voting Convertible Preferred Stock ("Series C Preferred") and 0.5 warrants to purchase shares of Common Stock (a total of 2,800,000 shares of Series C Preferred and 1,400,000 warrants to purchase shares of Common Stock).
    2


    Dynatronics Corporation
    Unaudited Pro Forma Condensed Combined Statement of Operations
    Year Ended June 30, 2017
      
    Historical
     Cronin (2)
      
    Historical
    Dynatronics
      
    Acquisition & Financing
    Adjustments (1)
     
    Note
    References
      
    Pro Forma
     Combined
     
    Net sales $24,269,347  $35,758,330  $-    $60,027,677 
    Cost of sales  15,361,954   24,249,832   -     39,611,786 
    Gross profit  8,907,393   11,508,498   -     20,415,891 
    Operating Expenses                  
      Selling, general and administrative  6,695,206   12,101,539   380,000 6a, 6i, 6k  19,176,745 
      Research and development  -   1,081,373   -     1,081,373 
      Depreciation  81,894   -   -     81,894 
      Total operating expenses  6,777,100   13,182,912   380,000     20,340,012 
    Operating Income (Loss)  2,130,293   (1,674,414)  (380,000)    75,879 
    Other Income (Expense)                  
      Interest expense  -   (277,630)  (170,000)6b  (447,630)
      Interest income  -   508   -     508 
      Other, net  151   85,141   -     85,292 
      Total other income (expense), net  151   (191,981)  (170,000)    (361,830)
    Income (Loss) Before Income Taxes  2,130,444   (1,866,395)  (550,000)    (285,951)
      Income tax expense  -   -   - 6c  - 
    Net Income (Loss)  2,130,444   (1,866,395)  (550,000)    (285,951)
      Deemed preferred stock dividends  -   (1,944,223)  (530,000)6d  (2,474,223)
      Stock and cash dividends  -   (482,510)  (110,000)6e  (592,510)
    Net Income (Loss) Attributable to Common Stockholders $2,130,444  $(4,293,128) $(1,190,000)   $(3,352,684)
    Earnings (Loss) per Share-Basic     $(1.36)    6f $(0.44)
    Earnings (Loss) per Share-Diluted     $(1.36)    6f $(0.44)
    Weighted Average Shares Outstanding-Basic      3,152,425   4,381,935 6f  7,534,360 
    Weighted Average Shares Outstanding-Diluted      3,152,425   4,381,935 6f  7,534,360 

    (1)  See Note 6 to the Unaudited Pro Forma Condensed Combined Financial Statements
    (2)  See Note 7 to the Unaudited Pro Forma Condensed Combined Financial Statements

    3


    Dynatronics Corporation
    Unaudited Pro Forma Condensed Combined Balance Sheet
    As of June 30, 2017
      Historical Cronin  Historical Dynatronics  Acquisition & Financing Adjustments (1)  Note References  Pro Forma Combined 
    Assets:               
    Cash and cash equivalents $1,365,175  $254,705  $(1,365,175) 6g $254,705 
    Accounts receivable, net  1,950,927   5,281,348   -      7,232,275 
    Other receivables  -   33,388   -      33,388 
    Inventories, net  5,570,182   7,397,682   -      12,967,864 
    Prepaid expenses and other  10,033   503,800   -      513,833 
    Total current assets  8,896,317   13,470,923   (1,365,175)     21,002,065 
    Property and equipment, net  887,382   4,973,477   -      5,860,859 
    Intangible assets, net  -   2,754,118   4,000,000  6a  6,754,118 
    Goodwill  -   4,302,486   4,013,474  5   8,315,960 
    Other assets  227,358   562,873   -      790,231 
    Total assets $10,011,057  $26,063,877  $6,648,299     $42,723,233 
                        
    Liabilities and Stockholders' Equity:                   
    Liabilities:                   
    Accounts payable  948,868   2,334,563   -      3,283,431 
    Accrued payroll and benefits expense  -   1,472,773   -      1,472,773 
    Accrued expenses  210,488   656,839   -      867,327 
    Income tax payable  -   8,438   -      8,438 
    Warranty reserve  -   202,000   -      202,000 
    Line of Credit  -   2,171,935   4,900,000  6b  7,071,935 
    Current portion of acquisition holdback  -   294,744   -      294,744 
    Current portion of long-term debt  -   151,808   -      151,808 
    Current portion of capital leases  -   193,818   -      193,818 
    Current portion of deferred gain  -   150,448   -      150,448 
    Total current liabilities  1,159,356   7,637,366   4,900,000      13,696,722 
    Long-term debt, net of current portion  -   461,806   -      461,806 
    Capital lease, net of current portion  -   3,087,729   -      3,087,729 
    Deferred gain, net of current portion  -   1,680,001   -      1,680,001 
    Acquisition holdback, net of current portion      750,000   -      750,000 
    Deferred rent  -   122,585   -      122,585 
    Total liabilities  1,159,356   13,739,487   4,900,000      19,798,843 
                        
    Commitments and Contingencies                   
                        
    Stockholders' Equity:                   
    Preferred stock  -   8,501,295   10,600,000  6j  19,101,295 
    Common stock  10,875   11,838,022   (10,875) 6j  11,838,022 
    Additional paid-in capital  46,278   -   (46,278) 6j  - 
    Retained Earnings/(Accumulated deficit)  8,794,548   (8,014,927)  (8,794,548) 6j  (8,014,927)
    Total equity  8,851,701   12,324,390   1,748,299      22,924,390 
    Total liabilities and equity $10,011,057  $26,063,877  $6,648,299     $42,723,233 

    (1)See Notes 5 and 6 to the Unaudited Pro Forma Condensed Combined Financial Statements

    4


    Dynatronics Corporation
    Notes to Pro Forma Condensed Combined Financial Statements
    (Unaudited)
    Note 1 - Description of Acquisition
    On September 26, 2017, Dynatronics Corporation ("Dynatronics" or the "Company") entered into an agreement (the "Asset Purchase Agreement") to acquire substantially all the assets of Bird & Cronin, Inc. ("Cronin"). At the time of closing (the "Closing") on October 2, 2017, the purchase price for the Company's acquisition of Cronin's assets (the "Acquisition") totals approximately $15,500,000, with the final purchase price subject to adjustments as the result of an $1,000,000 earn-out provision and as may otherwise be required by the Asset Purchase Agreement and indemnification claims, if any (the "Purchase Price").
    Note 2 - Basis of Presentation
    The Unaudited Pro Forma Condensed Combined Financial Statements are prepared in accordance with Article 8, rule 8-05, of the Securities and Exchange Commission Regulation S-X. The historical financial information has been adjusted to give effect to the transactions that are (i) directly attributable to the Acquisition, (ii) factually supportable and (iii) with respect to the Unaudited Pro Forma Condensed Combined Statements of Operations, expected to have a continuing impact on the operating results of the combined company. The historical information of Dynatronics and Cronin is presented in accordance with generally accepted accounting principles in the United States of America ("U.S. GAAP"), except that it does not contain all of the note disclosures normally required by U.S. GAAP.
    Note 3 - Reclassifications and Conforming Accounting Policies and Classifications
    Following the Acquisition, Dynatronics will conduct a review of Cronin's accounting policies in an effort to determine if any differences require reclassification of Cronin's results of operations or reclassification of assets or liabilities to conform to Dynatronics' accounting policies and classifications. As a result of that review, Dynatronics may identify differences between the accounting policies and classifications of the two companies that, when conformed, could have a material impact on these Unaudited Pro Forma Condensed Combined Financial Statements. At this time Dynatronics is not aware of any differences that would have a material impact on the Unaudited Pro Forma Condensed Combined Financial Statements.
    Note 4 - Calculation of Preliminary Estimated Purchase Price and Transaction Financing
    To effect this transaction the sellers received, or may receive at a future date, 1,581,935 shares of Series D Preferred valued at $4,000,000 and approximately $11,500,000 in cash, with approximately $4,900,000 of the cash provided from a loan facility and approximately $7,000,000 ($6,600,000, net of issuance costs) provided through the issuance of 2,800,000 units, with each unit comprised of one share of Series C Preferred and 0.5 warrants to purchase shares of Common Stock (a total of 2,800,000 shares of Series C Preferred and 1,400,000 warrants to purchase shares of Common Stock).
    Note 5 - Preliminary Estimated Purchase Price Allocation
    Under the acquisition method of accounting, the total purchase price, which equals fair value, is allocated to the tangible and identifiable intangible assets acquired and liabilities assumed based on their estimated fair values as of the date of the acquisition. Dynatronics has performed a preliminary estimate of the fair market value of Cronin's tangible and intangible assets and liabilities.
    The table below represents management's preliminary estimated fair value allocation of the total estimated consideration to Cronin's tangible and intangible assets and liabilities as of June 30, 2017:
    Total consideration $15,500,000 
    Tangible net assets acquired  (7,486,526)
    Identifiable intangible assets acquired  (4,000,000)
    Consideration allocated to goodwill $4,013,474 
    5

    Dynatronics Corporation
    Notes to Pro Forma Condensed Combined Financial Statements
    (Unaudited)
    Note 5 - Preliminary Estimated Purchase Price Allocation (Continued)
    This preliminary estimated purchase price allocation has been used to prepare pro forma adjustments in these Unaudited Pro Forma Condensed Combined Financial Statements. Upon completion of the fair value assessment after the Closing, it is anticipated that the final purchase price allocation will differ from the preliminary assessment outlined above. Any changes to the initial estimates of the fair value of assets and liabilities that are made within the measurement period, which will not exceed one year from the Closing, will be recorded as adjustments to those assets and liabilities and residual amounts will be allocated to goodwill.
    Note 6 - Pro Forma Adjustments
    The Unaudited Pro Forma Condensed Combined Statements of Operations do not include any material non-recurring charges directly attributable to the Acquisition that will arise in subsequent periods. In addition, the Unaudited Pro Forma Condensed Combined Financial Statements do not reflect the costs of any integration activities including any benefits that may result from realization of future cost savings from operating efficiencies or revenue synergies expected to result from the Acquisition. The Unaudited Pro Forma Condensed Combined Financial Statements reflect the following adjustments:
     (a) Tangible and Intangible Assets – Fair Value Adjustments
    The preliminary valuation identified that the total fair value for the property and equipment acquired approximated Cronin's net carrying value, at cost less accumulated depreciation, at June 30, 2017. As a result, no pro forma fair value increase or decrease to property and equipment or depreciation expense was assumed as of and for the year ended June 30, 2017.
    The preliminary valuation identified intangible assets consisting of customer relationships, covenant not to compete and trademarks/tradenames. The fair value of acquired intangible assets was estimated by management at $4,000,000. The calculation of these fair values is preliminary and subject to change. The following table summarizes the estimated fair values of Cronin's identifiable intangible assets and their estimated useful lives and uses a straight-line method of amortization as of and for the year ended June 30, 2017:
      
    Estimated
    Fair Value
      
    Estimated Useful
    Life in Years
      
    Amortization Expense
    for the Year Ended
    June 30, 2017
     
    Customer relationships $2,800,000   10  $280,000 
    Covenant not to compete  500,000   5   100,000 
    Trademarks/tradenames  700,000   10   70,000 
    Pro forma adjustments to intangible assets $4,000,000      $450,000 
     (b) Debt and Interest Expense
    The Loan Facility provides approximately $4,900,000 to partially finance the transaction, which is reflected as an adjustment to the Unaudited Pro Forma Condensed Combined Balance Sheet as of June 30, 2017.
    The Loan Facility is expected to bear interest at approximately 3.47%.

    The Unaudited Pro Forma Condensed Combined Statements of Operations reflect an adjustment to interest expense related to the Loan Facility for year ended June 30, 2017, of approximately $170,000.
    6


    Dynatronics Corporation
    Notes to Pro Forma Condensed Combined Financial Statements
    (Unaudited)

     (c) Income Tax Expense/Benefit
    Prior to the Acquisition, Cronin was not required to provide for income taxes as it was treated as a pass-through entity for U.S. federal and state income tax purposes. Federal and state income taxes were assessed at the owner level and each owner was liable for its own tax payments. The Pro Forma Unaudited Statement of Operations do not reflect an adjustment to income tax expense/benefit for year ended June 30, 2017, because the combined operations generated a loss. No deferred income tax asset is recorded because the accounting criteria to record such assets has not been met.

     (d) Deemed Preferred Stock Dividend Associated with Beneficial Conversion Feature

    Reflects deemed dividends associated with the issuance of the Series C Preferred and Series D Preferred with a combined beneficial conversion feature of approximately $530,000 for the year ended June 30, 2017.

     (e) Preferred Stock Dividends paid in Common Stock
    Reflects preferred stock dividends paid in cash with respect to the Series C Preferred and Series D Preferred of approximately $110,000 for the year ended June 30, 2017 reflecting required dividends for the estimated two month period from issuance of the preferred stock to conversion to Common Stock which will occur automatically upon voter approval.
     (f) Loss Per Share
    Reflects an adjustment to increase basic and diluted weighted average shares in connection with the issuance of 4,381,935 shares of Series C Preferred and Series D Preferred as part of the transaction. While the preferred shares would be anti-dilutive, they are included because the Company expects them to automatically convert to Common Stock upon shareholder approval in approximately two months from the time of issuance.  Common Stock warrants issued as part of the offering are not included as they would be anti-dilutive.

     (g) Cash
    Represents adjustments to cash to reflect estimated cash receipts and payments related to the Acquisition as of June 30, 2017, as follows:
    Receipts:   
    Issuance of debt $4,900,000 
    Issuance of preferred stock, net of issuance costs  6,600,000 
    Payments:    
    Distribution of Cash on hand to Seller  (1,365,175)
    Cash consideration for acquisition  (11,500,000)
    Net pro forma adjustments to cash and cash equivalents $(1,365,175)
     (h) Building and Lease Expense
    The Company entered into a lease agreement for the building and related improvements that includes a lease cost that approximates the lease expense included in the Cronin Pro Forma Condensed Combined Statement of Operations for the year ended June 30, 2017.
     (i) Transaction Expenses
    Reflects an adjustment of approximately $70,000 to remove transaction expenses recorded for the year ended June 30, 2017.
    7


    Dynatronics Corporation
    Notes to Pro Forma Condensed Combined Financial Statements
    (Unaudited)

    (j) Stockholders' Equity
    Reflects the issuance of approximately $6,600,000 of Series C Preferred (net of issuance costs) and $4,000,000 of Series D Preferred.  Additionally, reflects the elimination of the historical Common Stock and retained earnings of Cronin of $57,153 and $8,794,548, respectively, as of June 30, 2017.

     (k) Summary of Pro Forma Adjustments Affecting Selling, General and Administrative Expenses

    The table below summarizes all the pro forma entries, outlined above, that affect selling, general and administrative expenses for year ended June 30, 2017:
    Selling, General and Administrative Expenses 
    Year Ended
    June 30, 2017
     
    Add:   
    Amortization Expense $450,000 
    Remove:    
    Transaction Related Expense  (70,000)
       Net pro forma adjustments to selling, general and administrative expenses $380,000 

    Note 7 - Basis of the Cronin Statements of Operations within the Unaudited Pro Forma Condensed Combined Financial Statements
    For the purposes of the Unaudited Pro Forma Condensed Consolidated Financial Statements, information for Cronin has been obtained from the unaudited financial statements of Cronin for the nine-months ended June 30, 2017, and the unaudited financial statements of Cronin for the three months ended September 30, 2016. Cronin's unaudited statement of operations for the year ended June 30, 2017, has been constructed as follows:
      
    Three Months
    Ended
    September 30,
    2016
      
    Nine Months
    Ended
    June 30,
    2017
      
    Year Ended
    June 30,
    2017
     
      (a)  (b)  (a) + (b) 
    Net sales $6,346,084  $17,923,263  $24,269,347 
    Cost of sales  4,019,522   11,342,432   15,361,954 
                   Gross profit  2,326,562   6,580,831   8,907,393 
    Operating Expenses            
    Selling, general and administrative  1,577,078   5,118,128   6,695,206 
    Research and development  -   -   - 
    Depreciation  22,559   59,335   81,894 
    Total operating expense  1,599,637   5,177,463   6,777,100 
    Operating Income  726,925   1,403,368   2,130,293 
    Other Income  48   103   151 
    Income Before Income Taxes  726,973   1,403,471   2,130,444 
    Income tax expense  -   -   - 
    Net Income $726,973  $1,403,471  $2,130,444 

    8